logotest1logotest1logotest1logotest1
  • SHOP
  • COMBOS
  • TESTIMONIALS
  • CART
  • INGREDIENTS
    • 2-DEOXY-D-GLUCOSE (2DG)
    • ACACIA CYANOPHYLLA FLOWER
    • ACORI GRAMINEI RHIZOMA
    • AEGLE MARMELOS CORREA
    • AGARICUS BLAZEI
    • AGED GARLIC EXTRACT
    • AFRAMOMUM MELEGUETA
    • ALOE ARBORESCENS
    • ALBIZIA
    • ALPINIA OFFICINARUM
    • ALTERNANTHERA SESSILIS
    • AMERICAN GINSENG
    • AMYGDALIN
    • ANACYCLUS PYRETHRUM
    • ANGELICA ARCHANGELICA
    • ANGELICA SINENSIS
    • ANTRODIA
    • APIGENIN
    • ARTICHOKE LEAF
    • ARTOCARPIN
    • AJUGA TURKESTANICA
    • ASHWAGANDHA
    • ASPALATHIN
    • ASTRAGALUS COMPLANATUS
    • AVENA SATIVA
    • BACOPA MONNIERI
    • BAVACHIN
    • BEE POLLEN
    • BETULINIC ACID
    • BOSWELLIC ACID
    • BREVILIN A
    • CAMPESTEROL
    • CAPSAICIN
    • CARCININE
    • CASTICIN
    • CHRYSIN
    • CIANIDANOL
    • CINNAMOMUM ZEYLANICUM
    • CITRULLUS COLOCYNTHIS
    • CITRUS RETICULATA PEEL
    • CODONOPSIS
    • CONJUGATED LINOLEIC ACID
    • COSTUNOLIDE
    • CYANIDIN
    • CUCURBITACIN D
    • DAIDZEIN
    • DECURSIN
    • DELPHINIDIN
    • DIGITALIS PURPREA (DIGOXIN)
    • DIOSMIN
    • ECKLONIA CAVA
    • ELLAGIC ACID
    • EMBELIN
    • ERIODICTYOL
    • GALLIC ACID
    • GLYCITEIN
    • GLYCYRRHIZIN
    • HYPERFORIN
    • ICARIIN
    • ISORHAMNETIN
    • ISOORIENTIN
    • ISOVITEXIN
    • JACEOSIDIN
    • KAEMPFEROL
    • KIGELIA AFRICANA
    • KURARINONE
    • LEMON BALM
    • LICORICIDIN
    • LIPOIC ACID
    • LUPEOL
    • MAGNOLOL
    • MENAQUINONE 4
    • MULBERRY LEAF
    • NARINGENIN
    • NOBILETIN
    • OLEACEIN
    • OLEANOLIC ACID
    • OLIVE OIL
    • ORIDONIN
    • PARTHENOLIDE
    • PHLOROGLUCINOL
    • PHLORIZIN
    • PICEATANNOL
    • PRISTIMERIN
    • PROANTHOCYANIDINS
    • PROCYANIDIN B3
    • PSEUDOLARIC ACID B
    • PTEROSTILBENE
    • RUTIN
    • SOLIDAGO VIRGAUREA
    • TANGERETIN
    • TARAXASTEROL
    • TRICHOSTATIN A
    • WEDELOLACTONE
    • WOGONIN
    • YERBA MATE
  • ABOUT
  • SCIENTIFIC STUDIES
    • ADAPTOGENS
    • ADIPOCYTE APOPTOSIS (KILLING FAT CELLS)
    • ADDICTION & THE BRAIN
    • ADDICTION & STRESS
    • ADDICTION WITHDRAWAL
    • ADIPOCYTE DEDIFFERENTIATION (THE REVERSAL OF FAT FORMATION)
    • ADIPOCYTE DIFFERENTIATION
    • ADROPIN
    • ALLERGIES & CYTOKINES
    • ALDOSTERONE & OBESITY/HYPERTENSION
    • ALZHEIMER’S, DEMENTIA, PARKINSON’S
    • ANTI-ACNE EFFECT OF FLAVONOIDS AND POLYPHENOLS
    • ADVANCED GLYCATION END PRODUCTS (AGES)
    • ADDICTION TREATMENT
    • ADDICTION & DOPAMINE
    • AMPK
    • ANTI AGING
    • ANTIAGING EFFECTS OF COFFEE
    • ANTI-AGING EFFECTS OF FLAVONOIDS & POLYPHENOLS
    • ANTI-APOPTOTIC PATHWAYS
    • ANTI ATHEROGENIC
    • ANTI-CANCER EFFECTS OF FLAVONOIDS & POLYPHENOLS
    • ANTI CARIOGENIC (Protecting From Tooth Decay)
    • ANTI COVID-19 EFFECTS OF MEDICINAL PLANTS, FLAVONOIDS & POLYPHENOLS
    • ANTI GLYCATIVE
    • ANTI GLYCATION AGENTS
    • ANTI-INFLAMMATORY EFFECTS OF FLAVONOIDS & POLYPHENOLS
    • ANTI-VIRAL EFFECTS OF FLAVONOIDS & POLYPHENOLS
    • ANTI WRINKLE AGENTS
    • ANXIOGENIC
    • ANXIOLYTIC
    • APOPTOSIS
    • APOPTOSIS IN 3T3-L1
    • AUTOPHAGY
    • BCL-2
    • BCL-W
    • BCL-XL
    • BDNF
    • BECLIN-1 & AUTOPHAGY
    • BH3 MIMETICS
    • BIM aka BCL2L11
    • BIOMIMETIC HYDROXYAPATITE
    • BMI-1
    • BPA & OBESITY
    • BRASSINOSTEROIDS
    • CALORIE RESTRICTION
    • CALORIE RESTRICTION & LIFESPAN EXTENSION
    • CARBAMYLATION
    • CARBONYL SCAVENGER
    • CARBONYL STRESS
    • CARDIOPROTECTIVE AGENTS
    • CARDIAC GLYCOSIDES
    • CATALASE
    • CELL CYCLE ARREST
    • CENTENARIANS
    • CDK5
    • CHOLESTEROL EFFLUX
    • COGNITIVE ENHANCEMENT
    • COLD SHOCK PROTEINS
    • COLD-INDUCIBLE RNA-BINDING PROTEIN (CIRBP) & DNA REPAIR
    • CONDITIONED PLACE PREFERENCE
    • CORTICOTROPIN RELEASING FACTOR
    • CRYOTHERAPY
    • CRYOLIPOLYSIS: FREEZING FAT TO DEATH
    • CYP2E1
    • CYTOKINES IN PAIN, INFLAMMATION & AGING
    • DAF-16
    • DEPERSONALIZATION
    • DIABETES & CANCER
    • DIHYDROTESTOSTERONE (DHT)
    • DNA METHYLATION & AGING
    • DNA REPAIR
    • DNA REPAIR VIA FLAVONOIDS & POLYPHENOLS
    • DRY FASTING AND FLUID RESTRICTION FASTING
    • DYNORPHIN
    • ELLAGITANNINS
    • ENDOCRINE DISRUPTING CHEMICALS
    • ENLARGED HEART AND CARDIOMEGALY
    • EPIGENETIC ALTERATIONS
    • EPIGENETIC MODIFIERS
    • EPINEPHRINE
    • ERGOGENIC AGENTS (INCREASE ATHLETIC PERFORMANCE)
    • EXCITOXICITY & THE BRAIN
    • EXTRACELLULAR MATRIX STIFFENING (10TH HALLMARK OF AGING)
    • EXTRACELLULAR MICROVESICLES
    • EXTENDS LIFESPAN
    • EXTINCTION TRAINING
    • FASTING & THE BRAIN
    • FASTING & CANCER
    • FASTING MIMICKING DIET
    • FEAR EXTINCTION
    • FGF21
    • FLAVONES
    • GABA (γ-AMINOBUTYRIC ACID)
    • GALLOTANNINS
    • GLUCONEOGENESIS
    • GLUCOCORTICOID RECEPTOR ACTIVATION
    • GLUTAMATE & BRAIN
    • GLYCATION
    • GUT BRAIN AXIS
    • GYPENOSIDE
    • KLOTHO
    • K OPIOD RECEPTOR & ADDICTION
    • FASTING, CALORIE RESTRICTION & EXTENDING LIFESPAN
    • FGF21
    • FOXO3
    • FOXO4
    • HALLMARKS OF AGING
    • HAIR GROWTH
    • HAIR REGENERATION
    • HAIR REPIGMENTATION
    • HEPATOPROTECTIVE AGENTS (KEEPING LIVER HEALTHY)
    • HMGB1
    • HORMESIS
    • HPA AXIS
    • HSP70, THE ANTI-AGING PROTEIN
    • HSP90 INHIBITORS
    • HYPERGLYCEMIA
    • HYPERALGESIA
    • HYPERINSULINEMIA
    • HYPOTHALAMIC PITUITARY ADRENAL HPA AXIS
    • HYPOACTIVE SEXUAL DESIRE (WHY PEOPLE HAVE ZERO SEX DRIVE)
    • HYPOCRETIN OREXIN
    • IKK
    • IL-6/STAT3
    • IRISIN
    • ISOFLAVONES
    • IMMUNOSENESCENCE
    • INHIBITION OF ADVANCED GLYCATION END PRODUCTS
    • INCREASE PROTEIN SYNTHESIS
    • INCREASES SPERMATOGENESIS
    • INFECTOBESITY
    • INFLAMMATION & ANXIETY
    • INFLAMMATION & CANCER
    • INFLAMMATION & DEPRESSION
    • INFLAMMATION & OBESITY
    • INFLAMMAGING
    • INHIBITION OF RENAL GLUCOSE REABSORPTION
    • INSULIN & AGING
    • INSULIN & CANCER: HOW INSULIN LITERALLY PROTECTS CANCER CELLS FROM BEING KILLED
    • INSULIN & MTOR
    • INSULIN & OBESITY
    • INSULIN OXIDATIVE STRESS
    • INTERMITTENT FASTING
    • JAK INHIBITION ALLEVIATES SASP
    • JNK ACTIVATION PREVENTS PREMATURE SENESCENCE
    • KETONE BODIES
    • KETOGENIC DIET
    • LACTOBACILLUS REUTERI
    • LACTOFERRIN
    • LEYDIG CELL STEROIDOGENESIS
    • LIFESPAN EXTENSION
    • LIVER REGENERATION
    • LIPOLYTIC AGENTS
    • LIPID DROPLETS
    • LIPOLYSIS (THE DECOMPOSITION OF BODY FAT)
    • LOWERING CHOLESTEROL THRU FASTING, DIET & MEDICINAL PLANTS
    • MATRIX METALLOPROTEINASES (MMPs)
    • MCL-1
    • MDM2 INHIBITION AS SASP INHIBITOR
    • MEDICINAL MUSHROOMS
    • MEDITERRANEAN DIET
    • METABOLIC REPROGRAMMING
    • METABOLIC SYNDROME
    • METHIONINE RESTRICTION
    • MITOCHONDRIAL UNCOUPLING
    • MONKEYPOX
    • MSG (MONOSOSODIUM GLUTAMATE)
    • MUSCLE FORCE PRODUCTION
    • MUSCLE ATROPHY (PREVENTING)
    • MYOGENESIS
    • MYOSTATIN INHIBITION
    • MYOSTATIN INHIBITION PRESERVES MUSCLE
    • mTORC2
    • mTOR: THE RAPID AGING PATHWAY
    • NATURAL ANTICOAGULANTS
    • NATURAL AROMATASE INHIBITORS
    • NEUROGENESIS (GROWING NEW BRAIN CELLS)
    • NEUROCHEMISTRY OF ADDICTION
    • NEUROPLASTICITY
    • NEUROINFLAMMATION
    • NEUROPROTECTIVE AGENTS
    • NEUTRALIZING OXIDATIVE STRESS WITH MEDICINAL PLANTS
    • NMDA & ANXIETY & DEPRESSION
    • NMDA RECEPTOR & FEAR
    • NON OPIOD ANALGESICS
    • NOOTROPICS
    • NORADRENERGIC
    • NOREPINEPHRINE
    • NRF2: MASTER REGULATOR OF THE AGING PROCESS
    • NF-KB
    • OBESOGENS
    • ONCOGENE ACTIVATION INDUCED SENESCENCE
    • ORGANOTINS
    • OVERNUTRITION
    • OXIDATIVE STRESS & AGING
    • P16INK4A
    • P38MAPK
    • P53: TUMOR SUPRESSOR
    • PERIODONTITIS
    • PHOSPHATIDYLINOSITOL 3 KINASE
    • PHYTOCHEMICALS
    • PHYTOSTEROLS
    • PHYTOSTANOLS
    • PHYTOECDYSTEROIDS
    • PROANTHOCYANIDINS
    • PROTEIN CARBONYLATION
    • POLYAMINES & THEIR EFFECT ON BRAIN (NMDA, DEPRESSION, SUICIDE RISK)
    • POLYPHENOLS AS COVID-19 TREATMENT & PREVENTION
    • PPARY2
    • PREMATURE SENESCENCE
    • PREVENTING SKIN AGING
    • PUFAS
    • PURGATIVES
    • RAPAMYCIN (MTOR INHIBITION)
    • RED WINE
    • RENAL (KIDNEY) PROTECTIVE AGENTS
    • REMINERALIZATION OF TEETH
    • REPAIR OF DNA BREAKS “DOUBLE STRAND”
    • RESTORE INSULIN SENSITIVITY
    • REVERSAL OF OBESITY
    • SASP & ADIPOSE TISSUE
    • SEX HORMONE BINDING GLOBULIN
    • SENESCENT CELLS, SASP & SENOLYTICS
    • SENESCENCE-BETA-GALACTOSIDASE (SA-β-gal or SABG)
    • SGLT2 INHIBITORS
    • SGLT2 INHIBITION FOR LIFESPAN EXTENSION
    • SHBG
    • SIRT1
    • SKELETAL MUSCLE HYPERTROPHY (THE SCIENCE OF BUILDING MUSCLE)
    • SKIN ELASTICITY
    • SKIN PHOTOAGING (Preventing & Repairing)
    • SLEEP DEPRIVATION AS THERAPY FOR DEPRESSION
    • SIRT1 & LONGEVITY
    • SMALLPOX
    • SUGAR & AGING
    • STAR PROTEIN
    • STAT3
    • STEM CELL EXHAUSTION
    • STEM CELL REGENERATION
    • STEM CELL THERAPY
    • STIMULATED LIPOLYSYS
    • STEROIDOGENESIS (THE PRODUCTION OF HORMONES IN BODY)
    • STREPTOCOCCUS MUTANS (MAIN BACTERIA BEHIND TOOTH DECAY)
    • STRESS & AGING
    • STRESS & THE BRAIN
    • TELOMERE SHORTENING & PREMATURE AGING
    • TIME RESTRICTED FEEDING
    • THROMBOLYTICS (PLANT BASED)
    • TRAUMATIC BRAIN INJURY (HEALING)
    • TRYPTOPHAN HYDROXYLASE 2
    • VISCERAL ADIPOSITY
    • XENOBIOTICS
    • XENOESTROGEN
  • HOME
  • CONTACT
  • INTERSTELLAR 88/8: EXTREME WEIGHTLOSS PROTOCOL
  • The Ultimate Dry Fasting Resource
0

$0.00

✕
blank
OVERNUTRITION
September 21, 2021
blank
TIME RESTRICTED FEEDING
December 21, 2021
Post Views: 0
  1. APIGENIN: a promising molecule for cancer prevention
  2. APIGENIN and cancer chemoprevention: progress, potential and promise
  3. APIGENIN and its impact on gastrointestinal cancers
  4. APIGENIN suppresses cancer cell growth through ERβ
  5. Measurement and correlation of solubilities of APIGENIN and APIGENIN 7-O-rhamnosylglucoside in seven solvents at different temperatures
  6. Behavioral characterisation of the flavonoids APIGENIN and chrysin
  7. Evaluation of properties of APIGENIN and [G-3H] APIGENIN and analytic method development
  8. Flavonoids APIGENIN and quercetin inhibit melanoma growth and metastatic potential
  9. Cytotoxicity of APIGENIN on leukemia cell lines: implications for prevention and therapy
  10. Pharmacological profile of APIGENIN, a flavonoid isolated from Matricaria chamomilla
  11. Cell‐cycle arrest at G2/M and growth inhibition by APIGENIN in human colon carcinoma cell lines
  12. Bioavailability of APIGENIN from apiin-rich parsley in humans
  13. Influence of APIGENIN on gtf Gene Expression in Streptococcus mutans UA159
  14. APIGENIN induced apoptosis through p53-dependent pathway in human cervical carcinoma cells
  15. Anti-mutagenesis and anti-promotion by APIGENIN, robinetin and indole-3-carbinol
  16. APIGENIN inhibits tumor angiogenesis through decreasing HIF-1α and VEGF expression
  17. Protective role of APIGENIN on the status of lipid peroxidation and antioxidant defense against hepatocarcinogenesis in Wistar albino rats
  18. Anti-proliferative effect of APIGENIN and its apoptotic induction in human Hep G2 cells
  19. Selective growth-inhibitory, cell-cycle deregulatory and apoptotic response of APIGENIN in normal versus human prostate carcinoma cells
  20. APIGENIN inhibits VEGF and HIF‐1 expression via PI3K/AKT/p70S6K1 and HDM2/p53 pathways
  21. Synergistic effects of APIGENIN and paclitaxel on apoptosis of cancer cells
  22. Suppression of inducible cyclooxygenase and inducible nitric oxide synthase by APIGENIN and related flavonoids in mouse macrophages
  23. APIGENIN-induced-apoptosis is mediated by the activation of PKCδ and caspases in leukemia cells
  24. Metabolism of APIGENIN and related compounds in the rat. Metabolite formation in vivo and by the intestinal microflora in vitro
  25. Pharmacokinetics and metabolism of APIGENIN in female and male rats after a single oral administration
  26. APIGENIN acts on the tumor cell invasion process and regulates protease production
  27. Neuroprotective, anti-amyloidogenic and neurotrophic effects of APIGENIN in an Alzheimer’s disease mouse model
  28. Metabolism of APIGENIN by rat liver phase I and phase II enzymes and by isolated perfused rat liver
  29. Inhibitory effect of APIGENIN, a plant flavonoid, on epidermal ornithine decarboxylase and skin tumor promotion in mice
  30. Induction of p21/WAF1 and G1 cell‐cycle arrest by the chemopreventive agent APIGENIN
  31. Effects of the flavonoids quercetin and APIGENIN on hemostasis in healthy volunteers: results from an in vitro and a dietary supplement study
  32. APIGENIN, a component of Matricaria recutita flowers, is a central benzodiazepine receptors-ligand with anxiolytic effects
  33. The chemopreventive flavonoid APIGENIN induces G2/M arrest in keratinocytes
  34. APIGENIN induces apoptosis in human leukemia cells and exhibits anti-leukemic activity in vivo
  35. Antiadipogenic effect of dietary APIGENIN through activation of AMPK in 3T3-L1 cells
  36. Signal pathways involved in APIGENIN inhibition of growth and induction of apoptosis of human anaplastic thyroid cancer cells (ARO).
  37. Vasodilatory action mechanisms of APIGENIN isolated from Apium graveolens in rat thoracic aorta
  38. Anti-hyperglycemic action of APIGENIN-6-C-β-fucopyranoside from Averrhoa carambola
  39. APIGENIN inhibits expression of vascular endothelial growth factor and angiogenesis in human lung cancer cells: implication of chemoprevention of lung cancer
  40. Biopharmaceutics classification and intestinal absorption study of APIGENIN
  41. Enhanced anti-tumor effect of combination therapy with gemcitabine and APIGENIN in pancreatic cancer
  42. APIGENIN-induced prostate cancer cell death is initiated by reactive oxygen species and p53 activation
  43. Molecular basis for the action of a dietary flavonoid revealed by the comprehensive identification of APIGENIN human targets
  44. APIGENIN inhibits hepatoma cell growth through alteration of gene expression patterns
  45. Molecular targets for APIGENIN-induced cell cycle arrest and apoptosis in prostate cancer cell xenograft
  46. Endothelium-dependent vasorelaxant and antiproliferative effects of APIGENIN
  47. Inhibition of Streptococcus mutans biofilm accumulation and polysaccharide production by APIGENIN and tt-farnesol
  48. Preparation and in vitro evaluation of APIGENIN-loaded polymeric micelles
  49. APIGENIN induces cell cycle arrest and p21/WAF1 expression in a p53-independent pathway
  50. Study of antioxidant effect of APIGENIN, luteolin and quercetin by DNA protective method.
  51. Skin anti-inflammatory activity of APIGENIN-7-glucoside in rats.
  52. Increase in wild-type p53 stability and transactivational activity by the chemopreventive agent APIGENIN in keratinocytes
  53. APIGENIN blocks lipopolysaccharide-induced lethality in vivo and proinflammatory cytokines expression by inactivating NF-κB through the suppression of p65 …
  54. APIGENIN inhibits pancreatic cancer cell proliferation through G2/M cell cycle arrest
  55. Design and evaluation of a self-microemulsifying drug delivery system for APIGENIN
  56. Antidepressant-like behavioral and neurochemical effects of the citrus-associated chemical APIGENIN
  57. Production and characterization of antioxidant APIGENIN nanocrystals as a novel UV skin protective formulation
  58. Targeting the PI3K/Akt/mTOR axis by APIGENIN for cancer prevention
  59. Anti-inflammatory activity of structurally related flavonoids, APIGENIN, Luteolin and Fisetin
  60. Protective effect of APIGENIN on radiation-induced chromosomal damage in human lymphocytes
  61. Autophagy inhibition enhances APIGENIN-induced apoptosis in human breast cancer cells
  62. Induction of apoptosis by APIGENIN and related flavonoids through cytochrome c release and activation of caspase-9 and caspase-3 in leukaemia HL-60 cells
  63. Attenuation of osteoclastogenesis and osteoclast function by APIGENIN
  64. Protection of APIGENIN against kainate-induced excitotoxicity by anti-oxidative effects
  65. Study on interaction between APIGENIN and human serum albumin by spectroscopy and molecular modeling
  66. Molecular mechanisms for APIGENIN‐induced cell‐cycle arrest and apoptosis of hormone refractory human prostate carcinoma DU145 cells
  67. Effect of APIGENIN, kaempferol and resveratrol on the expression of interleukin-1beta and tumor necrosis factor-alpha genes in J774. 2 macrophages.
  68. APIGENIN induces morphological differentiation and G2-M arrest in rat neuronal cells
  69. APIGENIN (4 ‘, 5, 7-trihydroxyflavone) regulates hyperglycaemia, thyroid dysfunction and lipid peroxidation in alloxan-induced diabetic mice
  70. Flavonoid (myricetin, quercetin, kaempferol, luteolin, and APIGENIN) content of edible tropical plants
  71. Antigenotoxic effect of APIGENIN against anti-cancerous drugs
  72. Suppression of protein kinase C and nuclear oncogene expression as possible molecular mechanisms of cancer chemoprevention by APIGENIN and curcumin
  73. An increase in the luteolin: APIGENIN ratio in Marchantia polymorpha on UV-B enhancement
  74. APIGENIN inhibits growth and induces G2/M arrest by modulating cyclin-CDK regulators and ERK MAP kinase activation in breast carcinoma cells.
  75. Structure, conformation, and electronic properties of APIGENIN, luteolin, and taxifolin antioxidants. A first principle theoretical study
  76. APIGENIN modulates GABAergic and glutamatergic transmission in cultured cortical neurons
  77. APIGENIN induces apoptosis through a mitochondria/caspase-pathway in human breast cancer MDA-MB-453 cells
  78. APIGENIN suppresses the expression of VEGF, an important factor for angiogenesis, in endothelial cells via degradation of HIF-1α protein
  79. Flavonoid APIGENIN inhibits motility and invasiveness of carcinoma cells in vitro
  80. APIGENIN inhibited migration and invasion of human ovarian cancer A2780 cells through focal adhesion kinase
  81. Individual and interactive effects of APIGENIN analogs on G2/M cell-cycle arrest in human colon carcinoma cell lines
  82. Anti-inflammatory mechanisms of APIGENIN: inhibition of cyclooxygenase-2 expression, adhesion of monocytes to human umbilical vein endothelial cells, and …
  83. Metabolism of flavonoids via enteric recycling: mechanistic studies of disposition of APIGENIN in the Caco-2 cell culture model
  84. Induction of caspase-dependent, p53-mediated apoptosis by APIGENIN in human neuroblastoma
  85. APIGENIN prevents UVB-induced cyclooxygenase 2 expression: coupled mRNA stabilization and translational inhibition
  86. Stimulatory effect of genistein and APIGENIN on the growth of breast cancer cells correlates with their ability to activate ER alpha
  87. Antidepressant-like effects of APIGENIN and 2, 4, 5-trimethoxycinnamic acid from Perilla frutescens in the forced swimming test
  88. The role of APIGENIN in an experimental model of acute pancreatitis
  89. Stimulatory effect of APIGENIN-6-C-β-L-fucopyranoside on insulin secretion and glycogen synthesis
  90. Mechanisms of APIGENIN-7-glucoside as a hepatoprotective agent
  91. Protective effect of APIGENIN on ovariectomy-induced bone loss in rats
  92. Molecular targets of APIGENIN in colorectal cancer cells: involvement of p21, NAG-1 and p53
  93. APIGENIN-induced apoptosis in A375 and A549 cells through selective action and dysfunction of mitochondria
  94. APIGENIN: The Anxiolytic Constituent of Turnera aphrodisiaca.
  95. APIGENIN sensitizes colon cancer cells to antitumor activity of ABT-263
  96. Use of APIGENIN from Cordia dichotoma in the treatment of colitis
  97. Involvement of catalase in the apoptotic mechanism induced by APIGENIN in HepG2 human hepatoma cells
  98. Evaluation of APIGENIN using in vitro cytochalasin blocked micronucleus assay
  99. Absorption and Excretion of Luteolin and APIGENIN in Rats after Oral Administration of Chrysanthemum morifolium Extract
  100. The chemopreventive bioflavonoid APIGENIN modulates signal transduction pathways in keratinocyte and colon carcinoma cell lines
  101. Mechanism of action of the stimulatory effect of APIGENIN-6-C-(2 ″-O-α-l-rhamnopyranosyl)-β-l-fucopyranoside on 14C-glucose uptake
  102. D-Alanine: D-alanine ligase as a new target for the flavonoids quercetin and APIGENIN
  103. Acidichromism and ionochromism of luteolin and APIGENIN, the main components of the naturally occurring yellow weld: a spectrophotometric and fluorimetric study
  104. Enzyme assisted extraction of luteolin and APIGENIN from pigeonpea [Cajanuscajan (L.) Millsp.] leaves
  105. The bioavailability of APIGENIN-7-glucoside is influenced by human intestinal microbiota in rats
  106. Synthesis and biological evaluation of APIGENIN derivatives as antibacterial and antiproliferative agents
  107. A new cytotoxic acylated APIGENIN glucoside from Phyllanthus emblica L.
  108. Plant flavonoid APIGENIN inactivates Akt to trigger apoptosis in human prostate cancer: an in vitro and in vivo study
  109. Blockade of β-catenin signaling by plant flavonoid APIGENIN suppresses prostate carcinogenesis in TRAMP mice
  110. APIGENIN protects endothelium-dependent relaxation of rat aorta against oxidative stress
  111. Effects of APIGENIN and tt‐farnesol on glucosyltransferase activity, biofilm viability and caries development in rats
  112. APIGENIN inhibits the GLUT-1 glucose transporter and the phosphoinositide 3-kinase/Akt pathway in human pancreatic cancer cells
  113. Attenuation of oxidative damage and inflammatory responses by APIGENIN given to mice after irradiation
  114. APIGENIN induces apoptosis through proteasomal degradation of HER2/neu in HER2/neu-overexpressing breast cancer cells via the phosphatidylinositol 3-kinase/Akt …
  115. Isolation, identification and stability of acylated derivatives of APIGENIN 7-O-glucoside from chamomile (Chamomilla recutita [L.] Rauschert)
  116. Evidence for activation of mutated p53 by APIGENIN in human pancreatic cancer
  117. APIGENIN and tt-Farnesol with Fluoride Effects on S. mutans Biofilms and Dental Caries
  118. APIGENIN inhibits immunostimulatory function of dendritic cells: Implication of immunotherapeutic adjuvant
  119. APIGENIN-induced cell cycle arrest is mediated by modulation of MAPK, PI3K-Akt, and loss of cyclin D1 associated retinoblastoma dephosphorylation in human …
  120. APIGENIN shows synergistic anticancer activity with curcumin by binding at different sites of tubulin
  121. Antigenotoxicity, cytotoxicity, and apoptosis induction by APIGENIN, bisabolol, and protocatechuic acid
  122. Keratinocyte proliferation, differentiation, and apoptosis—differential mechanisms of regulation by curcumin, EGCG and APIGENIN
  123. Preparation of APIGENIN nanocrystals using supercritical antisolvent process for dissolution and bioavailability enhancement
  124. Preliminary enrichment and separation of genistein and APIGENIN from extracts of pigeon pea roots by macroporous resins
  125. Dietary flavonoid APIGENIN is a potential inducer of intracellular oxidative stress: the role in the interruptive apoptotic signal
  126. Simultaneous determination of luteolin and APIGENIN in dog plasma by RP-HPLC
  127. Evaluation of the effects of the flavonoid APIGENIN on apoptotic pathway gene expression on the colon cancer cell line (HT29)
  128. APIGENIN inhibits HGF-promoted invasive growth and metastasis involving blocking PI3K/Akt pathway and β4 integrin function in MDA-MB-231 breast cancer cells
  129. In vitro anti-inflammatory effect of APIGENIN in the Helicobacter pylori-infected gastric adenocarcinoma cells
  130. Studies on a novel p-coumaroyl glucoside of APIGENIN and on other flavonoids isolated from patchouli (Labiatae)
  131. APIGENIN down-regulates the hypoxia response genes: HIF-1α, GLUT-1, and VEGF in human pancreatic cancer cells
  132. APIGENIN induces apoptosis in Hep G2 cells: possible role of TNF-α and IFN-γ
  133. APIGENIN and luteolin modulate microglial activation via inhibition of STAT1-induced CD40 expression
  134. APIGENIN inhibits the production of NO and PGE2 in microglia and inhibits neuronal cell death in a middle cerebral artery occlusion-induced focal ischemia mice model
  135. Interactions between sulforaphane and APIGENIN in the induction of UGT1A1 and GSTA1 in CaCo-2 cells
  136. Absorption and emission of the APIGENIN and luteolin flavonoids: A TDDFT investigation
  137. APIGENIN and related compounds stimulate adult neurogenesis: Mars, Inc., the Salk Institute for Biological Studies: WO2008147483
  138. Quercetin, luteolin, APIGENIN and kaempferol contents of some foods
  139. Influence of the flavonoids APIGENIN, kaempferol, and quercetin on the function of organic anion transporting polypeptides 1A2 and 2B1
  140. The dietary flavonoids APIGENIN and (−)-epigallocatechin gallate enhance the positive modulation by diazepam of the activation by GABA of recombinant GABAA …
  141. APIGENIN suppresses insulin‐like growth factor I receptor signaling in human prostate cancer: An in vitro and in vivo study
  142. The dietary flavonoid APIGENIN sensitizes malignant tumor cells to tumor necrosis factor–related apoptosis-inducing ligand
  143. An APIGENIN-Derived Xanthine Oxidase Inhibitor from Palhinhaea cernua
  144. APIGENIN attenuates copper-mediated β-amyloid neurotoxicity through antioxidation, mitochondrion protection and MAPK signal inactivation in an AD cell model
  145. APIGENIN decreases cell viability and telomerase activity in human leukemia cell lines
  146. APIGENIN inhibits release of inflammatory mediators by blocking the NF-κB activation pathways in the HMC-1 cells
  147. APIGENIN inhibits antiestrogen-resistant breast cancer cell growth through estrogen receptor-α-dependent and estrogen receptor-α-independent mechanisms
  148. APIGENIN alleviates the symptoms of Staphylococcus aureus pneumonia by inhibiting the production of alpha-hemolysin
  149. Src kinase is a direct target of APIGENIN against UVB-induced skin inflammation
  150. Decreased pro-inflammatory cytokine production by LPS-stimulated PBMC upon in vitro incubation with the flavonoids APIGENIN, luteolin or chrysin, due to selective …
  151. Plant flavone APIGENIN inhibits HDAC and remodels chromatin to induce growth arrest and apoptosis in human prostate cancer cells: in vitro and in vivo study
  152. APIGENIN induces apoptosis in human lung cancer H460 cells through caspase-and mitochondria-dependent pathways
  153. Raman and surface-enhanced Raman spectra of chrysin, APIGENIN and luteolin
  154. APIGENIN inhibits proliferation of ovarian cancer A2780 cells through Id1
  155. The flavonoid APIGENIN improves glucose tolerance through inhibition of microRNA maturation in miRNA103 transgenic mice
  156. APIGENIN up-regulates transgelin and inhibits invasion and migration of colorectal cancer through decreased phosphorylation of AKT
  157. APIGENIN induces caspase-dependent apoptosis in human lung cancer A549 cells through Bax-and Bcl-2-triggered mitochondrial pathway
  158. Acute exposure of APIGENIN induces hepatotoxicity in Swiss mice
  159. Peroxidative metabolism of APIGENIN and naringenin versus luteolin and quercetin: glutathione oxidation and conjugation
  160. Reinvestigation of the structural assignment of signals in the 1H and 13C NMR spectra of the flavone APIGENIN
  161. APIGENIN and naringenin suppress colon carcinogenesis through the aberrant crypt stage in azoxymethane-treated rats
  162. Flavonoid APIGENIN is an inhibitor of the NAD+ ase CD38: implications for cellular NAD+ metabolism, protein acetylation, and treatment of metabolic syndrome
  163. Synergistic activity and mechanism of action of ceftazidime and APIGENIN combination against ceftazidime-resistant Enterobacter cloacae
  164. APIGENIN inhibits oxidative stress‐induced macromolecular damage in N‐nitrosodiethylamine (NDEA)‐induced hepatocellular carcinogenesis in Wistar albino rats
  165. Genotoxicities of nitropyrenes and their modulation by APIGENIN, tannic acid, ellagic acid and indole-3-carbinol in the Salmonella and CHO systems
  166. Inhibition of proteasome activity by the dietary flavonoid APIGENIN is associated with growth inhibition in cultured breast cancer cells and xenografts
  167. APIGENIN inhibits platelet adhesion and thrombus formation and synergizes with aspirin in the suppression of the arachidonic acid pathway
  168. Enzymatic synthesis of APIGENIN glucosides by glucosyltransferase (YjiC) from Bacillus licheniformis DSM 13
  169. APIGENIN causes G2/M arrest associated with the modulation of p21Cip1 and Cdc2 and activates p53-dependent apoptosis pathway in human breast cancer SK-BR-3 …
  170. The chemopreventive bioflavonoid APIGENIN inhibits prostate cancer cell motility through the focal adhesion kinase/Src signaling mechanism
  171. Acylated APIGENIN glycosides from alfalfa (Medicago sativa L.) var. Artal
  172. Oral administration of APIGENIN inhibits metastasis through AKT/P70S6K1/MMP-9 pathway in orthotopic ovarian tumor model
  173. APIGENIN-induced suicidal erythrocyte death
  174. Mechanism of apoptosis induced by APIGENIN in HepG2 human hepatoma cells: involvement of reactive oxygen species generated by NADPH oxidase
  175. APIGENIN inhibits proliferation and induces apoptosis in human multiple myeloma cells through targeting the trinity of CK2, Cdc37 and Hsp90
  176. Topical APIGENIN improves epidermal permeability barrier homoeostasis in normal murine skin by divergent mechanisms
  177. Anti-inflammatory effects of APIGENIN on nicotine-and lipopolysaccharide-stimulated human periodontal ligament cells via heme oxygenase-1
  178. DNA adducts with antioxidant flavonoids: morin, APIGENIN, and naringin
  179. APIGENIN Inhibits Tumor Necrosis Factor-Induced Intercellular Adhesion Molecule-1 Upregulation In Vivo
  180. Flavonoids such as Luteolin, Fisetin and APIGENIN Are Inhibitors of Interleukin-4 and Interleukin-13 Production by ActivatedHuman Basophils
  181. APIGENIN, a chemopreventive bioflavonoid, induces AMP‐activated protein kinase activation in human keratinocytes
  182. APIGENIN 7-glucoside and its 2 ″-and 6 ″-acetates from ligulate flowers of Matricaria chamomilla
  183. A comparative DFT study on the antioxidant activity of APIGENIN and scutellarein flavonoid compounds
  184. APIGENIN inhibits allergen-induced airway inflammation and switches immune response in a murine model of asthma
  185. APIGENIN protects HT22 murine hippocampal neuronal cells against endoplasmic reticulum stress-induced apoptosis
  186. APIGENIN impairs oral squamous cell carcinoma growth in vitro inducing cell cycle arrest and apoptosis
  187. A mechanism of APIGENIN-induced apoptosis is potentially related to anti-angiogenesis and anti-migration in human hepatocellular carcinoma cells
  188. Modulation of lipopolysaccharide-induced proinflammatory cytokine production in vitro and in vivo by the herbal constituents APIGENIN (chamomile), ginsenoside Rb1 …
  189. Combination of APIGENIN treatment with therapeutic HPV DNA vaccination generates enhanced therapeutic antitumor effects
  190. Degradation of HER2/neu by APIGENIN induces apoptosis through cytochrome c release and caspase-3 activation in HER2/neu-overexpressing breast cancer …
  191. APIGENIN, a non-mutagenic dietary flavonoid, suppresses lupus by inhibiting autoantigen presentation for expansion of autoreactive Th1 and Th17 cells
  192. The effects of APIGENIN‐7‐O‐β‐d‐glucuronopyranoside on reflux oesophagitis and gastritis in rats
  193. The flavones luteolin and APIGENIN inhibit in vitro antigen-specific proliferation and interferon-gamma production by murine and human autoimmune T cells
  194. FTIR, 1H NMR and EPR spectroscopy studies on the interaction of flavone APIGENIN with dipalmitoylphosphatidylcholine liposomes
  195. Chemoprotective effect of plant phenolics against anthracycline‐induced toxicity on rat cardiomyocytes. Part III. APIGENIN, baicalelin, kaempherol, luteolin and …
  196. Ibuprofen and APIGENIN induce apoptosis and cell cycle arrest in activated microglia
  197. Enhancement of UVB-induced apoptosis by APIGENIN in human keratinocytes and organotypic keratinocyte cultures
  198. Effects of chrysin, APIGENIN, genistein and their homoleptic copper (II) complexes on the growth and metastatic potential of cancer cells
  199. Cytotoxic APIGENIN Derivatives from Chrysopogon aciculatis
  200. Inhibitions of protein kinase C and proto-oncogene expressions in NIH 3T3 cells by APIGENIN
  201. Total synthesis of APIGENIN
  202. Conformational Changes of APIGENIN 7‐O‐(6‐O‐malonylglucoside), a Vacuolar Pigment from Parsley, with Solvent Composition and Proton Concentration
  203. Topical APIGENIN alleviates cutaneous inflammation in murine models
  204. APIGENIN promotes apoptosis, inhibits invasion and induces cell cycle arrest of T24 human bladder cancer cells
  205. The flavonoids APIGENIN and luteolin suppress ultraviolet A-induced matrix metalloproteinase-1 expression via MAPKs and AP-1-dependent signaling in HaCaT cells
  206. APIGENIN sensitizes doxorubicin-resistant hepatocellular carcinoma BEL-7402/ADM cells to doxorubicin via inhibiting PI3K/Akt/Nrf2 pathway
  207. APIGENIN induces apoptosis and blocks growth of medroxyprogesterone acetate-dependent BT-474 xenograft tumors
  208. Suppression of constitutive and tumor necrosis factor α-induced nuclear factor (NF)-κB activation and induction of apoptosis by APIGENIN in human prostate carcinoma …
  209. APIGENIN protects endothelial cells from lipopolysaccharide (LPS)-induced inflammation by decreasing caspase-3 activation and modulating mitochondrial function
  210. APIGENIN induces apoptosis via extrinsic pathway, inducing p53 and inhibiting STAT3 and NFκB signaling in HER2-overexpressing breast cancer cells
  211. APIGENIN sensitizes prostate cancer cells to Apo2L/TRAIL by targeting adenine nucleotide translocase-2
  212. APIGENIN induces apoptosis via tumor necrosis factor receptor-and Bcl-2-mediated pathway and enhances susceptibility of head and neck squamous cell carcinoma to …
  213. Synthesis, cytotoxic activity, and DNA binding properties of copper (II) complexes with hesperetin, naringenin, and APIGENIN
  214. The flavonoid APIGENIN protects brain neurovascular coupling against amyloid-β 25-35-induced toxicity in mice
  215. Interactions between dietary flavonoids APIGENIN or luteolin and chemotherapeutic drugs to potentiate anti-proliferative effect on human pancreatic cancer cells, in vitro
  216. APIGENIN protects ovalbumin-induced asthma through the regulation of Th17 cells
  217. APIGENIN inhibition of involucrin gene expression is associated with a specific reduction in phosphorylation of protein kinase Cδ Tyr311
  218. Characteristics of the isomeric flavonoids APIGENIN and genistein binding to hemoglobin by spectroscopic methods
  219. APIGENIN, a dietary antioxidant, modulates gamma radiation-induced oxidative damages in human peripheral blood lymphocytes
  220. Flavonoids, APIGENIN and icariin exert potent melanogenic activities in murine B16 melanoma cells
  221. Protective effect of APIGENIN on mouse acute liver injury induced by acetaminophen is associated with increment of hepatic glutathione reductase activity
  222. Protection by chrysin, APIGENIN, and luteolin against oxidative stress is mediated by the Nrf2-dependent up-regulation of heme oxygenase 1 and glutamate cysteine …
  223. APIGENIN, a plant‐derived flavone, activates transient receptor potential vanilloid 4 cation channel
  224. Pharmacokinetic study of luteolin, APIGENIN, chrysoeriol and diosmetin after oral administration of Flos Chrysanthemi extract in rats
  225. Structural determinants for activation and block of CFTR-mediated chloride currents by APIGENIN
  226. Preparation and in vitro evaluation of APIGENIN loaded lipid nanocapsules
  227. Differential modulation of cyclooxygenase-mediated prostaglandin production by the putative cancer chemopreventive flavonoids tricin, APIGENIN and quercetin
  228. APIGENIN-induced apoptosis is mediated by reactive oxygen species and activation of ERK1/2 in rheumatoid fibroblast-like synoviocytes
  229. Inhibitory effects of APIGENIN on the growth of gastric carcinoma SGC-7901 cells
  230. APIGENIN attenuates insulin-like growth factor-I signaling in an autochthonous mouse prostate cancer model
  231. Apoptotic effects of genistein, biochanin-A and APIGENIN on LNCaP and PC-3 cells by p21 through transcriptional inhibition of polo-like kinase-1
  232. Spectroscopic studies on the interaction of bovine serum albumin with surfactants and APIGENIN
  233. Green, yellow and red emitting CdTe QDs decreased the affinities of APIGENIN and luteolin for human serum albumin in vitro
  234. Tissue distribution in mice and metabolism in murine and human liver of APIGENIN and tricin, flavones with putative cancer chemopreventive properties
  235. APIGENIN affects leptin/leptin receptor pathway and induces cell apoptosis in lung adenocarcinoma cell line
  236. Overexpression of the Saussurea medusa chalcone isomerase gene in S. involucrata hairy root cultures enhances their biosynthesis of APIGENIN
  237. Reversion of vH-ras-trasformed NIH 3T3 cells by APIGENIN through inhibiting mitogen-activated protein kinase and its downstream oncogenes
  238. Prenylation enhances cytotoxicity of APIGENIN and liquiritigenin in rat H4IIE hepatoma and C6 glioma cells
  239. In vivo and in vitro percutaneous absorption of cancer preventive flavonoid APIGENIN in different vehicles in mouse skin
  240. Dietary phytophenols curcumin, naringenin and APIGENIN reduce infection-induced inflammatory and contractile pathways in human placenta, foetal membranes and …
  241. APIGENIN-induced apoptosis of leukemia cells is mediated by a bimodal and differentially regulated residue-specific phosphorylation of heat-shock protein–27
  242. Strategic formulation of APIGENIN-loaded PLGA nanoparticles for intracellular trafficking, DNA targeting and improved therapeutic effects in skin melanoma in vitro
  243. Activation of p38 MAPK pathway contributes to the melanogenic property of APIGENIN in B16 cells
  244. APIGENIN Attenuates 2-Deoxy-D-ribose-Induced Oxidative Cell Damage in HIT-T15 Pancreatic β-Cells
  245. Dietary APIGENIN suppresses IgE and inflammatory cytokines production in C57BL/6N mice
  246. Optimization of ultrasonic‐assisted enzymatic hydrolysis for the extraction of luteolin and APIGENIN from celery
  247. Anticancer mechanism of APIGENIN and the implications of GLUT-1 expression in head and neck cancers
  248. Determination of free radical scavenging activity of quercetin, rutin, luteolin and APIGENIN in H2O2-treated human ML cells K562.
  249. Gastric relaxation induced by APIGENIN and quercetin: analysis of the mechanism of action
  250. APIGENIN drives the production of reactive oxygen species and initiates a mitochondrial mediated cell death pathway in prostate epithelial cells
  251. Determination and assay validation of luteolin and APIGENIN in human urine after oral administration of tablet of Chrysanthemum morifolium extract by HPLC
  252. Cytotoxic effects of the dietary flavones chrysin and APIGENIN in a normal trout liver cell line
  253. APIGENIN protects ovalbumin-induced asthma through the regulation of GATA-3 gene
  254. Solubilities of APIGENIN in ethanol+ water at different temperatures
  255. APIGENIN ameliorates gamma radiation-induced cytogenetic alterations in cultured human blood lymphocytes
  256. Anti-mutagenic and pro-apoptotic effects of APIGENIN on human chronic lymphocytic leukemia cells
  257. Determination of APIGENIN in rat plasma by high-performance liquid chromatography
  258. Geminin is overexpressed in human pancreatic cancer and downregulated by the bioflavanoid APIGENIN in pancreatic cancer cell lines
  259. APIGENIN and tangeretin enhance gap junctional intercellular communication in rat liver epithelial cells
  260. APIGENIN induces apoptosis through mitochondrial dysfunction in U-2 OS human osteosarcoma cells and inhibits osteosarcoma xenograft tumor growth in vivo
  261. Flavonoid APIGENIN modified gene expression associated with inflammation and cancer and induced apoptosis in human pancreatic cancer cells through inhibition of …
  262. APIGENIN and cancer chemoprevention
  263. APIGENIN Inhibits the Expression of IL-6, IL-8, and ICAM-1 in DEHP-Stimulated Human Umbilical Vein Endothelial Cells and In Vivo
  264. Antigenotoxic effect of APIGENIN against mitomycin C induced genotoxic damage in mice bone marrow cells
  265. Effects of genistein, APIGENIN, quercetin, rutin and astilbin on serum uric acid levels and xanthine oxidase activities in normal and hyperuricemic mice
  266. Impact of adenomatous polyposis coli (APC) tumor supressor gene in human colon cancer cell lines on cell cycle arrest by APIGENIN
  267. Labeling of APIGENIN with 131I and bioactivity of 131I-APIGENIN in male and female rats
  268. The exposure of luteolin is much lower than APIGENIN when oral administration of Flos Chrysanthemi extract to rats
  269. Functional activation of monoamine transporters by luteolin and APIGENIN isolated from the fruit of Perilla frutescens (L.) Britt
  270. Antinociceptive effect of the Orbignya speciosa Mart.(Babassu) leaves: evidence for the involvement of APIGENIN
  271. Synergistic anti-glioma effect of Hydroxygenkwanin and APIGENIN in vitro
  272. Exploration of the wound healing potential of Helichrysum graveolens (Bieb.) Sweet: Isolation of APIGENIN as an active component
  273. Chemopreventive potential of APIGENIN in 7, 12-dimethylbenz (a) anthracene induced experimental oral carcinogenesis
  274. APIGENIN inhibits endothelial‐cell proliferation in G2/M phase whereas it stimulates smooth‐muscle cells by inhibiting P21 and P27 expression
  275. APIGENIN protects gamma-radiation induced oxidative stress, hematological changes and animal survival in whole body irradiated Swiss albino mice
  276. The dietary flavonoid APIGENIN enhances the activities of the anti-metastatic protein CD26 on human colon carcinoma cells
  277. Variation of APIGENIN quantity in diploid and tetraploid Chamomilla recutita (L.) Rauschert
  278. Flavonoids (APIGENIN, tangeretin) counteract tumor promoter-induced inhibition of intercellular communication of rat liver epithelial cells
  279. Anti-inflammatory effect of APIGENIN-7-neohesperidoside (rhoifolin) in carrageenin-induced rat oedema model
  280. APIGENIN suppresses the growth of colorectal cancer xenografts via phosphorylation and up-regulated FADD expression
  281. Effects of APIGENIN on steroidogenesis and steroidogenic acute regulatory gene expression in mouse Leydig cells
  282. Nitrogen-containing APIGENIN analogs: preparation and biological activity
  283. Preparation of novel APIGENIN‐enriched, liposomal and non‐liposomal, antiinflammatory topical formulations as substitutes for corticosteroid therapy
  284. Efficacy of PLGA-loaded APIGENIN nanoparticles in Benzo [a] pyrene and ultraviolet-B induced skin cancer of mice: Mitochondria mediated apoptotic signalling …
  285. Citrus flavonoids luteolin, APIGENIN, and quercetin inhibit glycogen synthase kinase-3β enzymatic activity by lowering the interaction energy within the binding cavity
  286. Inhibition of guinea pig intestinal peristalsis by the flavonoids quercetin, naringenin, APIGENIN and genistein
  287. Anticlastogenic effect of APIGENIN in human lymphocytes treated with ethinylestradiol
  288. Glycosidation of APIGENIN results in a loss of its activity on different growth parameters of arbuscular mycorrhizal fungi from the genus Glomus and Gigaspora
  289. … of IGF-I production and proliferation of human leiomyomal smooth muscle cells by Scutellaria barbata D. Don in vitro: isolation of flavonoids of APIGENIN and luteolin as …
  290. Total synthesis of APIGENIN 7, 4′-di-O-β-glucopyranoside, a component of blue flower pigment of Salvia patens, and seven chiral analogues
  291. APIGENIN, a bioactive flavonoid from Lycopodium clavatum, stimulates nucleotide excision repair genes to protect skin keratinocytes from ultraviolet B-induced …
  292. Oxidative coupling of APIGENIN
  293. Suppression by APIGENIN of peritoneal metastasis of intestinal adenocarcinomas induced by azoxymethane in Wistar rats
  294. APIGENIN inhibits NNK-induced focal adhesion kinase activation in pancreatic cancer cells
  295. APIGENIN chemotypes of Matricaria chamomilla L.
  296. APIGENIN di-C-glycosylflavones of Angiopteris (Marattiales)
  297. Quantitative determination of APIGENIN and its metabolism in rat plasma after intravenous bolus administration by HPLC coupled with tandem mass spectrometry
  298. APIGENIN–strong cytostatic and anti-angiogenic action in vitro contrasted by lack of efficacy in vivo
  299. Modulation of radiation-induced and mitomycin C-induced chromosome damage by APIGENIN in human lymphocytes in vitro
  300. Flavonoid dimers as bivalent modulators for P-glycoprotein-based multidrug resistance: synthetic APIGENIN homodimers linked with defined-length poly (ethylene …
  301. Characterization of APIGENIN and Luteolin Derivatives from Oil Palm (Elaeis guineensis Jacq.) Leaf Using LC–ESI-MS/MS
  302. Effect of APIGENIN on the reproductive system in male mice
  303. Preparing APIGENIN from leaves of Adinandra nitida
  304. Bioassay‐guided isolation of APIGENIN with GABA‐benzodiazepine activity from Tanacetum parthenium
  305. Complexation of APIGENIN and luteolin in weld lake: a DFT/TDDFT investigation
  306. Flavonoid quercetin, but not APIGENIN or luteolin, induced apoptosis in human myeloid leukemia cells and their resistant variants.
  307. APIGENIN blocks induction of vascular endothelial growth factor mRNA and protein in progestin-treated human breast cancer cells
  308. The flavonoid APIGENIN potentiates the growth inhibitory effects of gemcitabine and abrogates gemcitabine resistance in human pancreatic cancer cells
  309. On the accumulation of APIGENIN in chamomile flowers
  310. Dietary APIGENIN attenuates the development of atopic dermatitis-like skin lesions in NC/Nga mice
  311. APIGENIN inhibits the TNFα-induced expression of eNOS and MMP-9 via modulating Akt signalling through oestrogen receptor engagement
  312. Effect of dietary APIGENIN on colonic ornithine decarboxylase activity, aberrant crypt foci formation, and tumorigenesis in different experimental models
  313. Alfalfa (Medicago sativa L.) APIGENIN glycosides and their effect on the pea aphid (Acyrthosiphon pisum)
  314. Chlorpromazine and APIGENIN reduce adenovirus replication and decrease replication associated toxicity
  315. APIGENIN inhibits laser-induced choroidal neovascularization and regulates endothelial cell function
  316. New progress in the pharmacology of APIGENIN [J]
  317. APIGENIN induces DNA damage through the PKCδ-dependent activation of ATM and H2AX causing down-regulation of genes involved in cell cycle control and DNA …
  318. APIGENIN inhibits TGF-β1 induced fibroblast-to-myofibroblast transition in human lung fibroblast populations
  319. Protoapigenone, a natural derivative of APIGENIN, induces mitogen-activated protein kinase-dependent apoptosis in human breast cancer cells associated with …
  320. APIGENIN decreases expression of the myofibroblast phenotype
  321. Effects of APIGENIN on the expression of angiotensin-converting enzyme 2 in kidney in spontaneously hypertensive rats
  322. Effect of emodin and APIGENIN on invasion of human ovarian carcinoma HO-8910PM cells in vitro
  323. APIGENIN decreases hemin-mediated heme oxygenase-1 induction
  324. APIGENIN induces c-Myc-mediated apoptosis in FRO anaplastic thyroid carcinoma cells
  325. APIGENIN reduces human insulin fibrillation in vitro and protects SK-N-MC cells against insulin amyloids
  326. APIGENIN, a dietary flavonoid, sensitizes human T cells for activation-induced cell death by inhibiting PKB/Akt and NF-κB activation pathway
  327. Synthesis of a complete series of O-methyl analogues of naringenin and APIGENIN
  328. The pharmacokinetics of raloxifene and its interaction with APIGENIN in rat
  329. Effect of luteolin and APIGENIN on rosmarinic acid bioavailability in Caco-2 cell monolayers
  330. APIGENIN: is it a pro-or anti-inflammatory agent?
  331. Determination of luteolin and APIGENIN in celery using ultrasonic‐assisted extraction based on aqueous solution of ionic liquid coupled with HPLC quantification
  332. Production of cell-associated polysaccharides of Rhizobium fredii USDA205 is modulated by APIGENIN and host root extract
  333. Reversed-phase high-performance liquid chromatography analysis of APIGENIN and its glucosides in flowers of Matricaria chamomilla and chamomile extracts
  334. Time course changes of anti-and pro-apoptotic proteins in APIGENIN-induced genotoxicity
  335. Inhibition of superoxide anion-mediated impairment of endothelium by treatment with luteolin and APIGENIN in rat mesenteric artery
  336. Effects of lycopene and APIGENIN on human umbilical vein endothelial cells in vitro under angiogenic stimulation
  337. Inhibitory effect of APIGENIN on benzo (a) pyrene‐mediated genotoxicity in Swiss albino mice
  338. The chemopreventive flavonoid APIGENIN confers radiosensitizing effect in human tumor cells grown as monolayers and spheroids
  339. The spectroscopic properties of anticancer drug APIGENIN investigated by using DFT calculations, FT-IR, FT-Raman and NMR analysis
  340. RP-HPLC-DAD detrmination of flavonoids: separation of quercetin, luteolin and APIGENIN in Marchantia convoluta
  341. APIGENIN attenuates neointima formation via suppression of vascular smooth muscle cell phenotypic transformation
  342. APIGENIN prevents development of medroxyprogesterone acetate-accelerated 7, 12-dimethylbenz (a) anthracene-induced mammary tumors in Sprague–Dawley rats
  343. … ‐independent pathway for inhibitory phosphorylation of cyclin‐dependent kinase p34cdc2 and concomitant G2/M arrest by the chemopreventive flavonoid APIGENIN
  344. Enhancement of p53 expression in keratinocytes by the bioflavonoid APIGENIN is associated with RNA‐binding protein HuR
  345. Inhibition of ultraviolet light induced skin carcinogenesis in SKH-1 mice by APIGENIN, a plant flavonoid.
  346. Dietary flavonoid APIGENIN inhibits high glucose and tumor necrosis factor α-induced adhesion molecule expression in human endothelial cells
  347. Column-switching high-performance liquid chromatographic assay for determination of APIGENIN and acacetin in human urine with ultraviolet absorbance detection
  348. APIGENIN prevents deregulation in the expression pattern of cell-proliferative, apoptotic, inflammatory and angiogenic markers during 7, 12-dimethylbenz [a] …
  349. A short and facile synthetic route to hydroxylated flavones. New syntheses of APIGENIN, tricin, and luteolin
  350. APIGENIN isolated from the seeds of Perilla frutescens britton var crispa (Benth.) inhibits food intake in C57BL/6J mice
  351. The effect of APIGENIN on pharmacokinetics of imatinib and its metabolite N-desmethyl imatinib in rats
  352. APIGENIN induces apoptosis via downregulation of S‐phase kinase‐associated protein 2‐mediated induction of p27Kip1 in primary effusion lymphoma cells
  353. Hexaconazole induces antioxidant protection and APIGENIN-7-glucoside accumulation in Matricaria chamomilla plants subjected to drought stress
  354. Involvement of monoamine oxidase and noradrenaline uptake in the positive chronotropic effects of APIGENIN in rat atria
  355. The flavonoid APIGENIN downregulates CDK1 by directly targeting ribosomal protein S9
  356. APIGENIN-7-O-β-D-glucopyranoside, an anti-HIV principle from Kummerowia striata
  357. Relationships between the larval growth inhibition of Caenorhabditis elegans by APIGENIN derivatives and their structures
  358. APIGENIN inhibits larval growth of Caenorhabditis elegans through DAF-16 activation
  359. Electrochemical behavior of APIGENIN at a glassy carbon electrode and its analytical application
  360. Differential effects of quercetin, APIGENIN and genistein on signalling pathways of protease‐activated receptors PAR1 and PAR4 in platelets
  361. Influence of vehicle, distant topical delivery, and biotransformation on the chemopreventive activity of APIGENIN, a plant flavonoid, in mouse skin
  362. Antioxidant properties, superoxide dismutase and glutathione reductase activities in HepG2 cells with a fungal endophyte producing APIGENIN from pigeon pea …
  363. APIGENIN inhibits cell migration through MAPK pathways in human bladder smooth muscle cells
  364. The dietary flavones APIGENIN and luteolin impair smooth muscle cell migration and VEGF expression through inhibition of PDGFR-β phosphorylation
  365. Synthesis of carpachromene and related isopentenylated derivatives of APIGENIN
  366. 5-Fluorouracil combined with APIGENIN enhances anticancer activity through induction of apoptosis in human breast cancer MDA-MB-453 cells
  367. Isolation and structure elucidation of ligustroflavone, a new APIGENIN triglycoside from the leaves of Ligustrum vulgare L.
  368. An acylated flavone APIGENIN 7-O-β-D-(4 ″-cis-p-coumaroyl) glucoside from Echinops echinatus
  369. Direct semi-synthesis of the anticancer lead-drug protoapigenone from APIGENIN, and synthesis of further new cytotoxic protoflavone derivatives
  370. Micelles of TPGS modified APIGENIN phospholipid complex for oral administration: preparation, in vitro and in vivo evaluation
  371. Involvement of nuclear factor-kappa B, Bax and Bcl-2 in induction of cell cycle arrest and apoptosis by APIGENIN in human prostate carcinoma cells
  372. Inhibition of TPA‐induced cyclooxygenase‐2 (COX‐2) expression by APIGENIN through downregulation of Akt signal transduction in human keratinocytes
  373. Akt inhibition enhances the cytotoxic effect of APIGENIN in combination with PLX4032 in anaplastic thyroid carcinoma cells harboring BRAF V600E
  374. Estimation of APIGENIN, an anxiolytic constituent, in Turnera aphrodisiaca
  375. APIGENIN di-and trirhamnoside from Asplenium normale in Malaysia
  376. The effect of APIGENIN on cyclophosphamide and doxorubicin genotoxicity in vitro and in vivo
  377. Pancreatic Β-cell protective effect of rutin and APIGENIN isolated from Teucrium polium
  378. APIGENIN, chrysin, and luteolin selectively inhibit chymotrypsin-like and trypsin-like proteasome catalytic activities in tumor cells
  379. APIGENIN inhibits tumor necrosis factor alpha plus high glucose-induced LOX-1 expression in human endothelial cells
  380. Effects of APIGENIN, lycopene and astaxanthin on 7β-hydroxycholesterol-induced apoptosis and Akt phosphorylation in U937 cells
  381. Interspecies difference of luteolin and APIGENIN after oral administration of Chrysanthemum morifolium extract and prediction of human pharmacokinetics
  382. Proteomic study of granulocytic differentiation induced by APIGENIN 7-glucoside in human promyelocytic leukemia HL-60 cells
  383. Sub-toxic dose of APIGENIN sensitizes HepG2 cells to TRAIL through ERK-dependent up-regulation of TRAIL receptor DR5
  384. APIGENIN 7-glucoside diacetates in ligulate flowers of Matricaria chamomilla
  385. APIGENIN and LY294002 prolong EGF-stimulated ERK1/2 activation in PC12 cells but are unable to induce full differentiation
  386. APIGENIN-induced apoptosis in cervical cancer cell lines
  387. Spectrophotometric study of anthocyan copigmentation reactions. 4. Malvin and APIGENIN 7-glucoside
  388. Effect of APIGENIN on proliferation and apoptosis of human lung cancer NCI-H460 cells
  389. The flavonoid APIGENIN inhibits the proliferation of prostatic stromal cells via the MAPK-pathway and cell-cycle arrest in G1/S
  390. Expression of transforming growth factor-and determination of apoptotic index in histopathological sections for assessment of the effects of APIGENIN (4′, 5′, 7′ …
  391. APIGENIN isolated from the medicinal plant Elsholtzia rugulosa prevents β-amyloid 25–35-induces toxicity in rat cerebral microvascular endothelial cells
  392. 5, 6-Dichloro-ribifuranosylbenzimidazole-and APIGENIN-induced sensitization of colon cancer cells to TNF-α-mediated apoptosis
  393. Effect of the phenolic compounds APIGENIN and carnosic acid on oral carcinogenesis in hamster induced by DMBA
  394. Semisynthesis of APIGENIN and acacetin-7-O-β-D-glycosides from naringin and their cytotoxic activities
  395. Up‐regulation of insulin‐like growth factor binding protein‐3 by APIGENIN leads to growth inhibition and apoptosis of 22Rv1 xenograft in athymic nude mice
  396. Activation of Cl− channel and Na+/K+/2Cl− cotransporter in renal epithelial A6 cells by flavonoids: genistein, daidzein, and APIGENIN
  397. Neuroprotective effects of APIGENIN on acute transient focal cerebral ischemia-reperfusion injury in rats
  398. Studies of the interaction between APIGENIN and bovine serum albumin by spectroscopic methods
  399. Anti-proliferation and chemo-sensitization effects of APIGENIN on human lung cancer cells
  400. APIGENIN glycosides from the flowers of Bellis perennis L.
  401. The natural flavonoid APIGENIN suppresses Th1-and Th2-related chemokine production by human monocyte THP-1 cells through mitogen-activated protein kinase …
  402. KLF4 overexpression and APIGENIN treatment down regulated anti-apoptotic Bcl-2 proteins and matrix metalloproteinases to control growth of human …
  403. Differential mechanisms for the inhibition of human cytochrome P450 1A2 by APIGENIN and genistein
  404. APIGENIN glycosides from Thunbergia fragrans and Ruellia t uberosa
  405. (Delphinidin 3-gentiobiosyl)(APIGENIN 7-glucosyl) malonate from the flowers of Eichhornia crassipes
  406. Alfalfa (Medicago sativa L.) Flavonoids. 1. APIGENIN and Luteolin Glycosides from Aerial Parts
  407. Study on pro-apoptotic effect of APIGENIN on human gastric cancer cells and its underlying mechanisms [J]
  408. Quinacrine and a novel APIGENIN dimer can synergistically increase the pentamidine susceptibility of the protozoan parasite Leishmania
  409. The dietary flavonoid APIGENIN blocks phorbol 12-myristate 13-acetate-induced COX-2 transcriptional activity in breast cell lines
  410. APIGENIN‐induced nitric oxide production involves calcium‐activated potassium channels and is responsible for antiangiogenic effects
  411. Use of hollow fiber liquid phase microextraction and HPLC for extraction and determination of APIGENIN in human urine after consumption of Satureja sahendica …
  412. Evaluation of hepatic clearance and drug-drug interactions of luteolin and APIGENIN by using primary cultured rat hepatocytes
  413. A novel APIGENIN modified glassy carbon sensor electrode for the determination of copper ions in soil samples
  414. HPTLC densitometric quantification of glycyrrhizin, glycyrrhetinic acid, APIGENIN, kaempferol and quercetin from Glycyrrhiza glabra
  415. Interactions of the monomeric and dimeric flavones APIGENIN and amentoflavone with the plasma membrane of L929 cells; a fluorescence study
  416. APIGENIN enhances the cytotoxic effects of tumor necrosis factor-related apoptosis-inducing ligand in human rheumatoid arthritis fibroblast-like synoviocytes
  417. APIGENIN inhibits tumor necrosis factor α–induced cell proliferation and prostaglandin E2 synthesis by inactivating NFκB in endometriotic stromal cells
  418. Three Adducts of Butenolide and APIGENIN Glycoside from the Leaves of Machilus japonica
  419. Silica‐based monolithic column with evaporative light scattering detector for HPLC analysis of bacosides and APIGENIN in Bacopa monnieri
  420. Sequential hTERT knockdown and APIGENIN treatment inhibited invasion and proliferation and induced apoptosis in human malignant neuroblastoma SK-N-DZ and …
  421. An investigation on the interaction of DNA with hesperetin/APIGENIN in the presence of CTAB by resonance Rayleigh light scattering technique and its analytical …
  422. Determination of quercetin, luteolin, APIGENIN and acacetin in Flos Chrysanthemi Indici by RP-HPLC
  423. Inhibition of HIF‐1 alpha and VEGF expression by the chemopreventive bioflavonoid APIGENIN is accompanied by Akt inhibition in human prostate carcinoma PC3‐M …
  424. Validation of a capillary electrophoresis method for the quantitative determination of free and total APIGENIN in extracts of Chamomilla recutita
  425. Unbalanced activation of ERK1/2 and MEK1/2 in APIGENIN-induced HeLa cell death
  426. APIGENIN di-C-glycosides (ACG) content and composition in grains of bread wheat (Triticum aestivum) and related species
  427. APIGENIN inhibits release and gene expression of monocyte chemoattractant protein 1 (MCP-1) in J774. 2 macrophages
  428. APIGENIN sensitizes Huh-7 human hepatocellular carcinoma cells to TRAIL-induced apoptosis
  429. APIGENIN increases osteoblastic differentiation and inhibits tumor necrosis factor-α-induced production of interleukin-6 and nitric oxide in osteoblastic MC3T3-E1 cells
  430. Subtoxic levels of APIGENIN inhibit expression and secretion of VEGF by uveal melanoma cells via suppression of ERK1/2 and PI3K/Akt pathways
  431. Effects of dietary APIGENIN on tumor latency, incidence and multiplicity in a medroxyprogesterone acetate-accelerated 7, 12-dimethylbenz (a) anthracene-induced …
  432. Modulation of UVB‐induced and basal cyclooxygenase‐2 (COX‐2) expression by APIGENIN in mouse keratinocytes: Role of USF transcription factors
  433. Theoretical investigation of the structural and electronic properties of luteolin, APIGENIN and their deprotonated species
  434. Enhancement of pentobarbital-induced sleep by APIGENIN through chloride ion channel activation
  435. APIGENIN and amentoflavone glycosides in the Psilotaceae and their phylogenetic significance
  436. Biotransformations of quercetin and APIGENIN by a cell suspension culture of Cannabis sativa
  437. Combination of N-(4-hydroxyphenyl) retinamide and APIGENIN suppressed starvation-induced autophagy and promoted apoptosis in malignant neuroblastoma cells
  438. APIGENIN attenuates dopamine-induced apoptosis in melanocytes via oxidative stress-related p38, c-Jun NH2-terminal kinase and Akt signaling
  439. The flavonoid APIGENIN suppresses vitamin D receptor expression and vitamin D responsiveness in normal human keratinocytes
  440. Development and Validation of a RP-HPLC Method for The Simultaneous Determination of Luteolin and APIGENIN in Herb of Achillea millefolium L.
  441. Determination of antimutagenic properties of APIGENIN-7-O-rutinoside, a flavonoid isolated from Mentha longifolia (L.) Huds. ssp. longifolia with yeast DEL assay
  442. XLI.—Apiin and APIGENIN. Part II. Note on vitexin
  443. Protective effect of APIGENIN against hydrogen peroxide induced genotoxic damage on cultured human peripheral blood lymphocytes.
  444. The extraction of APIGENIN and luteolin from the sage Salvia officinalis L. from Jordan
  445. Biotransformation of chrysin and APIGENIN by Cunninghamella elegans
  446. Phorbol ester or epidermal growth‐factor‐induced MUC5AC mucin gene expression and production from airway epithelial cells are inhibited by APIGENIN and wogonin
  447. A Mew Acylated APIGENIN 4’–O–β–D–glucoside from the Leaves of Lycopodium clavatum L
  448. APIGENIN accelerates lipopolysaccharide induced apoptosis in mesenchymal stem cells through suppressing vitamin D receptor expression
  449. APIGENIN suppresses migration and invasion of transformed cells through down-regulation of CXC chemokine receptor 4 expression
  450. UV spectrometric and DC polarographic studies on APIGENIN and luteolin
  451. APIGENIN 4′-O-β-d-glucoside 7-O-β-d)-glucuronide: The copigment in the blue pigment of Centaurea cyanus
  452. A simple HPLC method for the determination of APIGENIN in mouse tissues
  453. An APIGENIN-induced decrease in K-antigen production by Sinorhizobium sp. NGR234 is y4gM-and nodD1-dependent
  454. Identification and quantitative determination of Luteolin and APIGENIN in the aerial parts and an extract of Stachys lavandulifolia by HPLC
  455. Über die Verbreitung von Flavonoiden bei pleurokarpen Laubmoosen II. APIGENIN and APIGENIN-7-rhamnoglucosid bei Pleurozium schreberi (Willd.) Mitt.
  456. miR-138 overexpression is more powerful than hTERT knockdown to potentiate APIGENIN for apoptosis in neuroblastoma in vitro and in vivo
  457. Effect and mechanism of APIGENIN on VEGF expression in human breast cancer cells
  458. Modulation of multidrug resistance protein 1 (MRP1/ABCC1)-mediated multidrug resistance by bivalent APIGENIN homodimers and their derivatives
  459. Analysis of APIGENIN in Blumea balsamifera Linn DC. and its inhibitory activity against aldose reductase in rat lens
  460. APIGENIN inhibits growth and motility but increases gap junctional coupling intensity in rat prostate carcinoma (MAT-LyLu) cell populations
  461. Determination of APIGENIN by LC with electrochemical detection
  462. Biochemistry, Molecular Biology: APIGENIN, Tyrosinase Inhibitor Isolated from the Flowers of Hemisteptia lyrata Bunge
  463. Inhibitory effects of naringenin, kaempherol, and APIGENIN on cholesterol biosynthesis in HepG2 and MCF-7 cells
  464. Bcl-2 inhibitor and APIGENIN worked synergistically in human malignant neuroblastoma cell lines and increased apoptosis with activation of extrinsic and intrinsic …
  465. WITHDRAWN: APIGENIN: A potent antigenotoxic and anticlastogenic agent
  466. APIGENIN 7β-rutinoside, a new flavonoid from the leaves of Citrus paradisi
  467. APIGENIN derivatives from Paulownia tomentosa Steud. var. tomentosa stem barks
  468. The new flavone ester APIGENIN 7-Op-hydroxybenzoate and three di-C-glycosylflavones from Pteris vittata
  469. … evoked adhesion molecule genetic alterations in astrocytes isolated from stroke-prone spontaneously hypertensive rats and the APIGENIN inhibition of their …
  470. The efficient total synthesis of bis-glycosyl APIGENIN from naringenin: a greener way
  471. High-performance liquid chromatographic determination and pharmacokinetic study of APIGENIN-7-O-β-D-glucoside in rat plasma after intravenous administration
  472. Protective effects of APIGENIN and quercetin on aflatoxin B 1-induced immunotoxicity in mice
  473. Investigation of APIGENIN-7-O-β-glucoside hydrolysis by β-glucosidase from almonds
  474. Enzyme pretreatment and negative pressure cavitation extraction of genistein and APIGENIN from the roots of pigeon pea [Cajanus cajan (L.) Millsp.] and the evaluation …
  475. APIGENIN reduces cyclosporine-A induced changes in lipid hydroperox-ides and total antioxidants in Sprague-Dawley rats.
  476. N-Myc knockdown and APIGENIN treatment controlled growth of malignant neuroblastoma cells having N-Myc amplification
  477. Response of soybean fungal and oomycete pathogens to APIGENIN and genistein
  478. Total synthesis of three naturally occurring 6, 8-di-C-glycosylflavonoids: phloretin, naringenin, and APIGENIN bis-C-β-D-glucosides
  479. XXVI.—A synthesis of pyrylium salts of anthocyanidin type. Part IV. Flavylium salts related to chrysin, APIGENIN, and luteolin
  480. Effects of APIGENIN on cell proliferation of human pancreatic carcinoma cell line BxPC-3 in vitro
  481. APIGENIN glycosides from Euphorbia humifusa Wild
  482. The para-O-methylation of APIGENIN to acacetin by cell-free extracts of Robinia pseudoacacia L.
  483. Effect of APIGENIN on the cardiomyocyte apoptosis in rats with ischemia and reperfusion and the expression of Bcl-2, Bax, Caspase-3
  484. APIGENIN-7-methylglucuronide from Cynara cardunculus L.
  485. Observation of APIGENIN anionic clusters in the gas phase
  486. Inhibition of PKB/Akt activity involved in APIGENIN-induced apoptosis in human gastric carcinoma cells
  487. The promising anticancer efficacy of parsley seeds flavonoid (APIGENIN) in induced mammary adenocarcinoma (AMN3) mice
  488. Aluminium (III), Fe (II) Complexes and Dyeing Properties of APIGENIN (5, 7, 4′-trihydroxy flavone)
  489. Studies on the anticancer effect of APIGENIN in KB cell xenograft nude mouse model
  490. Two New APIGENIN Glycosides from Cephalotaxus Harringtonia Var. Harringtonia
  491. HPTLC determination of APIGENIN in some Iranian liquid products of Matricaria chamomilla L.
  492. Dietary APIGENIN regulates high glucose and hypoxic reoxygenation-induced reductions in apelin expression in human endothelial cells
  493. Effects of APIGENIN on Glutamate-induced [Ca2+] i Increases in Cultured Rat Hippocampal Neurons
  494. Suppression of phorbol-12-myristate-13-acetate-induced tumor cell invasion by APIGENIN via the inhibition of p38 mitogen-activated protein kinase-dependent matrix …
  495. Calcium-and phosphatidylinositol 3-kinase/Akt-dependent activation of endothelial nitric oxide synthase by APIGENIN
  496. Effect of salicylic acid on flavonoids, APIGENIN, anthocyanin and carbohydrate in Matricaria chamomilla L.
  497. Caecal absorption of vitexin-2-O-xyloside and its aglycone APIGENIN, in the rat
  498. On the adsorption and electrochemical oxidation of flavones APIGENIN and acacetin at a glassy carbon electrode
  499. Hierarchy of carcinoma cell responses to APIGENIN: gap junctional coupling versus proliferation
  500. Syntheses and crystal structures of two APIGENIN alkylation derivatives
  501. Interaction of bovine serum albumin with luteolin and APIGENIN
  502. HPLC determination of luteolin and APIGENIN in herba ecliptae
  503. Influence of biotransformation of luteolin, luteolin 7-O-glucoside, 3′, 4′-dihydroxyflavone and APIGENIN by cultured rat hepatocytes on antioxidative capacity and …
  504. Isolation, purification and identification of APIGENIN-7-O-# beta#-D-glucuronide in marchantia convoluta with silica column chromatography, RP-HPLC and LC-ESI-MS
  505. In vitro effects of myricetin, morin, APIGENIN,(+)-taxifolin,(+)-catechin,(−)-epicatechin, naringenin and naringin on cytochrome b5 reduction by purified NADH …
  506. Rutinosides and vicianosides of quercetin, APIGENIN and luteolin from Sympohoricarpus albus L. Blake (Caprifoliaeae)
  507. The influence of APIGENIN on membrane and action potential in the liverwort Conocephalum conicum
  508. The promotive effects of antioxidative APIGENIN on the bioavailability of paclitaxel for oral delivery in rats
  509. Studies on the effects of anti-inflammatory and analgesic of APIGENIN [J]
  510. … , and Other Constituents from the leaves of Ochroma pyramidale (Balsa Wood, Bombacaceae): Preferred Conformations of 8-C-β-D-Glucopyranosyl-APIGENIN …
  511. LC-MS/MS simultaneous determination of scutellarin and APIGENIN of Herba Scutellariae barbatae produced in different districts
  512. Size and branching effects on the fluorescence of benzylic dendrimers possessing one APIGENIN fluorophore at the core
  513. APIGENIN modulates insulin-like growth factor axis: implications for prevention and therapy of prostate cancer
  514. Chemosensitization effects of APIGENIN on cisplatin in human nasopharyngeal carcinoma CNE-2Z cells
  515. Determination of hesperetin, luteolin and APIGENIN in flos buddlejae by capillary electrophoresis
  516. Chromatographic and spectrophotometric evidence for the occurrence of luteolin and APIGENIN C-glycosides in the cotyledons of buckwheat seedlings
  517. Effect of APIGENIN on proliferation, cell cycle and apoptosis of mouse T cells in vitro
  518. 555. The flavonoid glycosides of Dahlia variabilis. Part I. General introduction. Cyanidin, APIGENIN, and luteolin glycosides from the variety “Dandy.”
  519. Inhibition of interleukin-4 production in activated T cells via down-regulation of NF-AT DNA binding activity by APIGENIN, a flavonoid present in dietary plants
  520. CLVI.—A synthesis of pyrylium salts of anthocyanidin type. Part VI. Polyhydroxyflavylium salts related to chrysin, APIGENIN, lotoflavin, luteolin, galangin, fisetin, and …
  521. APIGENIN regulates lipopolysaccharides-induced activation of inflammasome
  522. Simultaneously determined of quercetin, luteolin and APIGENIN in Rosa laevigata by HPLC
  523. Dietary flavonoid APIGENIN inhibits endothelin-1-induced contraction of collagen gel
  524. Studies on fluorescence quenching method for determination of APIGENIN with CdSe/CdS quantum dots
  525. Flavanones and related compounds. III. The reduction of luteolin and APIGENIN trimethyl ether with sodium amalgam
  526. Isolation of gram quantities of a rhamnoglucoside of APIGENIN from grapefruit
  527. 97: APIGENIN inhibits pancreatic cancer cell proliferation via down-regulation of hypoxia inducible factor-1Α (HIF-1Α) and the glucose transporter (GLUT-1)
  528. High performance liquid chromatographic method for the determination of APIGENIN and selected flavonoids in human plasma using electrochemical detection
  529. Protective effect of APIGENIN on neurons against oxygen‐glucose deprivation/reperfusion induced injury
  530. The effect of APIGENIN on proliferation and NO secretion and phagocytosis of RAW264. 7 cells
  531. APIGENIN affects semen parameters in male mice
  532. The determination of APIGENIN 7-0-beta-glucoside in the Matricaria chamomilla ligulate flowers
  533. The protective effects of APIGENIN in myocardium of rats with ischemia reperfusion injury J
  534. Optimal recovery of APIGENIN from Torreya grandis by extraction, fractionation and structure elucidation
  535. Arbuscular mycorrhizal formation of crucifer leaf mustard induced by flavonoids APIGENIN and daidzein
  536. Study on estrogenic effect of genistein and APIGENIN in vitro
  537. Involvement of K+-Cl–Cotransport in the APIGENIN-Induced Generation of Reactive Oxygen Species in IMR-32 Human Neuroblastoma Cells
  538. VEGF expression is inhibited by APIGENIN in human breast cancer cells
  539. The Research on the Mechanism of the Effect of APIGENIN on the Leydig Cells of Rats [J]
  540. Über die Verbreitung von Flavonoiden bei pleurokarpen Laubmoosen I. APIGENIN-7-rhamnoglucosid bei Hylocomium splendens (Hedw.) Br. eur.
  541. The first total synthesis of 7-O-β-d-glucopyranosyl-4′-O-α-l-rhamnopyranosyl APIGENIN via a hexanoyl ester-based protection strategy
  542. The variability of (Z)‐ and (E)‐2‐β‐D‐glucopyranosyloxy‐4‐methoxycinnamic acids and APIGENIN glucosides in diploid and tetraploid Chamomilla recutita
  543. Total synthesis of APIGENIN-4′-yl 2-O-(p-coumaroyl)-β-d-glucopyranoside
  544. Transfer of apiose from UDP-apiose to 7-O-(β-D-glucosyl)-APIGENIN and 7-O-(β-D-glucosyl)-chrysoeriol with an enzyme preparation from parsley
  545. APIGENIN-induced apoptosis of bladder cancer cell BIU-87 and its mechanism [J]
  546. Inhibitory effects of APIGENIN and kaempferol on the essential solute carrier transporters
  547. HPTLC method for quantification of APIGENIN in the dried root powder of Gmelina arborea Linn.
  548. Isolation and Purification of APIGENIN and Luteolin from Pteris multifida Poir. by High-speed Counter-current Chromatography.
  549. Biological synthesis of 7-O-methyl APIGENIN from naringenin using Escherichia coli expressing two genes
  550. Effect of APIGENIN on expression of VEGF in cerebral ischemia and reperfusion rats
  551. Pharmacokinetics and tissue distribution of APIGENIN niosomes
  552. Determination of Psoralen and APIGENIN in Radix Fici Hirtae by HPLC
  553. Endothelium-dependent vasorelaxation effects induced by APIGENIN on the thoracic aorta of rats and its possible mechanism
  554. Effects of APIGENIN on caveolin-1 expression of focal cerebral ischemia-reperfusion in rats.
  555. Improvement of the antioxidant activity of APIGENIN in linoleic acid system by o-prenylation
  556. An enzyme‐linked immunosorbent assay for the measurement of plasma flavonoids in mice fed APIGENIN‐C‐glycoside
  557. Effect of high dose APIGENIN on antioxidase activity and DNA damage in rats
  558. 17. Chalkones: a new synthesis of chrysin, APIGENIN, and luteolin
  559. Preparation of APIGENIN niosomes and properties investigation
  560. APIGENIN and kaempferol effects on oral cancer FADU cells
  561. Quantitative Determination of APIGENIN in Pteris semipinnata L. by HPLC [J]
  562. A New Flavone Glucoside, APIGENIN 7-O-glucoside 4′-acetate and a New Fern Constituent, Quercetin 3-O-rhamnoside-7-O-glucoside from Dryopteris villarii
  563. Effects of APIGENIN, an antioxidant, on the bioavailability and pharmacokinetics of etoposide
  564. Pre-formulation study on APIGENIN in solid lipid nanoparticles
  565. Three new flavonoid glycosides, kaempferol 3-O-(caffeoylrhamnoside), APIGENIN 4′-O-(caffeoylglucoside) and 4′-O-(feruloylglucoside) from Dryopteris villarii
  566. High-performance thin-layer chromatographic quantification of kaempferol and APIGENIN in the whole-plant powder of Sida spinosa Linn.
  567. Acute toxicity, genetic toxicity and sub-chronic toxicity of APIGENIN
  568. The research on the effect of APIGENIN injected to lateral brain ventricle on the reproductive axis of female rat
  569. Recognition property and mechanism of molecularly imprinted polymers of APIGENIN
  570. Sub-cellular distribution and antioxidant potential of plant flavonoid APIGENIN
  571. Neuroprotective Effects of APIGENIN on Acute Transient Focal Cerebral Ischemia-reperfusion Injury in Rats [J]
  572. APIGENIN augments the growth inhibitory effects of doxorubicin in breast cancer cells derived from African American patients
  573. The Anti-Inflammatory Mechanisms of the Flavonoid APIGENIN In Vitro and In Vivo
  574. Enhancement of TRAIL-induced apoptosis in human hepatocellular carcinoma cells by APIGENIN
  575. CXVI.—Notes on luteolin and APIGENIN
  576. Inhibitory effects of APIGENIN on the expression of GATA-3 and Th2 cytokines in asthmatic mice
  577. Induction effects of APIGENIN, luteolin and vinpocetin on neutral endopeptidase (NEP) and angiotensin-converting enzyme activity (ACE) of SK-N-SH cells
  578. HPLC investigation on the determination of APIGENIN and its interaction with human serum albumin
  579. Development of RP-HPLC assay for determination of total luteolin and APIGENIN in plasma and its application to pharmacokinetics after single oral dose of …
  580. 6, 8,-di-C-β-D-Arabinopyranosyl APIGENIN from Thea sinensis var. macrophylla
  581. Protective Effect of APIGENIN against Ethinylestradiol induced Toxic Effects in the Third Instar Larvae of Transgenic Drosophila melanogaster (hsp70-lacZ) Bg 9
  582. On the isolation of APIGENIN from manchurian kaoliang (andropogon sorghum, brot)
  583. Determination of Quercetin, APIGENIN and Luteolin in Viola yedoensis Makino by RP-HPLC
  584. The study on separation and purification of APIGENIN using collagen fiber adsorbent
  585. Progress in the research of pharmacology of APIGENIN [J]
  586. APIGENIN induces apoptosis in human leukemia cells and exhibits anti-leukemic activity in athymic nude mice
  587. APIGENIN causes growth arrest in pancreatic cancer cells through down-regulation of the replication inhibitor protein, Geminin via both transcription and ubiquitin …
  588. APIGENIN induction of p53-independent apoptosis in MDA-MB-231 breast cancers
  589. Anti cancer activity of APIGENIN isolated from Sorghum (Sorghum bicolor L. Moench)
  590. The first total synthesis of APIGENIN 7-O-β-D-cellobiosyl-4′-O-β-D-glucopyranoside isolated from Salvia uliginosa
  591. The Roles of APIGENIN on Leydig Cells in Testes of Rats [J]
  592. Growth and telomerase inhibition of SK-MEL 28 melanoma cell line by a plant flavonoid, APIGENIN
  593. Effect of APIGENIN on gap junctional intercellular communication in human Tenon’s capsule fibroblasts.
  594. HPLC determination of parthenolide and APIGENIN contents versus label claims in Iranian products
  595. Role of –cotransporter in the APIGENIN-induced Stimulation of Melanogenesis in B16 Melanoma Cells
  596. Researches on the Structure and Antioxidant Activity of APIGENIN-La (III) Complex
  597. Theoretical Study of the Structural and Electronic Properties of Luteolin and APIGENIN Dyes
  598. APIGENIN induces pancreatic cancer cell apoptosis by a P53-mediated mechanism
  599. The Process Research of Extraction of APIGENIN in Apium graveolens [J]
  600. APIGENIN inhibits pancreatic cancer cell proliferation via down-regulation of the GLUT-1 glucose transporter through the phosphoinositide 3-kinase (PI3K)/Akt …
  601. Thermospray liquid chromatography-mass spectrometry (TSP LC-MS) analysis of acetylated APIGENIN 7-glucosides from Chamomilla recutita
  602. Synthesis of water-soluble APIGENIN
  603. APIGENIN suppresses IKK activation and downstream signaling leading to prostate cancer inhibition.
  604. Determination of Quercetin, Kaempferol, Luteolin, APIGENIN in Semen Plantaginis By RP-HPLC [J]
  605. Study on Interaction between APIGENIN and Human Serum Albumin by Spectroscopy and Molecular Modeling [J]
  606. Protective Effect and Mechanisms of APIGENIN against Free Radical-induced DNA Damage [J]
  607. LC determination of luteolin-7-O-β-D-glucoside and APIGENIN-7-O-β-D-glucoside in rat plasma after administration of Humulus scandens extract and its application …
  608. APIGENIN blocks tumor growth, invasion and metastasis by upregulation of maspin in TRAMP model
  609. AMPK-mTOR axis as key target for chemoprevention of UV-induced skin cancer by the bioflavonoid APIGENIN
  610. APIGENIN A Potent Anti-Inflammatory Flavonoid: Its Efficacy In Lung Inflammation And Target Identification Provides Novel Potential Alternative Therapeutic …
  611. Plant flavonoid APIGENIN preferentially binds with GC-rich DNA sequences and inhibits DNA methylation
  612. Transcriptional repression of androgen receptor in human prostate cancer cells by plant flavone APIGENIN
  613. Research on joint anti-MRSA activity of APIGENIN in vitro
  614. The Effect of APIGENIN on the Estrous Cycle in Female SD Mice [J]
  615. Effects of Genistein, APIGENIN, Quercetin, Rutin and Astilbin on xanthine oxidase activities and serum uric acid levels in hyperuricemic mice
  616. Content determination of luteolin and APIGENIN in Mongolian medicine Scabiosa tschilliensis by HPLC
  617. Simultaneous determination of APIGENIN and kaempferol in the Wikstroemia indica (L.) CA Mey. by HPLC [J]
  618. Preparation of APIGENIN solid lipid nanoparticles
  619. Effect of APIGENIN from mallotus apelta on proliferation and apoptosis in nude mice bearing human gastric carcinoma
  620. Antiinflammatory and Antinociceptive properties of luteolin diglucuronide and APIGENIN diglucuronide obtained from Perilla nankinensis
  621. Dietary flavonoid APIGENIN is not effective in preventing development of a bleomycin-induced murine model of scleroderma
  622. 3-C-(6 ″’-O-Acetyl-β-cellobiosyl) APIGENIN, a New Flavonoid from Pteris vittata
  623. Effect of APIGENIN on the Proliferation and Differentiation of 3T3-L1 Preadipocytes [J]
  624. Protective effect of APIGENIN in acute cerebral injury of rats [J]
  625. Total synthesis of 8-(1, 1-dimethylallyl)-APIGENIN
  626. Effect of Kaempferol, APIGENIN on injury of mitochondria in H_2O_2-induced cardiomyocyte apoptosis [J]
  627. Behavioural responses of Lymnaea acuminata against APIGENIN, morusin and quercetin in bait pellets
  628. DETERMINATION OF APIGENIN, LUTEOLIN AND ISOQUERCITRIN BYCAPILLARY ZONE ELECTROPHORESIS [J]
  629. Pharmacokinetics of luteolin and APIGENIN in rats after single oral administration of Chrysanthemum morifolium extract at the dose of effectiveness and approximate to …
  630. Preparation and spectral characterization of APIGENIN molecularly imprinted polymer
  631. A rapid densitometric method for the quantification of APIGENIN-7-glucoside in Euphorbia prostrata herb using HPTLC.
  632. Inhibitory effects of APIGENIN on human ovarian cancer cell strain SKOV3 growth [J]
  633. Antioxidant action of APIGENIN, quercetin-3, 3′-dimethyl etherhe and quercetagetin-3, 6-dimethyl ether-7-o-glucoside in vitro
  634. Pharmacokinetics of APIGENIN solid lipid nanoparticles in rats
  635. RP-HPLC simultaneous determination of luteolin, APIGENIN and kaempferol in Verbena oficinalis L.
  636. Determination of APIGENIN in Leaves of large leaf water dropwort by HPLC
  637. Effect of APIGENIN on SBP of spontaneous hypertension rats and its mechanism.
  638. Evaluation of induced apoptosis of APIGENIN in 3 lines of human B cell lymphoma in vitro
  639. Effect of APIGENIN on hepatic fibrosis induced by carbon tetrachloride in mice
  640. Study on intestinal absorption kinetics of APIGENIN in rats
  641. APIGENIN inhibits TNFα-induced cell proliferation in endometriotic stromal cells
  642. Effects of kaempferol, APIGENIN and daidzein on H_2O_2-induced apoptosis in neonatal rat cardiomyocytes [J]
  643. Study on pro-apoptotic effect of APIGENIN on human ovarian cancer cells and its underlying mechanisms
  644. Determination of the concentration of APIGENIN in rat plasma and bile by HPLC method
  645. Induction of differentiation of Hep G2 cells by APIGENIN
  646. Targeting TSP1 and inhibiting angiogenesis in UV-induced skin cancer by APIGENIN.
  647. The Protection of APIGENIN on Autoimmune Hepatitis in Mice [J]
  648. The Protective Effect of APIGENIN on Hepatic Ischemia Reperfusion Injury in Rats
  649. APIGENIN enhances gemcitabine-induced pancreatic cancer cell apoptosis
  650. Protective effects of APIGENIN against methyl methanesulfonate induced hsp70 expression in the third instar larvae of transgenic Drosophila melanogaster (hsp70-lacZ …
  651. APIGENIN induces p53-dependent apoptosis and G 2/M arrest in breast cancer T47D cells
  652. APIGENIN Delays the Senescence of Human Umbilical Vein Endothelial Cells in Vitro [J]
  653. HPLC determination of luteolin and APIGENIN in rat bile and its application
  654. Effect of APIGENIN on matrix metall-oproteinases and CD44v6 in human colon cancer cell SW480
  655. Effects of APIGENIN on membrane potential in the liverwort Conocephalum conicum
  656. Effect of Lateral Ventricle Injection of APIGENIN on Ovary Function of Female Rats during Estrus
  657. APIGENIN augments the therapeutic efficacy in vitro in thymidine kinase gene system on prostate cancer
  658. APIGENIN inhibits the expression of VEGF in human breast cancer cells named MDA-MB-231 [J]
  659. APIGENIN Derivatives of Paulownia coreana Uyeki Leaves
  660. EFFECT OF APIGENIN ON EXPRESSION OF NF-κB AND ICAM-1 IN RAT MYOCARDIUM WITH ISCHEMIA REPERFUSION [J]
  661. HPLC determination of luteolin and APIGENIN in Siphonostegia chinensis
  662. Effects of APIGENIN on the Proliferation and Cytokine Gene Expression of Murine T Lymphocytes [J]
  663. Biokonverzija APIGENIN-7-O-β-glukozida u vodenom dvofaznom sistemu
  664. In vivo radioprotective effect of curcumin, taurine, APIGENIN and kampferol on DNA damage in mouse
  665. Effect of APIGENIN on Early Cognition of Rats with Ischemic Hypoxia Neonatal Brain Damage
  666. Anti-inflammatory Effect of APIGENIN on Microglia after Oxygen Glucose Deprivation and Reperfusion
  667. Studies on pharmacy characters and pharmacokinetics of oral APIGENIN loaded solid lipid nanoparticle
  668. Induction of apoptosis through up-regulating PTEN in human hepatocellular carcinoma HepG2 cell line by APIGENIN
  669. Plant flavonoid APIGENIN inhibits prostate carcinogenesis by suppressing β-catenin signaling pathways
  670. Determination of Luteolin and APIGENIN in Chrysanthemum morifolium Extract by RP-HPLC [J]
  671. APIGENIN-mediated modulations of PI3K-Akt and MAPK signaling pathways causes growth Inhibition and cell cycle arrest in human prostate cancer cells
  672. Determination of the Contents of Lomefloxacin Hydrochloridum, Quercetin and APIGENIN in Propolis from Different Production Areas by HPLC
  673. Enzymatic Synthesis of APIGENIN Glucosides by Glucosyltransferase (YjiC) from Bacillus licheniformis DSM 13
  674. Suppression of early colon cancer lesions by APIGENIN and naringenin is in part due to their downregulation of p21, TLR‐4, and MCT‐1 expression
  675. High-performance liquid chromatography for determination of psoralene, bergapten and APIGENIN in Ficus hirta Vahl
  676. Effect of APIGENIN on the Expression of NF-κB and iNOS in Transient Focal Cerebral Ischemia and Reperfusion Model of Rats
  677. Insight into the mechanisms by which APIGENIN, curcumin and sulfasalazine induce apoptosis in colon cancer cells
  678. The Pattern of Accumulation of APIGENIN in the Ligulate Flowers of Chamomilla recutita in Extremely Varying Ecological Conditions
  679. Optimization of mobile phase condition by using HCI program for extracting luteolin and APIGENIN from celery
  680. Inhibition of Viability and Induction of Apoptosis by APIGENIN via Induction of Glutathione Depletion in Human Hepatocellular Carcinoma Hep G2 Cell Line [J]
  681. Dietary flavonoid APIGENIN sensitizes malignant tumor cells to tumor necrosis factor-related apoptosis-inducing ligand
  682. APIGENIN INHIBITS HUMAN PANCREATIC CANCER CELL PROLIFERATION THROUGH G2/M CELL CYCLE ARREST.
  683. Cell apoptotic determination by Annexin V-FITC assay in APIGENIN and rutin-induced cell death in breast cancer cells
  684. Selectively Inhibition of Cell Viability and Induction of Apoptosis in Human Gastric Cancer BGC-823 Cell Line by APIGENIN [J]
  685. Identification of APIGENIN metabolites in rat liver perfusate by column switching high performance liquid chromatography/electrospray ionization mass spectrometry
  686. Modulation of AKT, ERK and Mcl-1 by APIGENIN sensitizes colon cancer cells to anti-tumor activities of ABT263.
  687. Role of NADPH oxidase-mediated generation of reactive oxygen species in the APIGENIN-induced melanogenesis in B16 melanoma cells
  688. APIGENIN inhibits TGF-beta-induced VEGF expression in human prostate carcinoma cells via Smad2/3 and Src/FAK/Akt signaling pathways
  689. APIGENIN inhibits constitutive and TNFalpha-mediated NF-kappaB activation and induces apoptosis in human prostate carcinoma PC-3 cells: Correlation with NF …
  690. HPLC determination of APIGENIN-7-O-β-D-neospheroside and APIGENIN-7-O-β-D-glucopyranoside in the leaves of Exochorda serratifolia S. Moore
  691. Research progress in antitumor effect and its mechanism of APIGENIN
  692. HPTLC densitometric quantification of glycyrrhizin, glycyrrhetinic acid, APIGENIN, kaempferol and quercetin from Glycyrrhiza glabra.
  693. Dietary APIGENIN and naringenin protect against colon carcinogenesis by lowering high multiplicity aberrant crypt foci and enhancing apoptosis in azoxymethane …
  694. Efficient synthesis of APIGENIN
  695. Hypnosedative activity of P. alata and its correlation with APIGENIN
  696. Effect of APIGENIN on Reproduction and Reproductive Endocrinology
  697. Progress in anti-tumor mechanisms of APIGENIN.
  698. Effect of 3-methyladenine on APIGENIN-induced autophagy and apoptosis in the breast cancer T47D cell line
  699. APIGENIN biotransformation using microorganism
  700. APIGENIN Biotransformation Using Microorganism
  701. Cytotoxic effects of APIGENIN on multiple myeloma cells
  702. Protective effect of APIGENIN in acute cerebral injury of rats
  703. The anti-tumour effects of APIGENIN in neuroblastoma.
  704. APIGENIN 4′-O-methyltransferase
  705. Determination of Nuezhenide and APIGENIN 7-O-neohesperidoside in Shanxiangyuan tablets by HPLC
  706. Determination of APIGENIN in Herba Spirodrlae by HPLC
  707. Determination of the protein binding rates of APIGENIN with different kinds of plasma by HPLC
  708. Metabolism of APIGENIN by rat intestinal flora
  709. New APIGENIN Triosides From The Seeds of Syzygium aromaticum
  710. APIGENIN-ask a busy flavone!
  711. Study on Optimization of Complexing Condition between APIGENIN and Zinc by Orthogonal Design
  712. Effect of APIGENIN on Proliferation and Metastasis of Cell Line MDA-MB-231
  713. APIGENIN INHIBITS TNF-INDUCED CELL PROLIFERATION IN
  714. The influence of APIGENIN on growth and apoptosis in prostate cancer cells
  715. Determination of APIGENIN in chamomile by HPLC
  716. Odredjivanje APIGENINa i APIGENIN 7-0-beta-glukozida u jezicastim cvetovima kamilice [Matricaria chamomilla].
  717. The inhibitory effects of APIGENIN in the in vitro activation and proliferation of mouse lymphocytes
  718. Molecular mechanism of APIGENIN induced apoptosis in leukemia
  719. Vasorelaxation and Antiproliferation of APIGENIN
  720. Effects of APIGENIN on HeLa Cell Growth in Vitro [J]
  721. The Effect of APIGENIN on Gram Positives and Negative Bacteria
  722. Src kinase is a novel target for anti-skin inflammation of APIGENIN
  723. Study on metabolism of APIGENIN from celery leaf in human
  724. Effects of APIGENIN on H_2O_2-induced Apoptosis in Melanocytes
  725. The inhibitory effects of APIGENIN in the in vitro activation and proliferation of mouse lymphocytes
  726. Experimental research of the effect of APIGENIN on the biological activity of human colon cancer cell line Lovo and its mechanism in vitro
  727. In-vitro glycosylation of APIGENIN by YjiC from Bacillus licheniformis
  728. Effect of APIGENIN on cell cycle of spermatogenic cells of male mice.
  729. Evaluation of induced apoptosis of APIGENIN in 3 lines of human B cell lymphoma in vitro
  730. APIGENIN Induces Apoptosis in Primary Effusion Lymphoma.
  731. The Therapeutic Efficacy of APIGENIN in a Murine Model of Scleroderma
  732. Determination of Psoralen and APIGENIN in Radix Fici Hirtae by HPLC
  733. Determination of APIGENIN in corn silk by HPLC
  734. Determination of APIGENIN in Celery by Dansyl chloride Fluorescence Quenching Spectrophotometry
  735. Effects of APIGENIN on the pharmacokinetics of nimodipine in rats
  736. The inhibitory effect of APIGENIN associated with cytoxan on mice inoculated with cervical cancer cell (U14)
  737. The effects of APIGENIN on the recovery of neurological function following focal cerebral ischemia and reperfusion
  738. Labeling of APIGENIN with {sup 131} I and bioactivity of {sup 131} I-APIGENIN in male and female rats
  739. Effect and mechanism of APIGENIN on in vitro maturation of Xenopus oocytes
  740. APIGENIN-induced apoptosis of bladder cancer cell BIU-87 and its mechanism
  741. Effect of APIGENIN on hippocampus neuron injury induced by A?-amyloid 25-35
  742. APIGENIN Protects Normal Blood Cells Against Adriamycin-Induced Injury Depending on Antioxidative Action
  743. Inhibitory effect of APIGENIN on human Tenon capsule fibroblasts
  744. APIGENIN potassium: a promising molecule for radiation protection
  745. Study on Inclusion Compound of APIGENIN with Hydroxypropyl-β-Cyclodextrin [J]
  746. APIGENIN inactivates Akt to trigger apoptosis in human prostate cancer cells
  747. Study on the APIGENIN of Antitumor Chinese Herbal Herb FLOS BUDDLEJAE [J]
  748. THE GROWTH INHIBITION AND APOPTOSIS-INDUCING EFFECTS OF APIGENIN IN HUMAN GASTRIC CARCINOMA CELLS
  749. Effect of APIGENIN on CIK Cells Killing Colonic Cancer SW1116 Cells
  750. Determination of Quercetin and APIGENIN in Verbena officinals from different regions and different times
  751. Roles for Flavonoid APIGENIN in Regulation of the Mammalian Stress Response
  752. APIGENIN inhibition of involucrin gene expression is associated with a specific reduction in phosphorylation of Protein Kinase C δ Tyr311
  753. Effects of APIGENIN, a Flavonoid, on the Bioavailability of Tamoxifen in Rats
  754. APIGENIN inhibition on alpha glucosidase in mice intestinal
  755. Protective Effect of APIGENIN on Human Umbiliacal Vein Cells Injuries Induced by Homocysteine
  756. Preparation and Characterization of APIGENIN-loaded Lipid Nanocapsules
  757. Preparation and in vitro release test of APIGENIN-loaded chitosan microspheres [J]
  758. Involvement of early growth response gene 1 (EGR-1) in growth suppression of the human colonic tumor cells by APIGENIN and its derivative isovitexin
  759. Evaluation of topical delivery properties of APIGENIN in different vehicles and the implications in skin cancer prevention
  760. Synthesis and Anti-hepatoma Activities of APIGENIN etherified and brominated derivatives
  761. Determination of APIGENIN content from celery by high performance liquid chromatography (HPLC)
  762. Isolation of APIGENIN From Trigonella foenum Graecum Seed Extract Using Column Chromatograpy on Lab Scale
  763. The molecular mechanism (s) of skin chemoprevention by the plant flavonoid APIGENIN
  764. Molecular basis for the action of a dietary flavonoid revealed by the comprehensive identification of APIGENIN human targets
  765. Structural analysis of lipopolysaccharides from Sinorhizobium sp. NGR234 induced by APIGENIN
  766. Mechanism for APIGENIN complexing with cellular phosphatidylcholine
  767. APIGENIN glucosides in tetraploid bisabolol variety of camomile
  768. APIGENIN enhances the proliferative inhibition effect of aspirin in colon cancer cells by inhibiting COX-2
  769. APIGENIN intake regulates Fox ‘O’signaling in an autochthonous mouse model of prostate cancer
  770. Effects of APIGENIN on H2O2-induced apoptosis in melanocytes.
  771. Evaluating the Inhibitory Activity of APIGENIN Extracted from Salvia officinalis leaves on the Growth of L20B Cancer Cell Line
  772. Effect of APIGENIN on Learning Ability of Senile Mice Induced by D-Galactose
  773. Growth inhibitory effects of gemcitabine are augmented by the flavonoid APIGENIN in human pancreatic cancer cells
  774. Radiolabeling of APIGENIN with 131I and biodistribution in rats
  775. Effect of APIGENIN on P38MAPK in Partial Cerebral Tissues of Intermittent Hypoxia Weanling Rats
  776. APIGENIN INHIBITS GLUTAMATE-INDUCED CALCIUM SIGNALING IN CULTURED RAT HIPPOCAMPAL NEURONS
  777. Electrochemical research on the APIGENIN of antitumor Chinese medicinal herb FLOS BUDDLEJAE.
  778. APIGENIN-induced prostate cancer cell death is initiated by reactive oxygen species and p53 activation
  779. Effect of APIGENIN on SOD, GSH-Px, CAT Activities in Male Mice Liver
  780. UVB-induced apoptosis in keratinocytes is enhanced by the chemopreventive bioflavonoid APIGENIN.
  781. APIGENIN-induced cell cycle arrest at G2/M in human colon cancer cells
  782. The killing effect and its mechanism about C6 lines transfected with TK gene after treated with APIGENIN/GCV after in vitro
  783. Induction of caspase-dependent, p53-mediated apoptosis by APIGENIN in 22Rv1 athymic nude mice tumor xenograft
  784. APIGENIN, a chemopreventive flavonoid, enhances p53 expression through RNA-binding protein HuR
  785. APIGENIN regulates prostate cancer matrix composition and cell attachment through an integrin alpha 1 dependent pathway
  786. APIGENIN intake suppresses IGF-I signaling in an autochthonous mouse model of prostate cancer
  787. Impact of APIGENIN on ovarian granulosa cell apoptosis in female rats
  788. Role of Membrane Ion Transporters in the APIGENIN-Induced Melanogenesis in B16 Melanoma Cells
  789. Inhibition of prostate carcinogenesis in TRAMP mice by oral intake of plant flavonoid APIGENIN
  790. Effect of glycogen synthase kinase‐3B inhibition by APIGENIN on markers of proliferation, inflammation and apoptosis in pancreatic cancer
  791. Synthesis and anti-multidrug resistant Staphylococcuc aureus (MRSA) activity of alkylated APIGENIN
  792. Combinatory effects of the bioflavonoid APIGENIN with chemotherapeutic drugs on prostate, colon, and lung cancer cell lines
  793. The effects of APIGENIN on proteoglycan synthesis in the human lumbar discs under hydrostatic pressure
  794. Role of glutathione depletion in APIGENIN-induced apoptosis of osteogenic sarcoma MG-63 cell line in vitro [J]
  795. APIGENIN down-regulates constitutive activation of AKT and induces apoptosis in primary effusion lymphoma cells
  796. Abstract C7: Inhibitory effects of flavonoid APIGENIN by oral administration on angiogenesis of ovarian cancer through decrease VEGF expression in mouse model.
  797. APIGENIN: Chemopreventive and chemotherapeutic potential for progestin-dependent breast cancer
  798. Mechanism study of APIGENIN inducing apoptosis of human ovarian cancer cells through inhibiting protein kinase B activity
  799. Effect of the near UV radiation on the flavonoid content of APIGENIN and quercetol of the Ononis spinosa L.
  800. APIGENIN and quercetin promote ΔpH-dependent accumulation of IAA in membrane vesicles
  801. APIGENIN and naringenin favorably modulate aberrant crypt foci development and colonic cell cytokinetics
  802. The inhibitory effect of APIGENIN-O-7–D-glucuronopyranoside on esophagitis and gastritis in rats
  803. Inhibitory mechanism of rat aortic vascular smooth muscle cell proliferation by APIGENIN
  804. Complex effects of dietary APIGENIN on prevention of MPA-accelerated DMBA-induced mammary tumors in Sprague-Dawley rats.
  805. NANOSCALE MOLECULAR DYNAMICS SIMULATION OF ANTICANCER DRUGS, QUERCETIN AND APIGENIN IN A LIPID BILAYER MEMBRANE
  806. Sensitization of Human Ovarian Cancer CoC1 Cells to TRAIL-induced Apoptosis by APIGENIN
  807. Alfalfa (Medicugo sutiva L.) APIGENIN Glycosides and Their Effect on the Pea Aphid (Acyrthosiphon pisum)
  808. Determination of Vitexin and APIGENIN-7-O-β-D-Pyranglycu Ronide in Broussonetia papyrifera by HPLC
  809. Chromatographic analyses of matrine and APIGENIN for rodent tissue distribution studies
  810. HPLC [high pressure liquid chromatography] determination of APIGENIN and its glucosides in chamomile (Matricaria chamomilla L.)
  811. The Infusion of Intermittent Hypoxia on p38MAPK and UItrastructure Changes in Marginal Striatum of Weanling Rats and the Intervention Effects of APIGENIN
  812. Effect of APIGENIN on apoptotic rate and matrix metabolism of human nucleus pulposus cells cultured in vitro under hydrostatic pressure
  813. Study on Interaction between APIGENIN and Herring Sperm DNA by Acridine Orange as a Fluorescence Probe
  814. Inhibition of growth and induction of differentiation by APIGENIN, baicalein and quercetin in colon cancer cells
  815. APIGENIN Induces Alterations of Reactive Oxygen Species, Ca+2 and Mitochondria Membrane Potential in Human Lung Cancer H460 and A549 Cells
  816. Anti-Ulcer Effect of $ APIGENIN-7-O-{\beta}-D-Glucuronide $ Isolated from Chrysanthemum morifolium Ramataelle
  817. APIGENIN prevents chemically-induced skin tumor formation and inhibits COX-2 expression and activity in SKH-1 mouse epidermis
  818. Potentiation of Human Cervical Cancer HeLa Cells to TRAIL-induced Apoptosis by APIGENIN
  819. Effects of APIGENIN on proteoglycan core protein’s gene expression in the human lumbar disc nucleus pulposus in response to hydrostatic pressure
  820. [61] UDP-apiose: 7-O-(β-d-glucosyl) APIGENIN apiosyltransferase from Parsley
  821. Protective effect of quercetin and APIGENIN on hydrogen peroxideinduced apoptosis in HeLa cells
  822. Chemopreventive Efficacy of APIGENIN against N-Nitrosodiethylamine-Induced and Phenobarbital-Promoted Experimental Hepatoma
  823. Differential modulation of cyclooxygenase (COX) enzymes by the two putative cancer chemopreventive flavones APIGENIN and tricin
  824. RP-HPLC-DAD determination of quercetin, luteolin and APIGENIN in Marchantia covoluta
  825. Content determination of vitexin and APIGENIN-7-O-β-D-pyranglycuronide in Broussonetia papyrifera leaves by HPLC.
  826. Effect of APIGENIN on Oxidative Stress Induced by Daidzein and Genistein in Hamster Ovary Cells
  827. APIGENIN and naringenin decrease cell number in a dose dependent manner in non‐transformed young adult mouse colonocytes (YAMC) but not in those expressing …
  828. APIGENIN blocks medroxyprogesterone acetate-dependent progression of BT-474 human breast tumor xenografts by inducing apoptosis
  829. APIGENIN, a non-mutagenic dietary flavonoid, suppresses lupus by inhibiting autoantigen presentation for expansi…
  830. Flavones from marchantia convoluta: isolation of APIGENIN-7-O-Beta-D-glucuronide and 5-hydroxyl-7-methoxyl-2-methylchromone
  831. Antioxidant properties and five new phenylpropanoid esters of APIGENIN from Sideritis syriaca L
  832. Effect of parsley intake on urinary APIGENIN excretion, blood antioxidant enzymes and biomarkers for oxidative stress in humans.
  833. Thomas Jefferson University, Department of Pathology, Anatomy and Cell Biology, Oral Administration of APIGENIN Inhibits Metastasis through AKT/P70S6K1/MMP-9 …
  834. APIGENIN prevents development of progestin-accelerated 7, 12-dimethylbenz (a) anthracene (DMBA)-induced mammary tumors in Sprague-Dawley rats
  835. SIMULTANEOUS DETERMINATION OF LUTEOLIN AND QUERCETIN AND APIGENIN IN BIDENS TRIPARTITAA L. BY RP-HPLC
  836. APIGENIN induces apoptosis through proteasomal degradation of HER2/neu in HER2/neu-overexpressing breast cancer cells via the phosphatidylinositol 3-kinase/Akt …
  837. Sensitization of Human Ovarian Cancer CoC1 Cells to TNF-Related Apoptosis-Inducing Ligand (TRAIL)-Induced Apoptosis by APIGENIN [J]
  838. QS301. APIGENIN Potentiates Gemcitabine-Induced Growth Arrest of Pancreatic Cancer Cells Through Blocking of Gemcitabine-Induced Upregulation of Cell Cycle …
  839. Effect of APIGENIN, kaempferol and resveratrol on the expression of interleukin-1b and tumor necrosis factor-a genes in J774. 2 macrophages
  840. Fluorescence Spectroscopic Study on the Mechanism of Interaction of Bovine Serum Albumin with Luteolin, APIGENIN or Puerarin
  841. Bioassay-guided isolation of APIGENIN with GABA-benzodiazepine activity from Tanacetum parthenium
  842. APIGENIN and Kaempferol inhibit LPS‐induced inflammatory responses by regulating intracellular translocation of RNA‐binding protein HuR in macrophages
  843. Antiarthritic Activity of APIGENIN, Scutellarein and Pectinolinergenin Glycosides from Clerodendron inerme
  844. The changes in APIGENIN, luteolin and their-7-O-glucosides content during Herba millefolii (Achillea collina Becker ex. Rchb. var.’Alba’) onthogenesis.
  845. Effect of APIGENIN on the expression of microglia in penumbra and cerebral water content after focal cerebral ischemia-reperfusion injury in rats.
  846. Study on APIGENIN Quantitation Analysis from Celery Extractions by High-performance Liquid Chromatography (HPLC) and High-performance Lamina …
  847. Isolation of APIGENIN-7, 4′-Dimethylethers from Leaves of Aquilaria Sinensis (Lour.) Gilg by High-Speed Counter-Current Chromatography and Its Scavenging Effect …
  848. HPLC determination of quercetin, luteolin and APIGENIN inLamiophlomis rotata (Benth.) Kudo and its capsules
  849. Potent Suppressive Effect of Resveratrol and APIGENIN on Pro‐Inflammatory Responses in Lipopolysaccharide and IFN‐γ‐activated Microglia and Macrophages …
  850. KLF4 overexpression and APIGENIN treatment inhibited cell migration and induced apoptosis in human malignant neuroblastoma SK-N-DZ and IMR32 cells
  851. APIGENIN protects 7, 12-dimethylbenz (a) anthracene–induced chromosomal abnormalities and DNA damage in the bone marrow cells of golden Syrian hamsters
  852. GEMININ, A REPLICATION INHIBITOR PROTEIN, IS OVER-EXPRESSED IN PANCREATIC CANCER TISSUE AND APIGENIN AFFECTS REPLICATION BY DOWN …
  853. Knockdown of N-Myc and concurrent treatment with APIGENIN controlled growth of human malignant neuroblastoma cells having N-Myc amplification
  854. Genetic control of APIGENIN di-C-glycoside biosynthesis in bread wheat grain and their role as yellow pigments of Asian alkaline noodles.
  855. Abstract# 5116: 5-Fluorouracil combined with APIGENIN enhances anticancer activity through induction of apoptosis in human breast cancer MDA-MB-453 cells
  856. Abstract# 3089: APIGENIN Inhibits HGF-Promoted Invasive Growth and Metastasis in MDA-MB-231 Breast Cancer Cells
  857. Simultaneous isolation of catechin, epicatechin, rutin and APIGENIN from spearmint (Mentha spicata L.) leaves by supercritical carbon dioxide (SC-CO2) …
  858. … , and other constituents from the leaves of Ochroma pyramidale (balsa wood, Bombacaceae): preferred conformations of 8-CbD-glucopyranosyl-APIGENIN …
  859. Abstract# 2962: APIGENIN downregulates XIAP protein expression through HDAC1 in prostate cancer
  860. 1456: The Flavonoid APIGENIN Inhibits the Proliferation of Prostatic Stromal Cells by Cell Cycle Arrest in G1/S
  861. 270 APIGENIN DECREASES HEMIN-MEDIATED HEME OXYGENASE-1 INDUCTION
  862. 7-(3-benzyloxypropyl) APIGENIN, a novel cytotoxic flavone derivative
  863. Abstract# 2990: Inhibition of histone deacetylase by plant flavone APIGENIN: A novel mechanism of chemoprotection
  864. Abstract# 961: Anti-proliferative activity of APIGENIN in colorectal and breast cancer cells
  865. Inhibition of HIF-1 alpha and VEGF expression by the chemopreventive bioflavonoid APIGENIN is accompanied by Akt inhibition in human prostate carcinoma PC3-M …
  866. Suppression of neurotensin receptor type 1 expression and function by APIGENIN in human colorectal cancers involves protein kinase CK2/JNK pathway
  867. UVB-induced COX-2 transcription in mouse keratinocytes requires the Ebox, ATF/CRE and NF-IL6 responsive elements and is inhibited by the bioflavonoid APIGENIN.
  868. 3′-Hydroxylation of APIGENIN by a Membrane-Bound Enzyme of Primary Leaves of Secale cereale: Localization and Characterization
  869. 4-HPR and APIGENIN together suppressed autophagy and cell survival pathways to increase apoptosis in human malignant neuroblastoma SH-SY5Y cells
  870. The therapeutic potential of APIGENIN
  871. Health functionality of APIGENIN: A review
  872. APIGENIN in cancer therapy: anti-cancer effects and mechanisms of action
  873. APIGENIN: A current review on its beneficial biological activities
  874. APIGENIN as neuroprotective agent: Of mice and men
  875. APIGENIN: A dietary flavonoid with diverse anticancer properties
  876. APIGENIN and breast cancers: from chemistry to medicine
  877. Role of APIGENIN in cancer prevention via the induction of apoptosis and autophagy
  878. Potential role of flavonoids in treating chronic inflammatory diseases with a special focus on the anti-inflammatory activity of APIGENIN
  879. Enhanced in vitro and in vivo skin deposition of APIGENIN delivered using ethosomes
  880. Flavonoid APIGENIN inhibits lipopolysaccharide-induced inflammatory response through multiple mechanisms in macrophages
  881. Pharmacokinetic properties and drug interactions of APIGENIN, a natural flavone
  882. Inhibition of PI3K/Akt/mTOR pathway by APIGENIN induces apoptosis and autophagy in hepatocellular carcinoma cells
  883. Plant flavone APIGENIN: An emerging anticancer agent
  884. APIGENIN inhibits renal cell carcinoma cell proliferation
  885. The significant impact of APIGENIN on different aspects of autoimmune disease
  886. Anti-inflammatory effects of APIGENIN in lipopolysaccharide-induced inflammatory in acute lung injury by suppressing COX-2 and NF-kB pathway
  887. Isolation of APIGENIN from subcritical water extracts: Optimization of the process
  888. Antibacterial attributes of APIGENIN, isolated from Portulaca oleracea L.
  889. A review on flavonoid APIGENIN: Dietary intake, ADME, antimicrobial effects, and interactions with human gut microbiota
  890. Inhibitory mechanism of APIGENIN on α-glucosidase and synergy analysis of flavonoids
  891. Probing into therapeutic anti-cancer potential of APIGENIN: recent trends and future directions
  892. Neuroprotective effect of APIGENIN in rats after contusive spinal cord injury
  893. Protective effect of APIGENIN against oxidative stress-induced damage in osteoblastic cells
  894. Insights into novel anticancer applications for APIGENIN.
  895. APIGENIN induces autophagic cell death in human papillary thyroid carcinoma BCPAP cells
  896. APIGENIN suppresses the senescence-associated secretory phenotype and paracrine effects on breast cancer cells
  897. APIGENIN in the regulation of cholesterol metabolism and protection of blood vessels
  898. The flavonoid APIGENIN inhibits hepatitis C virus replication by decreasing mature microRNA122 levels
  899. Inhibition of the STAT3 signaling pathway contributes to APIGENIN-mediated anti-metastatic effect in melanoma
  900. APIGENIN: A natural bioactive flavone-type molecule with promising therapeutic function
  901. APIGENIN-7-O-glucoside versus APIGENIN: Insight into the modes of anticandidal and cytotoxic actions
  902. APIGENIN-induced apoptosis is enhanced by inhibition of autophagy formation in HCT116 human colon cancer cells
  903. The effects of APIGENIN on lipopolysaccharide-induced depressive-like behavior in mice
  904. APIGENIN loaded nanoparticle delayed development of hepatocellular carcinoma in rats
  905. Curcumin and APIGENIN–novel and promising therapeutics against chronic neuroinflammation in Alzheimer’s disease
  906. APIGENIN attenuates doxorubicin induced cardiotoxicity via reducing oxidative stress and apoptosis in male rats
  907. APIGENIN induced MCF‐7 cell apoptosis‐associated reactive oxygen species
  908. APIGENIN induces cell shrinkage in Candida albicans by membrane perturbation
  909. Combination therapy of LysGH15 and APIGENIN as a new strategy for treating pneumonia caused by Staphylococcus aureus
  910. Resveratrol as a bioenhancer to improve anti-inflammatory activities of APIGENIN
  911. APIGENIN inhibits African swine fever virus infection in vitro
  912. APIGENIN sensitizes hepatocellular carcinoma cells to doxorubic through regulating miR-520b/ATG7 axis
  913. APIGENIN suppresses PD-L1 expression in melanoma and host dendritic cells to elicit synergistic therapeutic effects
  914. APIGENIN pretreatment enhances growth and salinity tolerance of rice seedlings
  915. Protective effect of APIGENIN on ischemia/reperfusion injury of the isolated rat heart
  916. APIGENIN inhibits IL-6 transcription and suppresses esophageal carcinogenesis
  917. APIGENIN suppresses the stem cell-like properties of triple-negative breast cancer cells by inhibiting YAP/TAZ activity
  918. APIGENIN and naringenin regulate glucose and lipid metabolism, and ameliorate vascular dysfunction in type 2 diabetic rats
  919. Formulation and characterization of an APIGENIN-phospholipid phytosome (APLC) for improved solubility, in vivo bioavailability, and antioxidant potential
  920. APIGENIN inhibits growth of breast cancer cells: the role of ERα and HER2/neu
  921. Protective effect of APIGENIN against N-nitrosodiethylamine (NDEA)-induced hepatotoxicity in albino rats
  922. Antitumor and anti-invasive effect of APIGENIN on human breast carcinoma through suppression of IL-6 expression
  923. Neuroprotective and neurotrophic effects of APIGENIN and Luteolin in MPTP induced parkinsonism in mice
  924. Protective role of APIGENIN in cisplatin-induced renal injury
  925. Deep eutectic solvent-based microwave-assisted extraction of genistin, genistein and APIGENIN from pigeon pea roots
  926. Dietary APIGENIN reduces LPS‐induced expression of miR‐155 restoring immune balance during inflammation
  927. Exposure of breast cancer cells to a subcytotoxic dose of APIGENIN causes growth inhibition, oxidative stress, and hypophosphorylation of Akt
  928. Neuroprotective effects of APIGENIN against inflammation, neuronal excitability and apoptosis in an induced pluripotent stem cell model of Alzheimer’s disease
  929. Enhanced bioavailability of APIGENIN via preparation of a carbon nanopowder solid dispersion
  930. The flavonoid APIGENIN reduces prostate cancer CD44+ stem cell survival and migration through PI3K/Akt/NF-κB signaling
  931. Protective effects of APIGENIN and myricetin against cisplatin-induced nephrotoxicity in mice
  932. Modulation of thyroidal radioiodide uptake by oncological pipeline inhibitors and APIGENIN
  933. Anti-inflammatory effect of APIGENIN on LPS-induced pro-inflammatory mediators and AP-1 factors in human lung epithelial cells
  934. APIGENIN inhibits prostate cancer progression in TRAMP mice via targeting PI3K/Akt/FoxO pathway
  935. APIGENIN blocks IKKα activation and suppresses prostate cancer progression
  936. Biosynthesis of two flavones, APIGENIN and genkwanin, in Escherichia coli
  937. APIGENIN potentiates the growth inhibitory effects by IKK-β-mediated NF-κB activation in pancreatic cancer cells
  938. Inhibition of mTOR by APIGENIN in UVB-irradiated keratinocytes: a new implication of skin cancer prevention
  939. APIGENIN suppresses colorectal cancer cell proliferation, migration and invasion via inhibition of the Wnt/β-catenin signaling pathway
  940. APIGENIN retards atherogenesis by promoting ABCA1-mediated cholesterol efflux and suppressing inflammation
  941. APIGENIN restricts FMDV infection and inhibits viral IRES driven translational activity
  942. Plant flavone APIGENIN binds to nucleic acid bases and reduces oxidative DNA damage in prostate epithelial cells
  943. Oxidative stress triggered by APIGENIN induces apoptosis in a comprehensive panel of human cervical cancer-derived cell lines
  944. Inhibition of glutamine utilization sensitizes lung cancer cells to APIGENIN-induced apoptosis resulting from metabolic and oxidative stress
  945. APIGENIN inhibits proliferation and invasion, and induces apoptosis and cell cycle arrest in human melanoma cells
  946. Protective effects of APIGENIN against furan-induced toxicity in mice
  947. Analysis of the erythroid differentiation effect of flavonoid APIGENIN on K562 human chronic leukemia cells
  948. A comprehensive assessment of APIGENIN as an antiproliferative, proapoptotic, antiangiogenic and immunomodulatory phytocompound
  949. APIGENIN Inhibits Enterovirus-71 Infection by Disrupting Viral RNA Association with trans-Acting Factors
  950. The substituent effect on the radical scavenging activity of APIGENIN
  951. APIGENIN inhibits NF-κB and snail signaling, EMT and metastasis in human hepatocellular carcinoma
  952. APIGENIN reverses depression-like behavior induced by chronic corticosterone treatment in mice
  953. Sustainability and antimicrobial assessments of APIGENIN based polybenzoxazine film
  954. The effects of APIGENIN-biosynthesized ultra-small platinum nanoparticles on the human monocytic THP-1 cell line
  955. APIGENIN as an anti-quinolone-resistance antibiotic
  956. Activity of the dietary flavonoid, APIGENIN, against multidrug-resistant tumor cells as determined by pharmacogenomics and molecular docking
  957. APIGENIN, a natural flavonoid, attenuates EAE severity through the modulation of dendritic cell and other immune cell functions
  958. APIGENIN inhibits migration and invasion via modulation of epithelial mesenchymal transition in prostate cancer
  959. APIGENIN ameliorates chronic mild stress-induced depressive behavior by inhibiting interleukin-1β production and NLRP3 inflammasome activation in the rat brain
  960. APIGENIN inhibits osteoblastogenesis and osteoclastogenesis and prevents bone loss in ovariectomized mice
  961. APIGENIN enhances the cisplatin cytotoxic effect through p53‑modulated apoptosis
  962. APIGENIN ameliorates HFD-induced NAFLD through regulation of the XO/NLRP3 pathways
  963. Effect of APIGENIN isolated from Aster yomena against Candida albicans: APIGENIN-triggered apoptotic pathway regulated by mitochondrial calcium signaling
  964. APIGENIN, a dietary flavonoid, inhibits proliferation of human bladder cancer T-24 cells via blocking cell cycle progression and inducing apoptosis
  965. Inhibition of Epstein-Barr virus reactivation by the flavonoid APIGENIN
  966. Antioxidative and protective actions of APIGENIN in a paracetamol-induced hepatotoxicity rat model
  967. The natural flavonoid APIGENIN sensitizes human CD44+ prostate cancer stem cells to cisplatin therapy
  968. APIGENIN alleviates STZ-induced diabetic cardiomyopathy
  969. Oxidative stress triggered by naturally occurring flavone APIGENIN results in senescence and chemotherapeutic effect in human colorectal cancer cells
  970. APIGENIN inhibits pancreatic stellate cell activity in pancreatitis
  971. Studies on the interaction of APIGENIN with calf thymus DNA by spectroscopic methods
  972. The flavonoid compound APIGENIN prevents colonic inflammation and motor dysfunctions associated with high fat diet-induced obesity
  973. APIGENIN reduces survival of choriocarcinoma cells by inducing apoptosis via the PI3K/AKT and ERK1/2 MAPK pathways
  974. APIGENIN induces ROS‐dependent apoptosis and ER stress in human endometriosis cells
  975. APIGENIN ameliorates dyslipidemia, hepatic steatosis and insulin resistance by modulating metabolic and transcriptional profiles in the liver of high-fat diet-induced …
  976. In vitro and in vivo anti-tumoral effects of the flavonoid APIGENIN in malignant mesothelioma
  977. APIGENIN inhibits colonic inflammation and tumorigenesis by suppressing STAT3-NF-κB signaling
  978. APIGENIN as an effective anticancer natural product: Spotlight on TRAIL, WNT/β‐catenin, JAK‐STAT pathways, and microRNAs
  979. Intraperitoneal administration of APIGENIN in liver ischemia/reperfusion injury protective effects
  980. Probing the potential of APIGENIN liposomes in enhancing bacterial membrane perturbation and integrity loss
  981. APIGENIN inhibits PMA-induced expression of pro-inflammatory cytokines and AP-1 factors in A549 cells
  982. APIGENIN induces apoptosis by targeting inhibitor of apoptosis proteins and Ku70–Bax interaction in prostate cancer
  983. Anti-oxidant and anti-inflammatory effects of APIGENIN in a rat model of sepsis: an immunological, biochemical, and histopathological study
  984. Study on the pulmonary delivery system of APIGENIN-loaded albumin nanocarriers with antioxidant activity
  985. Effect of APIGENIN on Leishmania amazonensis Is Associated with Reactive Oxygen Species Production Followed by Mitochondrial Dysfunction
  986. Protective role of APIGENIN on rotenone induced rat model of Parkinson’s disease: Suppression of neuroinflammation and oxidative stress mediated apoptosis
  987. APIGENIN impacts the growth of the gut microbiota and alters the gene expression of Enterococcus
  988. APIGENIN promotes osteogenic differentiation of human mesenchymal stem cells through JNK and p38 MAPK pathways
  989. APIGENIN inhibits the self-renewal capacity of human ovarian cancer SKOV3‑derived sphere-forming cells
  990. APIGENIN attenuates adriamycin-induced cardiomyocyte apoptosis via the PI3K/AKT/mTOR pathway
  991. Activation of PPARγ by a natural flavonoid modulator, APIGENIN ameliorates obesity-related inflammation via regulation of macrophage polarization
  992. APIGENIN attenuates oxidative injury in ARPE-19 cells thorough activation of Nrf2 pathway
  993. Protective effect of APIGENIN on Freund’s complete adjuvant-induced arthritis in rats via inhibiting P2X7/NF-κB pathway
  994. APIGENIN 7-glucoside from Stachys tibetica Vatke and its anxiolytic effect in rats
  995. Intestinal anti-inflammatory activity of APIGENIN K in two rat colitis models induced by trinitrobenzenesulfonic acid and dextran sulphate sodium
  996. Mushroom (Agaricus bisporus) polyphenoloxidase inhibited by APIGENIN: Multi-spectroscopic analyses and computational docking simulation
  997. Dual drug loaded liposome bearing APIGENIN and 5-Fluorouracil for synergistic therapeutic efficacy in colorectal cancer
  998. APIGENIN inhibits epithelial-mesenchymal transition of human colon cancer cells through NF-κB/Snail signaling pathway
  999. APIGENIN promotes TRAIL-mediated apoptosis regardless of ROS generation
  1000. Solvent effects on the intramolecular hydrogen-bond and anti-oxidative properties of APIGENIN: A DFT approach
  1001. APIGENIN alleviates endotoxin-induced myocardial toxicity by modulating inflammation, oxidative stress, and autophagy
  1002. APIGENIN reactivates Nrf2 anti-oxidative stress signaling in mouse skin epidermal JB6 P+ cells through epigenetics modifications
  1003. Induction of NRF2‐mediated gene expression by dietary phytochemical flavones APIGENIN and luteolin
  1004. APIGENIN ameliorates streptozotocin-induced diabetic nephropathy in rats via MAPK-NF-κB-TNF-α and TGF-β1-MAPK-fibronectin pathways
  1005. Isolation and Identification of a Flavone APIGENIN from Marine Red Alga Acanthophora spicifera with Antinociceptive and Anti-Inflammatory Activities
  1006. Downregulation of NEDD9 by APIGENIN suppresses migration, invasion, and metastasis of colorectal cancer cells
  1007. APIGENIN exerts anti-inflammatory effects in an experimental model of acute pancreatitis by down-regulating TNF-α
  1008. APIGENIN induces both intrinsic and extrinsic pathways of apoptosis in human colon carcinoma HCT-116 cells
  1009. The apoptotic effect of APIGENIN on human gastric carcinoma cells through mitochondrial signal pathway
  1010. Development and optimization of APIGENIN-loaded transfersomal system for skin cancer delivery: in vitro evaluation
  1011. APIGENIN, a dietary flavonoid, induces apoptosis, DNA damage, and oxidative stress in human breast cancer MCF-7 and MDA MB-231 cells
  1012. Dissolution and bioavailability improvement of bioactive APIGENIN using solid dispersions prepared by different techniques
  1013. APIGENIN-induced lysosomal degradation of β-catenin in Wnt/β-catenin signaling
  1014. Comparative evaluation of the effect of cyclodextrins and pH on aqueous solubility of APIGENIN
  1015. APIGENIN restrains colon cancer cell proliferation via targeted blocking of pyruvate kinase M2-dependent glycolysis
  1016. APIGENIN and its methylglyoxal-adduct inhibit advanced glycation end products-induced oxidative stress and inflammation in endothelial cells
  1017. Development and characterization of a green procedure for APIGENIN extraction from Scutellaria barbata D. Don
  1018. APIGENIN, by activating p53 and inhibiting STAT3, modulates the balance between pro-apoptotic and pro-survival pathways to induce PEL cell death
  1019. The protective effect of APIGENIN on myocardial injury in diabetic rats mediating activation of the PPAR-γ pathway
  1020. Oral efficacy of APIGENIN against cutaneous leishmaniasis: involvement of reactive oxygen species and autophagy as a mechanism of action
  1021. Dietary APIGENIN exerts immune-regulatory activity in vivo by reducing NF-κB activity, halting leukocyte infiltration and restoring normal metabolic function
  1022. APIGENIN overcomes drug resistance by blocking the signal transducer and activator of transcription 3 signaling in breast cancer cells
  1023. APIGENIN attenuates experimental autoimmune myocarditis by modulating Th1/Th2 cytokine balance in mice
  1024. APIGENIN enhances skeletal muscle hypertrophy and myoblast differentiation by regulating Prmt7
  1025. APIGENIN, a modulator of PPARγ, attenuates HFD-induced NAFLD by regulating hepatocyte lipid metabolism and oxidative stress via Nrf2 activation
  1026. APIGENIN inhibits cell proliferation, migration, and invasion by targeting Akt in the A549 human lung cancer cell line
  1027. APIGENIN inhibits cancer stem cell‐like phenotypes in human glioblastoma cells via suppression of c‐met signaling
  1028. APIGENIN accumulation and expression analysis of APIGENIN biosynthesis relative genes in celery
  1029. Anti—chikungunya activity of luteolin and APIGENIN rich fraction from Cynodon dactylon
  1030. APIGENIN induces the apoptosis and regulates MAPK signaling pathways in mouse macrophage ANA-1 cells
  1031. APIGENIN mediated protection of OGD-evoked neuron-like injury in differentiated PC12 cells
  1032. APIGENIN inhibits TGF‐β‐induced VEGF expression in human prostate carcinoma cells via a Smad2/3‐and Src‐dependent mechanism
  1033. Effect of APIGENIN, kaempferol and resveratrol on the gene expression and protein secretion of tumor necrosis factor alpha (TNF-α) and interleukin-10 (IL-10) in RAW …
  1034. Hydrogen-bonding interactions between APIGENIN and ethanol/water: a theoretical study
  1035. APIGENIN and naringenin ameliorate PKCβII-associated endothelial dysfunction via regulating ROS/caspase-3 and NO pathway in endothelial cells exposed to high …
  1036. APIGENIN potentiates TRAIL therapy of non-small cell lung cancer via upregulating DR4/DR5 expression in a p53-dependent manner
  1037. Treatment of dermatophytosis by a new antifungal agent ‘APIGENIN‘
  1038. Development and evaluation of injectable nanosized drug delivery systems for APIGENIN
  1039. Induction of caspase-dependent apoptosis by APIGENIN by inhibiting STAT3 signaling in HER2-overexpressing MDA-MB-453 breast cancer cells
  1040. APIGENIN inhibits TNFα/IL-1α-induced CCL2 release through IKBK-epsilon signaling in MDA-MB-231 human breast cancer cells
  1041. APIGENIN and hesperidin augment the toxic effect of doxorubicin against HepG2 cells
  1042. APIGENIN sensitizes BEL-7402/ADM cells to doxorubicin through inhibiting miR-101/Nrf2 pathway
  1043. Effect of APIGENIN-7-glucoside, genkwanin and naringenin on tyrosinase activity and melanin synthesis in B16F10 melanoma cells
  1044. APIGENIN protects against alcohol-induced liver injury in mice by regulating hepatic CYP2E1-mediated oxidative stress and PPARα-mediated lipogenic gene …
  1045. APIGENIN inhibits the inducible expression of programmed death ligand 1 by human and mouse mammary carcinoma cells
  1046. Plant-derived flavone APIGENIN: the small-molecule with promising activity against therapeutically resistant prostate cancer
  1047. APIGENIN suppresses GLUT-1 and p-AKT expression to enhance the chemosensitivity to cisplatin of laryngeal carcinoma Hep-2 cells: an in vitro study
  1048. APIGENIN attenuates oxidative stress and neuronal apoptosis in early brain injury following subarachnoid hemorrhage
  1049. α-Mangostin and APIGENIN induced cell cycle arrest and programmed cell death in SKOV-3 ovarian cancer cells
  1050. APIGENIN attenuates streptozotocin-induced pancreatic β cell damage by its protective effects on cellular antioxidant defense
  1051. Shear rheology and in-vitro release kinetic study of APIGENIN from lyotropic liquid crystal
  1052. Selective toxicity of APIGENIN on cancerous hepatocytes by directly targeting their mitochondria
  1053. APIGENIN isolated from Daphne genkwa Siebold et Zucc. inhibits 3T3-L1 preadipocyte differentiation through a modulation of mitotic clonal expansion
  1054. Targeted hyaluronic acid-based lipid nanoparticle for APIGENIN delivery to induce Nrf2-dependent apoptosis in lung cancer cells
  1055. Utilizing spray drying technique to improve oral bioavailability of APIGENIN
  1056. Anti-inflammatory effect of APIGENIN and hydroalcoholic extract of Dracocephalum kotschyi on acetic acid-induced colitis in rats
  1057. APIGENIN mediated gold nanoparticle synthesis and their anti-cancer effect on human epidermoid carcinoma (A431) cells
  1058. Mitigating effects of APIGENIN on edifenphos-induced oxidative stress, DNA damage and apoptotic cell death in human peripheral blood lymphocytes
  1059. The effects of APIGENIN on the expression of Fas/FasL apoptotic pathway in warm liver ischemia-reperfusion injury in rats
  1060. APIGENIN inhibits in vitro and in vivo tumorigenesis in cisplatin-resistant colon cancer cells by inducing autophagy, programmed cell death and targeting m-TOR …
  1061. Fabrication of APIGENIN loaded gellan gum–chitosan hydrogels (GGCH-HGs) for effective diabetic wound healing
  1062. APIGENIN and luteolin display differential hypocholesterolemic mechanisms in mice fed a high-fat diet
  1063. Suppression of NF-κB and NF-κB-regulated gene expression by APIGENIN through IκBα and IKK pathway in TRAMP mice
  1064. APIGENIN ameliorates hypertension-induced cardiac hypertrophy and down-regulates cardiac hypoxia inducible factor-lα in rats
  1065. APIGENIN alleviates myocardial reperfusion injury in rats by downregulating miR-15b
  1066. APIGENIN inhibits the proliferation and invasion of osteosarcoma cells by suppressing the Wnt/β-catenin signaling pathway
  1067. APIGENIN produced by maize flavone synthase I and II protects plants against UV‐B‐induced damage
  1068. The flavones APIGENIN and luteolin induce FOXO1 translocation but inhibit gluconeogenic and lipogenic gene expression in human cells
  1069. APIGENIN suppresses the apoptosis of H9C2 rat cardiomyocytes subjected to myocardial ischemia‑reperfusion injury via upregulation of the PI3K/Akt pathway
  1070. APIGENIN protects blood–brain barrier and ameliorates early brain injury by inhibiting TLR4-mediated inflammatory pathway in subarachnoid hemorrhage rats
  1071. APIGENIN prevents metabolic syndrome in high-fructose diet-fed mice by Keap1-Nrf2 pathway
  1072. Solubility and thermodynamic parameters of APIGENIN in different neat solvents at different temperatures
  1073. Targeting the SPOCK1-snail/slug axis-mediated epithelial-to-mesenchymal transition by APIGENIN contributes to repression of prostate cancer metastasis
  1074. APIGENIN inhibits TGF-β1-induced proliferation and migration of airway smooth muscle cells
  1075. APIGENIN suppresses mouse peritoneal fibrosis by down-regulating miR34a expression
  1076. APIGENIN inhibits d-galactosamine/LPS-induced liver injury through upregulation of hepatic Nrf-2 and PPARγ expressions in mice
  1077. The natural plant flavonoid APIGENIN is a strong antioxidant that effectively delays peripheral neurodegenerative processes
  1078. Oxidation pathways underlying the pro-oxidant effects of APIGENIN
  1079. … of neuronal differentiation of murine N2a cells by two polyphenols present in the mediterranean diet mimicking neurotrophins activities: resveratrol and APIGENIN
  1080. Extraction, purification, and hydrolysis behavior of APIGENIN-7-O-glucoside from Chrysanthemum morifolium tea
  1081. APIGENIN inhibits the proliferation of adenoid cystic carcinoma via suppression of glucose transporter-1
  1082. Dietary APIGENIN promotes lipid catabolism, thermogenesis, and browning in adipose tissues of HFD-Fed mice
  1083. APIGENIN attenuates heart injury in lipopolysaccharide-induced endotoxemic model by suppressing sphingosine kinase 1/sphingosine 1-phosphate signaling pathway
  1084. Efficacy of APIGENIN and miltefosine combination therapy against experimental cutaneous leishmaniasis
  1085. APIGENIN inhibits glioma cell growth through promoting microRNA-16 and suppression of BCL-2 and nuclear factor-κB/MMP‑9
  1086. APIGENIN causes biochemical modulation, GLUT4 and Cd38 alterations to improve diabetes and to protect damages of some vital organs in experimental …
  1087. The flavonoid APIGENIN ameliorates cisplatin-induced nephrotoxicity through reduction of p53 activation and promotion of PI3K/Akt pathway in human renal …
  1088. Attenuation of oxidative stress of erythrocytes by the plant-derived flavonoids vitexin and APIGENIN
  1089. APIGENIN has anti-atrophic gastritis and anti-gastric cancer progression effects in Helicobacter pylori-infected Mongolian gerbils
  1090. APIGENIN C-glycosides of Microcos paniculata protects lipopolysaccharide induced apoptosis and inflammation in acute lung injury through TLR4 signaling pathway
  1091. An improved synthesis of APIGENIN
  1092. APIGENIN exhibits protective effects in a mouse model of d-galactose-induced aging via activating the Nrf2 pathway
  1093. Direct comparison of metabolic health effects of the flavonoids quercetin, hesperetin, epicatechin, APIGENIN and anthocyanins in high-fat-diet-fed mice
  1094. APIGENIN inhibited hypoxia induced stem cell marker expression in a head and neck squamous cell carcinoma cell line
  1095. APIGENIN attenuates β-receptor-stimulated myocardial injury via safeguarding cardiac functions and escalation of antioxidant defence system
  1096. Preparation of inclusion complex of APIGENIN-hydroxypropyl-β-cyclodextrin by using supercritical antisolvent process for dissolution and bioavailability enhancement
  1097. APIGENIN attenuates patulin-induced apoptosis in HEK293 cells by modulating ROS-mediated mitochondrial dysfunction and caspase signal pathway
  1098. Isolation, identification and characterization of APIGENIN from Justicia gendarussa and its anti-inflammatory activity
  1099. APIGENIN attenuates atherogenesis through inducing macrophage apoptosis via inhibition of AKT Ser473 phosphorylation and downregulation of …
  1100. Synthesis, nitric oxide release, and α-glucosidase inhibition of nitric oxide donating APIGENIN and chrysin derivatives
  1101. APIGENIN attenuates melanoma cell migration by inducing anoikis through integrin and focal adhesion kinase inhibition
  1102. The flavonoid APIGENIN is a progesterone receptor modulator with in vivo activity in the uterus
  1103. Induction of caspase-dependent extrinsic apoptosis by APIGENIN through inhibition of signal transducer and activator of transcription 3 (STAT3) signalling in …
  1104. Downregulating CD26/DPPIV by APIGENIN modulates the interplay between Akt and Snail/Slug signaling to restrain metastasis of lung cancer with multiple …
  1105. APIGENIN reverses lung injury and immunotoxicity in paraquat-treated mice
  1106. Protective effects of APIGENIN against paraquat-induced acute lung injury in mice
  1107. APIGENIN inhibits growth and migration of fibroblasts by suppressing FAK signaling
  1108. A pH-sensitive microemulsion-filled gellan gum hydrogel encapsulated APIGENIN: Characterization and in vitro release kinetics
  1109. APIGENIN inhibits HeLa sphere‑forming cells through inactivation of casein kinase 2α
  1110. APIGENIN inhibits UVA-induced cytotoxicity in vitro and prevents signs of skin aging in vivo
  1111. APIGENIN ameliorates the obesity‐induced skeletal muscle atrophy by attenuating mitochondrial dysfunction in the muscle of obese mice
  1112. Synergistic apoptotic effects of APIGENIN TPGS liposomes and tyroservatide: implications for effective treatment of lung cancer
  1113. APIGENIN inhibits enterovirus 71 replication through suppressing viral IRES activity and modulating cellular JNK pathway
  1114. Antioxidant and photoprotective activity of APIGENIN and its potassium salt derivative in human keratinocytes and absorption in Caco-2 cell monolayers
  1115. The antidepressant effects of APIGENIN are associated with the promotion of autophagy via the mTOR/AMPK/ULK1 pathway
  1116. APIGENIN, a potent suppressor of dendritic cell maturation and migration, protects against collagen‐induced arthritis
  1117. APIGENIN manipulates the ubiquitin–proteasome system to rescue estrogen receptor-β from degradation and induce apoptosis in prostate cancer cells
  1118. Enhanced action of APIGENIN and naringenin combination on estrogen receptor activation in non-malignant colonocytes: Implications on sorghum-derived …
  1119. The roles of synovial hyperplasia, angiogenesis and osteoclastogenesis in the protective effect of APIGENIN on collagen-induced arthritis
  1120. Bioinformatics and in vitro experimental analyses identify the selective therapeutic potential of interferon gamma and APIGENIN against cervical squamous cell …
  1121. Solubility determination and thermodynamic data of APIGENIN in binary {Transcutol®+ water} mixtures
  1122. Cocrystal of APIGENIN with higher solubility, enhanced oral bioavailability, and anti-inflammatory effect
  1123. APIGENIN-7-O-β-D-(-6”-p-coumaroyl)-Glucopyranoside treatment elicits neuroprotective effect against experimental ischemic stroke
  1124. Polymethoxyflavone APIGENIN-trimethylether suppresses LPS-induced inflammatory response in nontransformed porcine intestinal cell line IPEC-J2
  1125. APIGENIN inhibits UVB-induced skin carcinogenesis: the role of thrombospondin-1 as an anti-inflammatory factor
  1126. Phenolic compounds APIGENIN, hesperidin and kaempferol reduce in vitro lipid accumulation in human adipocytes
  1127. Therapeutic potential of APIGENIN, a plant flavonoid, for imatinib-sensitive and resistant chronic myeloid leukemia cells
  1128. APIGENIN induces apoptosis by suppressing Bcl-xl and Mcl-1 simultaneously via signal transducer and activator of transcription 3 signaling in colon cancer
  1129. APIGENIN protects against bleomycin‑induced lung fibrosis in rats
  1130. Inhibition of autophagy ameliorates atherogenic inflammation by augmenting APIGENIN-induced macrophage apoptosis
  1131. APIGENIN induces caspase-dependent apoptosis by inhibiting signal transducer and activator of transcription 3 signaling in HER2-overexpressing SKBR3 …
  1132. Luteolin and APIGENIN attenuate 4-hydroxy-2-nonenal-mediated cell death through modulation of UPR, Nrf2-ARE and MAPK pathways in PC12 cells
  1133. APIGENIN prevents ultraviolet-B radiation induced cyclobutane pyrimidine dimers formation in human dermal fibroblasts
  1134. APIGENIN regulates interleukin-1β-induced production of matrix metalloproteinase both in the knee joint of rat and in primary cultured articular chondrocytes
  1135. Transcriptome-based repurposing of APIGENIN as a potential anti-fibrotic agent targeting hepatic stellate cells
  1136. Preventive effect of APIGENIN against isoproterenol‐induced apoptosis in cardiomyoblasts
  1137. In silico approaches for investigating the binding propensity of APIGENIN and luteolin against class I HDAC isoforms
  1138. Enhancing oral bioavailability using preparations of APIGENIN-loaded W/O/W emulsions: In vitro and in vivo evaluations
  1139. APIGENIN attenuates isoflurane-induced cognitive dysfunction via epigenetic regulation and neuroinflammation in aged rats
  1140. APIGENIN attenuates acrylonitrile-induced neuro-inflammation in rats: Involved of inactivation of the TLR4/NF-κB signaling pathway
  1141. Chrysin, Abundant in Morinda citrifolia Fruit Water–EtOAc Extracts, Combined with APIGENIN Synergistically Induced Apoptosis and Inhibited Migration in Human …
  1142. Anti-inflammatory and neuroprotective effect of APIGENIN: studies in the GFAP-IL6 mouse model of chronic neuroinflammation
  1143. APIGENIN attenuates diabetes-associated cognitive decline in rats via suppressing oxidative stress and nitric oxide synthase pathway
  1144. APIGENIN and luteolin attenuate the breaching of MDA-MB231 breast cancer spheroids through the lymph endothelial barrier in vitro
  1145. APIGENIN attenuates edifenphos-induced toxicity by modulating ROS-mediated oxidative stress, mitochondrial dysfunction and caspase signal pathway in rat liver and …
  1146. APIGENIN induced apoptosis in esophageal carcinoma cells by destruction membrane structures
  1147. APIGENIN attenuates acute myocardial infarction of rats via the inhibitions of matrix metalloprotease-9 and inflammatory reactions
  1148. Protective effects of APIGENIN against acrylonitrile-induced subchronic sperm injury in rats
  1149. Improved solubility and oral bioavailability of APIGENIN via Soluplus/Pluronic F127 binary mixed micelles system
  1150. APIGENIN protects the brain against ischemia/reperfusion injury via caveolin-1/VEGF in vitro and in vivo
  1151. APIGENIN inhibits COX-2, PGE2, and EP1 and also initiates terminal differentiation in the epidermis of tumor bearing mice
  1152. APIGENIN protects against renal tubular epithelial cell injury and oxidative stress by high glucose via regulation of NF-E2-related factor 2 (Nrf2) pathway
  1153. Identification and Characterization of APIGENIN 6-C-Glucosyltransferase Involved in Biosynthesis of Isosaponarin in Wasabi (Eutrema japonicum)
  1154. Development and validation of an HPTLC method for APIGENIN 7-O-glucoside in chamomile flowers and its application for fingerprint discrimination of chamomile-like …
  1155. APIGENIN supplementation protects the development of dextran sulfate sodium-induced murine experimental colitis by inhibiting canonical and non-canonical …
  1156. APIGENIN inhibits fibroblast proliferation and reduces epidural fibrosis by regulating Wnt3a/β-catenin signaling pathway
  1157. APIGENIN attenuates PM2. 5-induced airway hyperresponsiveness and inflammation by down-regulating NF-κB in murine model of asthma
  1158. APIGENIN attenuates hippocampal oxidative events, inflammation and pathological alterations in rats fed high fat, fructose diet
  1159. … p53, stabilized by its interplay with HSP90, activates a positive feed-back loop between NRF2 and p62 that induces chemo-resistance to APIGENIN in pancreatic cancer …
  1160. APIGENIN protects mice from pneumococcal pneumonia by inhibiting the cytolytic activity of pneumolysin
  1161. Cirsium japonicum var. maackii and APIGENIN block Hif‐2α‐induced osteoarthritic cartilage destruction
  1162. An ointment consisting of the phage lysin LysGH15 and APIGENIN for decolonization of methicillin-resistant Staphylococcus aureus from skin wounds
  1163. APIGENIN potentiates the antitumor activity of 5-FU on solid Ehrlich carcinoma: Crosstalk between apoptotic and JNK-mediated autophagic cell death platforms
  1164. Fabrication, in-vitro characterization, and enhanced in-vivo evaluation of carbopol-based nanoemulsion gel of APIGENIN for UV-induced skin carcinoma
  1165. Whole transcriptomic analysis of APIGENIN on TNFα immuno-activated MDA-MB-231 breast cancer cells
  1166. The antiproliferative and apoptotic effects of APIGENIN on glioblastoma cells
  1167. Dietary APIGENIN reduces induction of LOX-1 and NLRP3 expression, leukocyte adhesion, and acetylated low-density lipoprotein uptake in human endothelial cells …
  1168. Comprehensive assessment of antioxidant activities of APIGENIN isomers: vitexin and isovitexin
  1169. APIGENIN attenuates inflammation in experimentally induced acute pancreatitis-associated lung injury
  1170. De novo biosynthesis of APIGENIN, luteolin, and eriodictyol in the actinomycete Streptomyces albus and production improvement by feeding and spore …
  1171. Combined effect of APIGENIN and ferulic acid on frozen‐thawed boar sperm quality
  1172. Resveratrol, piperine and APIGENIN differ in their NADPH-oxidase inhibitory and reactive oxygen species-scavenging properties
  1173. Cytotoxicity and Anti-inflammatory Properties of APIGENIN-Derived Isolaxifolin
  1174. APIGENIN: Selective CK2 inhibitor increases Ikaros expression and improves T cell homeostasis and function in murine pancreatic cancer
  1175. Synergistic interactions of APIGENIN, naringin, quercetin and emodin on inhibition of 3T3-L1 preadipocyte differentiation and pancreas lipase activity
  1176. Effect of APIGENIN on apoptosis induced by renal ischemia/reperfusion injury in vivo and in vitro
  1177. Effects of APIGENIN pretreatment against renal ischemia/reperfusion injury via activation of the JAK2/STAT3 pathway
  1178. APIGENIN, a natural flavonoid, inhibits glutamate release in the rat hippocampus
  1179. APIGENIN-7-O-β-D-glucuronide inhibits LPS-induced inflammation through the inactivation of AP-1 and MAPK signaling pathways in RAW 264.7 macrophages and …
  1180. Protective effects of APIGENIN against 3-MCPD-induced renal injury in rat
  1181. Anti-inflammatory effect of an APIGENIN-Maillard reaction product in macrophages and macrophage-endothelial cocultures
  1182. Mutual Interaction of Phenolic Compounds and Microbiota: Metabolism of Complex Phenolic APIGENIN-C- and Kaempferol-O-Derivatives by Human Fecal Samples
  1183. Aptamer-conjugated APIGENIN nanoparticles to target colorectal carcinoma: a promising safe alternative of colorectal cancer chemotherapy
  1184. The flavonoid APIGENIN delays forgetting of passive avoidance conditioning in rats
  1185. Protective effects of APIGENIN against 1-methyl-4-phenylpyridinium ion‑induced neurotoxicity in PC12 cells
  1186. APIGENIN inhibits ethanol-induced oxidative stress and LPS-induced inflammatory cytokine production in cultured rat hepatocytes
  1187. Effects of the vegetable polyphenols epigallocatechin-3-gallate, luteolin, APIGENIN, myricetin, quercetin, and cyanidin in primary cultures of human retinal …
  1188. APIGENIN induces dermal collagen synthesis via smad2/3 signaling pathway
  1189. Chemopreventive APIGENIN controls UVB-induced cutaneous proliferation and angiogenesis through HuR and thrombospondin-1
  1190. Nutritional preconditioning of APIGENIN alleviates myocardial ischemia/reperfusion injury via the mitochondrial pathway mediated by notch1/hes1
  1191. APIGENIN-7-glycoside prevents LPS-induced acute lung injury via downregulation of oxidative enzyme expression and protein activation through inhibition of MAPK …
  1192. Enhanced solubility and bioavailability of APIGENIN via preparation of solid dispersions of mesoporous silica nanoparticles
  1193. Validation of a RP-HPLC-DAD method for chamomile (Matricaria recutita) preparations and assessment of the marker, APIGENIN-7-glucoside, safety and anti …
  1194. Design, synthesis, and characterization of novel APIGENIN analogues that suppress pancreatic stellate cell proliferation in vitro and associated pancreatic fibrosis in …
  1195. Protective effects of APIGENIN on LPS-induced endometritis via activating Nrf2 signaling pathway
  1196. Protective effect of APIGENIN on acrylonitrile-induced inflammation and apoptosis in testicular cells via the NF-κB pathway in rats
  1197. APIGENIN ameliorates post-stroke cognitive deficits in rats through histone acetylation-mediated neurochemical alterations
  1198. Activation of TRPV4 by dietary APIGENIN antagonizes renal fibrosis in deoxycorticosterone acetate (DOCA)–salt-induced hypertension
  1199. Effects of APIGENIN on experimental ischemia/reperfusion injury in the rat ovary
  1200. Antitumor and radiosensitizing synergistic effects of APIGENIN and cryptotanshinone against solid Ehrlich carcinoma in female mice
  1201. In Vitro Effect of APIGENIN and Danshen in Tibial Dyschondroplasia Through Inhibition of Heat-Shock Protein 90 and Vascular Endothelial Growth Factor Expressions …
  1202. Pharmacokinetic drug interactions between APIGENIN, rutin and paclitaxel mediated by P-glycoprotein in rats
  1203. Synergistic antibacterial effect of APIGENIN with β-lactam antibiotics and modulation of bacterial resistance by a possible membrane effect against methicillin resistant …
  1204. APIGENIN in combination with Akt inhibition significantly enhances thyrotropin-stimulated radioiodide accumulation in thyroid cells
  1205. APIGENIN combined with gefitinib blocks autophagy flux and induces apoptotic cell death through inhibition of HIF-1α, c-Myc, p-EGFR, and glucose metabolism …
  1206. APIGENIN and quercetin ameliorate mitochondrial alterations by tunicamycin-induced ER stress in 3T3-L1 adipocytes
  1207. Novel APIGENIN based small molecule that targets snake venom metalloproteases
  1208. Involvement of GABAergic pathway in the sedative activity of APIGENIN, the main flavonoid from Passiflora quadrangularis pericarp
  1209. The flavonoid APIGENIN from Croton betulaster Mull inhibits proliferation, induces differentiation and regulates the inflammatory profile of glioma cells
  1210. APIGENIN inhibits IL-31 cytokine in human mast cell and mouse skin tissues
  1211. APIGENIN, a plant flavone playing Noble roles in Cancer prevention via modulation of key cell signaling networks
  1212. Clerodendrum petasites S. Moore: The therapeutic potential of phytochemicals, hispidulin, vanillic acid, verbascoside, and APIGENIN
  1213. Eriocitrin and APIGENIN as new carbonic anhydrase VA inhibitors from a virtual screening of calabrian natural products
  1214. Deciphering the molecular mechanisms sustaining the estrogenic activity of the two major dietary compounds zearalenone and APIGENIN in ER-positive breast cancer …
  1215. APIGENIN enhances the antitumor effects of cetuximab in nasopharyngeal carcinoma by inhibiting EGFR signaling
  1216. APIGENIN attenuates myocardial ischemia/reperfusion injury via the inactivation of p38 mitogen‑activated protein kinase
  1217. APIGENIN suppresses the IL-1β-induced expression of the urokinase-type plasminogen activator receptor by inhibiting MAPK-mediated AP-1 and NF-κB signaling in …
  1218. APIGENIN reduce lipoteichoic acid-induced inflammatory response in rat cardiomyoblast cells
  1219. APIGENIN from Croton betulaster Müll restores the immune profile of microglia against glioma cells
  1220. Angiogenic effects of APIGENIN on endothelial cells after hypoxia-reoxygenation via the caveolin-1 pathway
  1221. Preparation, characterization and antitumor activity evaluation of APIGENIN nanoparticles by the liquid antisolvent precipitation technique
  1222. The estrogenic effects of APIGENIN, phloretin and myricetin based on uterotrophic assay in immature Wistar albino rats
  1223. Enhanced chemotherapeutic efficacy of APIGENIN liposomes in colorectal cancer based on flavone-membrane interactions
  1224. Recovery of chicken growth plate by heat-shock protein 90 inhibitors epigallocatechin-3-gallate and APIGENIN in thiram-induced tibial dyschondroplasia
  1225. Antispasmodic activity of APIGENIN and luteolin, two components of Dracocephalum kotschyi extract, on rat ileum contractions
  1226. Natural plant flavonoid APIGENIN directly disrupts Hsp90/Cdc37 complex and inhibits pancreatic cancer cell growth and migration
  1227. Expression pattern of NMDA receptors reveals antiepileptic potential of APIGENIN 8-C-glucoside and chlorogenic acid in pilocarpine induced epileptic mice
  1228. AgFNS overexpression increase APIGENIN and decrease anthocyanins in petioles of transgenic celery
  1229. Microwave-assisted simultaneous extraction of luteolin and APIGENIN from tree peony pod and evaluation of its antioxidant activity
  1230. Ultrasonically enhanced extraction of luteolin and APIGENIN from the leaves of Perilla frutescens (L.) Britt. using liquid carbon dioxide and ethanol
  1231. The stability and activity changes of APIGENIN and luteolin in human cervical cancer Hela cells in response to heat treatment and Fe2+/Cu2+ addition
  1232. A System-Level Investigation into the Mechanisms of APIGENIN against Inflammation
  1233. Discovery of xanthine oxidase inhibitors and/or α-glucosidase inhibitors by carboxyalkyl derivatization based on the flavonoid of APIGENIN
  1234. APIGENIN alleviates TGF-β1-induced nasal mucosa remodeling by inhibiting MAPK/NF-kB signaling pathways in chronic rhinosinusitis
  1235. Suppression of AKT potentiates synergistic cytotoxicity of APIGENIN with TRAIL in anaplastic thyroid carcinoma cells
  1236. One-step phosphorylated poly (amide-amine) dendrimer loaded with APIGENIN for simultaneous remineralization and antibacterial of dentine
  1237. Effects of potassium APIGENIN and verbena extract on the wound healing process of SKH‐1 mouse skin
  1238. APIGENIN inhibits growth and induces apoptosis in human cholangiocarcinoma cells
  1239. APIGENIN inhibits growth of the Plasmodium berghei and disrupts some metabolic pathways in mice
  1240. APIGENIN reduces the excessive accumulation of lipids induced by palmitic acid via the AMPK signaling pathway in HepG2 cells
  1241. Ethyl oleate food-grade O/W emulsions loaded with APIGENIN: Insights to their formulation characteristics and physico-chemical stability
  1242. Synthesis and anti-cancer activities of APIGENIN derivatives
  1243. Axl receptor tyrosine kinase is a novel target of APIGENIN for the inhibition of cell proliferation
  1244. Novel APIGENIN-loaded sodium hyaluronate nano-assemblies for targeting tumor cells
  1245. Photoprotective and antigenotoxic effects of the flavonoids APIGENIN, naringenin and pinocembrin
  1246. Simultaneous determination of oleanolic acid, ursolic acid, quercetin and APIGENIN in Swertia mussotii Franch by capillary zone electrophoresis with running buffer …
  1247. 5‐Fluorouracil combined with APIGENIN enhances anticancer activity through mitochondrial membrane potential (ΔΨm)‐mediated apoptosis in hepatocellular …
  1248. Anti-inflammation and anti-fibrosis with PEGylated, APIGENIN loaded PLGA nanoparticles in chronic pancreatitis disease
  1249. Simultaneous determination and pharmacokinetic study of quercetin, luteolin, and APIGENIN in rat plasma after oral administration of matricaria chamomilla l …
  1250. Storage stability of sorghum phenolic extracts’ flavones luteolin and APIGENIN
  1251. Suppression of rat and human androgen biosynthetic enzymes by APIGENIN: possible use for the treatment of prostate cancer
  1252. Degradable poly (APIGENIN) polymer inhibits tumor cell adhesion to vascular endothelial cells
  1253. Inhibitory effect of hydroalcoholic and flavonoids extracts of Dracocephalum kotschyi, and its components luteolin, APIGENIN and APIGENIN-4′-galactoside on intestinal …
  1254. Food polyphenol APIGENIN inhibits the cytochrome P450 monoxygenase branch of the arachidonic acid cascade
  1255. Inhibitory effect of APIGENIN on pharmacokinetics of venlafaxine in vivo and in vitro
  1256. Impact of APIGENIN and kaempferol on human head and neck squamous cell carcinoma
  1257. Isolation of a flavonoid, APIGENIN 7-O-glucoside, from Mentha longifolia (L.) Hudson subspecies longifolia and its genotoxic potency
  1258. Olive leaf components APIGENIN 7-glucoside and luteolin 7-glucoside direct human hematopoietic stem cell differentiation towards erythroid lineage
  1259. Evaluation of the neuroprotective, anticonvulsant, and cognition-improvement effects of APIGENIN in temporal lobe epilepsy: Involvement of the mitochondrial …
  1260. Effect of saponins and APIGENIN mixtures on feeding behavior of the pea aphid, Acyrthosiphon pisum Harris
  1261. Effects of C-glycosylation on anti-diabetic, anti-Alzheimer’s disease and anti-inflammatory potential of APIGENIN
  1262. APIGENIN rich-Limonium duriusculum (de Girard) Kuntze promotes apoptosis in HCT116 cancer cells
  1263. Anti-degenerative effect of APIGENIN, Luteolin and Quercetin on human keratinocyte and chondrocyte cultures: SAR evaluation
  1264. Inhibiting GLUT-1 expression and PI3K/Akt signaling using APIGENIN improves the radiosensitivity of laryngeal carcinoma in vivo
  1265. APIGENIN reduces the Toll-like receptor-4-dependent activation of NF-κB by suppressing the Akt, mTOR, JNK, and p38-MAPK
  1266. P53 AND CYCLIN B1 MEDIATE APOPTOTIC EFFECTS OF APIGENIN AND RUTIN IN ERï¡+-BREAST CANCER MCF-7 CELLS
  1267. APIGENIN naturally occurring flavonoids: occurrence and bioactivity
  1268. Adsorption/desorption characteristics and enrichment of quercetin, luteolin and APIGENIN from Flos populi using macroporous resin
  1269. Controlled release oral delivery of APIGENIN containing pellets with antioxidant activity
  1270. APIGENIN, an Anticancer Active Compound Isolated from Macaranga gigantifolia Leaves
  1271. β3-Adrenoreceptor activity limits APIGENIN efficacy in Ewing sarcoma cells: a dual approach to prevent cell survival
  1272. The role of APIGENIN in testicular damage in experimental ischemia-reperfusion injury in rats
  1273. APIGENIN-7-O-β-d-(-6 ″-p-coumaroyl)-glucopyranoside pretreatment attenuates myocardial ischemia/reperfusion injury via activating AMPK signaling
  1274. LC-MS/MS method for the simultaneous quantification of luteolin, wedelolactone and APIGENIN in mice plasma using hansen solubility parameters for liquid-liquid …
  1275. Antidiarrhoeal assessment of hydroalcoholic and hexane extracts of Dracocephalum kotschyi Boiss. and APIGENIN in mice
  1276. APIGENIN-induced ABCC1-mediated efflux of glutathione from mature erythrocytes inhibits the proliferation of Plasmodium falciparum
  1277. Synergistic antimicrobial activity of APIGENIN against oral pathogens
  1278. In vitro photosafety and efficacy screening of APIGENIN, chrysin and beta-carotene for UVA and VIS protection
  1279. Inhibition of MDA‐MB‐231 breast cancer cell proliferation and tumor growth by APIGENIN through induction of G2/M arrest and histone H3 acetylation‐mediated …
  1280. A novel, highly-water-soluble APIGENIN derivative provides neuroprotection following ischemia in male rats by regulating the ERK/Nrf2/HO-1 pathway
  1281. Luteolin and APIGENIN activate the Oct‐4/Sox2 signal via NFATc1 in human periodontal ligament cells
  1282. Determination of luteolin and APIGENIN in herbs by capillary electrophoresis with diode array detection
  1283. Application of molecular imaging technology in evaluating the inhibiting effect of APIGENIN in vivo on subcutaneous hepatocellular carcinoma
  1284. APIGENIN inhibits sciatic nerve denervation–induced muscle atrophy
  1285. In vitro and in vivo activities of flavonoids-APIGENIN, baicalin, chrysin, scutellarin-in regulation of hypertension-a review for their possible effects in pregnancy-induced …
  1286. Synthetic investigation toward APIGENIN 5-O-glycoside camellianin B as well as the chemical structure revision
  1287. Chrysin, APIGENIN and Acacetin Inhibit Tumor Necrosis Factor-Related Apoptosis—Inducing Ligand Receptor-1 (TRAIL-R1) on Activated RAW264. 7 Macrophages
  1288. A cytotoxic C-glycosylated derivative of APIGENIN from the leaves of Ocimum basilicum var. thyrsiflorum
  1289. Levels of APIGENIN and immunostimulatory activity of leaf extracts of bangunbangun (Plectranthus amboinicus Lour)
  1290. APIGENIN inhibits tumor necrosis factor-α-induced production and gene expression of mucin through regulating nuclear factor-kappa B signaling pathway in …
  1291. Dose-and time-dependent pharmacokinetics of APIGENIN trimethyl ether
  1292. Protective effects of the APIGENIN-O/C-diglucoside saponarin from Gypsophila trichotoma on carbone tetrachloride-induced hepatotoxicity in vitro/in vivo in rats
  1293. Food-derived compounds APIGENIN and luteolin modulate mRNA splicing of introns with weak splice sites
  1294. The potential application of strategic released APIGENIN from polymeric carrier in pulmonary fibrosis
  1295. Effects of friedelin on the intestinal permeability and bioavailability of APIGENIN
  1296. New APIGENIN glycoside, polyphenolic constituents, anti-inflammatory and hepatoprotective activities of Gaillardia grandiflora and Gaillardia pulchella aerial …
  1297. The therapeutic effects of APIGENIN and dexamethasone on 5‐fluorouracil‐induced oral mucositis–a pilot study using a Syrian hamster model
  1298. APIGENIN and APIGENINidin isolates from the Sorghum bicolor leaf targets inflammation via cyclo‐oxygenase‐2 and prostaglandin‐E2 blockade
  1299. Absorption Properties of Luteolin and APIGENIN in Genkwa Flos Using In Situ Single-Pass Intestinal Perfusion System in the Rat
  1300. New cytotoxic APIGENIN derivatives from Selaginella doederleinii
  1301. Synthesis and α-glucosidase inhibitory activity of chrysin, diosmetin, APIGENIN, and luteolin derivatives
  1302. Synergistic effect of graphene oxide coated nanotised APIGENIN with paclitaxel (GO-NA/PTX): a ROS dependent mitochondrial mediated apoptosis in ovarian cancer
  1303. APIGENIN oxidovanadium (IV) cation interactions. Synthesis, spectral, bovine serum albumin binding, antioxidant and anticancer studies
  1304. Effect of APIGENIN on dendritic cells maturation and function in murine splenocytes
  1305. Effect on oxidative stress, glucose uptake level and lipid droplet content by APIGENIN 7, 4′-dimethyl ether isolated from Piper longum L
  1306. Effect of APIGENIN on protein expressions of PPARs in liver tissues of rats with nonalcoholic steatohepatitis
  1307. Inhibition of IL-6/STAT3 axis and targeting Axl and Tyro3 receptor tyrosine kinases by APIGENIN circumvent taxol resistance in ovarian cancer cells
  1308. APIGENIN-7-diglucuronide protects retinas against bright light-induced photoreceptor degeneration through the inhibition of retinal oxidative stress and inflammation
  1309. APIGENIN-induced HIF-1α inhibitory effect improves abnormal glucolipid metabolism in AngⅡ/hypoxia-stimulated or HIF-1α-overexpressed H9c2 cells
  1310. The functional characterization of a site-specific APIGENIN 4′-O-methyltransferase synthesized by the liverwort species Plagiochasma appendiculatum
  1311. Molecular docking analysis of APIGENIN and quercetin from ethylacetate fraction of Adansonia digitata with malaria-associated calcium transport protein: An in …
  1312. APIGENIN prevents TNF-α induced apoptosis of primary rat retinal ganglion cells
  1313. The effect of Fusarium inoculation and fungicide application on concentrations of flavonoids (APIGENIN, kaempferol, luteolin, naringenin, quercetin, rutin …
  1314. Anticalculi activity of APIGENIN and celery (Apium graveolens L.) extract in rats induced by ethylene glycol–ammonium chloride
  1315. The inhibitory effect of APIGENIN on the agonist-induced regulation of vascular contractility via calcium desensitization-related pathways
  1316. Comparative transcriptome analysis of celery leaf Blades identified an R2R3-MYB transcription factor that regulates APIGENIN metabolism
  1317. Anti-diabetic activity of Egyptian celery APIGENIN
  1318. Total synthesis of scutellarin and APIGENIN 7-O-β-d-glucuronide
  1319. Efflux transport of chrysin and APIGENIN sulfates in HEK293 cells overexpressing SULT1A3: The role of multidrug resistance-associated protein 4 (MRP4/ABCC4)
  1320. Effects of APIGENIN and APIGENIN-loaded nanogel on induction of apoptosis in human chronic myeloid leukemia cells
  1321. Synthesis, characterization and free radical scavenging activity of APIGENIN with or without magnesium (II)
  1322. Adsorption and inhibitive properties of APIGENIN derivatives as eco-Friendly corrosion inhibitors for brass in nitric acid solution
  1323. Effects of APIGENIN on the expression levels of B‑cell lymphoma‑2, Fas and Fas ligand in renal ischemia‑reperfusion injury in rats
  1324. Protective Role of APIGENIN Against Aβ 25–35 Toxicity Via Inhibition of Mitochondrial Cytochrome c Release
  1325. Effect of luteolin and APIGENIN on the expression of Oct-4, Sox2, and c-Myc in dental pulp cells with in vitro culture
  1326. Efficacy of Concanavalin-A conjugated nanotransfersomal gel of APIGENIN for enhanced targeted delivery of UV induced skin malignant melanoma
  1327. Simultaneous quantification of glycyrrhetinic acid and APIGENIN using HPTLC from Glycyrrhiza glabra Linn
  1328. Plant flavone APIGENIN protects against cyclosporine-induced histological and biochemical changes in the kidney in rats
  1329. Preparation, in-vitro release and antioxidant potential of formulation of APIGENIN with hydroxypropyl-β-cyclodextrin modified microemulsion
  1330. APIGENIN reduces NF-κB and subsequent cytokine production as protective effect in a rodent animal model of lung ischemia-reperfusion injury
  1331. Simultaneously improving the physicochemical properties, dissolution performance, and bioavailability of APIGENIN and daidzein by co-crystallization with theophylline
  1332. APIGENIN relaxes rat intrarenal arteries, depresses Ca2+-activated Cl− currents and augments voltage-dependent K+ currents of the arterial smooth muscle …
  1333. Synergistic protective effect of chlorogenic acid, APIGENIN and caffeic acid against carbon tetrachloride-induced hepatotoxicity in male mice
  1334. APIGENIN decreases acinar cell damage in pancreatitis
  1335. Simultaneous ultra performance liquid chromatography determination and antioxidant activity of linarin, luteolin, chlorogenic acid and APIGENIN in different parts of …
  1336. Anti-oxidative and anti-apoptotic effects of APIGENIN on number of viable and apoptotic blastomeres, zona pellucida thickness and hatching rate of mouse …
  1337. Tuning phospholipid bilayer permeability by flavonoid APIGENIN: Electrochemical and atomic force microscopy study
  1338. Comparative pharmacokinetic profiles of selected irreversible tyrosine kinase inhibitors, neratinib and pelitinib, with APIGENIN in rat plasma by UPLC–MS/MS
  1339. Identification and analysis of APIGENIN metabolites in rats
  1340. Dietary APIGENIN potentiates the inhibitory effect of interferon-α on cancer cell viability through inhibition of 26S proteasome-mediated interferon receptor degradation
  1341. Determination of total APIGENIN in herbs by micellar electrokinetic chromatography with UV detection
  1342. Quantification of APIGENIN trimethyl ether in rat plasma by liquid chromatography–tandem mass spectrometry: application to a pre-clinical pharmacokinetic study
  1343. Commitment of human pluripotent stem cells to a neural lineage is induced by the pro-estrogenic flavonoid APIGENIN
  1344. APIGENIN inhibits C5a-induced proliferation of human nasopharyngeal carcinoma cells through down-regulation of C5aR
  1345. APIGENIN-mediated Alterations in Viability and Senescence of SW480 Colorectal Cancer Cells Persist in The Presence of L-thyroxine
  1346. APIGENIN-7-O-glucoside oxidation catalyzed by P450-bioinspired systems
  1347. The effects of APIGENIN and curcumin on autophagy related cell death and apoptosis
  1348. APIGENIN and Quercetin: Potential Therapeutic Challenging Effective Against in Alzheimer’s Disease
  1349. Construction, in vitro release and rheological behavior of APIGENIN-encapsulated hexagonal liquid crystal
  1350. Comparative bio-accessibility, bioavailability and bioequivalence of quercetin, APIGENIN, glucoraphanin and carotenoids from freeze-dried vegetables …
  1351. APIGENIN inhibits human SW620 cell growth by targeting polyamine catabolism
  1352. APIGENIN isolated from A. americana encodes human and Aspergillus oryzae S2 α-amylase inhibitions: credible approach for antifungal and antidiabetic therapies
  1353. APIGENIN, a novel candidate involving herb-drug interaction (HDI), interacts with organic anion transporter 1 (OAT1)
  1354. Protective effect of APIGENIN on bleomycin-induced pulmonary fibrosis in mice by increments of lung antioxidant ability and PPARγ expression
  1355. APIGENIN-7-O-β-D-glucuronide inhibits modified low-density lipoprotein uptake and foam cell formation in macrophages
  1356. Involvement of Bcl-2 signal pathway in the protective effects of APIGENIN on anoxia/reoxygenation-induced myocardium injury
  1357. Dietary APIGENIN in the prevention of endothelial cell dysfunction
  1358. Four in vitro activities of APIGENIN to human colorectal carcinoma cells susceptible to air-oxidative and heating treatments
  1359. APIGENIN and wogonin regulate epidermal growth factor receptor signaling pathway involved in MUC5AC mucin gene expression and production from …
  1360. Study on extraction and purification of APIGENIN and the physical and chemical properties of its complex with lecithin
  1361. RNA-seq analysis of the Rhizobium tropici CIAT 899 transcriptome shows similarities in the activation patterns of symbiotic genes in the presence of APIGENIN …
  1362. Novel triazole analogs of APIGENIN‑7‑methyl ether exhibit potent antitumor activity against ovarian carcinoma cells via the induction of mitochondrial‑mediated …
  1363. QM/MM–PB/SA scoring of the interaction strength between Akt kinase and APIGENIN analogues
  1364. APIGENIN-7-O-β-D-glycoside isolation from the highly copper-tolerant plant Elsholtzia splendens
  1365. Phytochemical investigation of Sonchus oleraceus (Family: Asteraceae) cultivated in Iraq, isolation and identification of quercetin and APIGENIN
  1366. APIGENIN reduces proteasome inhibition-induced neuronal apoptosis by suppressing the cell death process
  1367. UHPLC assisted simultaneous separation of APIGENIN and prednisolone and its application in the pharmacokinetics of APIGENIN
  1368. Inhibitory effect of APIGENIN on losartan metabolism and CYP2C9 activity in vitro
  1369. Prediction of C-glycosylated APIGENIN (vitexin) biosynthesis in Ficus deltoidea based on plant proteins identified by LC-MS/MS
  1370. Anti-inflammatory and anti-apoptotic potentials of APIGENIN against liver injury induced by ischemia-reperfusion in rats
  1371. APIGENIN from daily vegetable celery can accelerate bone defects healing
  1372. Antibacterial activity of APIGENIN, luteolin, and their C-glucosides
  1373. APIGENIN inhibits indoxyl sulfate-induced endoplasmic reticulum stress and anti-proliferative pathways, CHOP and IL-6/p21, in human renal proximal tubular …
  1374. Bioactivity guided isolation of APIGENIN from Stachys lavandulifolia Vahl. in mice with anxiolytic effects
  1375. Preparation and characterization of novel pseudo ceramide-based nanostructured lipid carriers for transdermal delivery of APIGENIN
  1376. Relaxation of isolated guinea-pig trachea by APIGENIN, a constituent of celery, via inhibition of phosphodiesterase
  1377. Development and validation of a novel high-performance thin-layer chromatography method for the simultaneous determination of APIGENIN and luteolin in Hygrophila …
  1378. Simultaneous separation of APIGENIN, luteolin and rosmarinic acid from the aerial parts of the copper-tolerant plant Elsholtzia splendens
  1379. Extraction of luteolin and APIGENIN from leaves of perilla frutescens (L.) Britt. with liquid carbon dioxide
  1380. α-Mangostin and APIGENIN induced the necrotic death of BT474 breast cancer cells with autophagy and inflammation
  1381. Retracted-miR-423-5p knockdown enhances the sensitivity of glioma stem cells to APIGENIN through the mitochondrial pathway
  1382. Healing of Growth Plate Cartilage by Hypoxia Inducible Factor-1a Inhibitor APIGENIN on Thiram Induced Tibial Dyschondroplasia.
  1383. BH3 mimetic ABT-263 enhances the anticancer effects of APIGENIN in tumor cells with activating EGFR mutation
  1384. Bronchodilator effect of APIGENIN and luteolin, two components of Dracocephalum kotschyi on isolated rabbit trachea
  1385. Validated HPTLC method for quantification of luteolin and APIGENIN in Premna mucronata Roxb., Verbenaceae
  1386. Features of APIGENIN, luteolin, hesperetin and naringenin in crop and body
  1387. Quercetin and APIGENIN of Cymbopogon citratus mediate inhibition of HCT-116 and PC-3 cell cycle progression and ameliorate Doxorubicin-induced testicular …
  1388. Non-clinical studies for evaluation of 8-C-rhamnosyl APIGENIN purified from Peperomia obtusifolia against acute edema
  1389. Alteration in biochemical parameters in the brain of transgenic Drosophila melanogaster model of Parkinson’s disease exposed to APIGENIN
  1390. Determining the contents of rupestonic acid, vitexicarpin, APIGENIN, and luteolin in Artemisia rupestris L. in different growth stages by thin-layer chromatographic …
  1391. APIGENIN ameliorates vascular injury in rats with high fructose-induced metabolic disturbance by inhibiting PI3K/AKT/GLUT1
  1392. APIGENIN modulates the expression levels of pro-inflammatory mediators to reduce the human insulin amyloid-induced oxidant damages in SK-N-MC cells
  1393. Competitive inhibition of quercetin and APIGENIN at the ATP binding site of D-alanine-D-alanine ligase of Helicobacter pylori–A molecular modeling approach
  1394. The non-additive contribution of hydroxyl substituents to Akt kinase–APIGENIN affinity
  1395. The effects of experimental conditions of fluorescence quenching on the binding parameters of APIGENIN to bovine serum albumin by response surface methods
  1396. APIGENIN protects myocardium by inhibiting the TGF-β1-mediated Smad signaling transduction pathway in acute myocardial infarcted rats
  1397. APIGENIN exerts anticancer effects on human cervical cancer cells via induction of apoptosis and regulation of Raf/MEK/ERK signalling pathway
  1398. Microbial metabolism of prenylated APIGENIN derivatives by Mucor hiemalis
  1399. APIGENIN restores impairment of autophagy and downregulation of unfolded protein response regulatory proteins in keratinocytes exposed to ultraviolet B …
  1400. Intestinal permeability and transport of APIGENIN across caco-2 cell monolayers
  1401. Identification of the vibrational spectra of APIGENIN and luteolin
  1402. The flavone APIGENIN blocks nuclear translocation of sterol regulatory element-binding protein-2 in the hepatic cells WRL-68
  1403. Solubility and dissolution rate improvement of the inclusion complex of APIGENIN with 2-hydroxypropyl-β-cyclodextrin prepared using the liquid antisolvent precipitation …
  1404. Traversal of the Blood–Brain Barrier by Cleavable l-Lysine Conjugates of APIGENIN
  1405. Larvicidal activity and Biochemical effects of APIGENIN against filarial vector Culex quinquefasciatus
  1406. APIGENIN increases maspin expression and suppresses invasiveness in prostate cancer cells
  1407. APIGENIN improves myocardial function and attenuates cardiotoxicity induced by doxorubicin in male rats
  1408. Identification of APIGENIN and luteolin in Artemisia annua L. for the quality control
  1409. Induction of apoptosis by gamma-irradiated APIGENIN in H1975 human non-small lung cells
  1410. Anti-inflammatory Activity of Bioactive Flavonoid APIGENIN-7-O-β-D-Glucuronide Methyl Ester from Ethyl Acetate Leaf Extract of Manilkara zapota on …
  1411. GW27-e0367 APIGENIN attenuates the cardiac remodeling in experimental diabetic cardiomyopathy
  1412. APIGENIN restores normal vascular reactivity in diabetic rats via protein kinase C inhibition
  1413. 39 Studies on the antidiabetic activity of APIGENIN in mice with streptozotocin-induced diabetes
  1414. Analysis of anthocyanin and APIGENIN contents and the expression profiles of biosynthesis-related genes in the purple and non-purple varieties of celery.
  1415. The antagonism between APIGENIN and protoapigenone to the PDK-1 target in Macrothelypteris torresiana
  1416. Simultaneous estimation of luteolin and APIGENIN in methanol leaf extract of Bacopa monnieri Linn by HPLC
  1417. New acylated APIGENIN glycosides from edge flowers of Matricaria chamomilla
  1418. In Vitro Anti Cancer Activity and detection of Quercetin, APIGENIN in Methanol extract of Euphorbia nivulia Buch.-Ham. By HPTLC Technique
  1419. Total synthesis of 8-(6 ″-umbelliferyl)-APIGENIN and its analogs as anti-diabetic reagents
  1420. Vasodilation Effect of Oleanolic Acid and APIGENIN as a Metabolite compound of Anredera cordifolia (Ten) V Steenis on isolated rabbit aortic and frog heart
  1421. Effects of APIGENIN on lipopolysaccharide induced proliferation of rat aortic vascular smooth muscle cells
  1422. APIGENIN inhibits rat neurosteroidogenic 5α-reductase 1 and 3α-hydroxysteroid dehydrogenase
  1423. Reversal of Warburg effect by APIGENIN and 5-Fluorouracil loaded dual drug liposomes result in enhanced colorectal chemotherapy
  1424. Protective role of APIGENIN against rotenone induced model of parkinson’s disease: behavioral study
  1425. Development and validation of a high-performance thin-layer chromatographic—densitometric method for the quantification of APIGENIN in Ocimum basilicum L. seed …
  1426. Determination of captopril in rat plasma by LC-MS/MS in presence of APIGENIN
  1427. Electrochemical determination of APIGENIN as an anti-gastric cancer drug in Lobelia chinensis using modified screen-printed electrode
  1428. A18239 APIGENIN ameliorates streptozotocin induced diabetic nephropathy in rats by modulation of oxidative stress, apoptosis and inflammation through MAPK …
  1429. Molecular mechanism of APIGENIN on inhibition of LPS-induced inflammatory mediators in murine macrophages
  1430. Probing the influence of carboxyalkyl groups on the molecular flexibility and the charge density of APIGENIN derivatives
  1431. Isolation of APIGENIN-7-O-(6”-OE-caffeoyl)-β-D-glucopyranoside from Leucas aspera L. with anti-inflammatory and wound healing activities
  1432. Anti-Tumor Potential of APIGENIN and Luteolin in Cervical Cancer
  1433. Extraction of APIGENIN and luteolin from leaves of alfalfa (Medicago sativa L.) using mixtures of liquid carbon dioxide and ethanol
  1434. APIGENIN suppresses angiogenesis by inhibiting tube formation and inducing apoptosis
  1435. Effects of APIGENIN on self-renewal and uPAR expression in NCI-H446 cell line
  1436. The Effects of APIGENIN on Cell Proliferation and Apoptosis in Glioblastoma Multiforme
  1437. Adsorption properties for separation of APIGENIN from Viola yedoensis on LSA-10 resin
  1438. Isolation and molecular recognization of 6-prenyl APIGENIN towards MAO-A as the active principle of seeds of Achyranthes aspera
  1439. A highly selective and sensitive fluorescence sensor for the detection of APIGENIN based on nitrogen doped carbon dots and its application in cell imaging
  1440. Subchronic Exposure of APIGENIN Induces Hepatic Oxidative Stress in Male Rats
  1441. Insight into the novel inhibition mechanism of APIGENIN to Pneumolysin by molecular modeling
  1442. Scale-up of one-step synthesis of acacetin and APIGENIN using 915 MHz microwaves
  1443. Contribution of APIGENIN di-C-glycosides and lutein to the colour of yellow alkaline noodles
  1444. Supercritical carbon dioxide extraction of APIGENIN from parsley leaves pre-treated to maximize yield
  1445. Bioaccessibility of APIGENIN from Mangifera indica (Water Lily Var.) during in vitro gastrointestinal digestion.
  1446. Antiproliferative effect of APIGENIN: A flavonoid in sarcoma 180 cell line
  1447. Effect of APIGENIN on acrylontrile-induced lipid peroxidation and DNA damage in sperm of male rats
  1448. Ex vivo and in silico Molecular Docking Studies of Aldose Reductase Inhibitory Activity of APIGENIN from Morus indica L.
  1449. The polyphenolic compound APIGENIN and applications to cervical cancer
  1450. Effects of APIGENIN on marked enzymes and oxidation-reduction balance in testicular of male rats
  1451. Hypolipidemic Effect of APIGENIN Extracted From Parsley (Petroselinum sativum L.) Leaves In Cadmium Chloride Treated Rats (Part II)
  1452. Identification of APIGENIN-7-Glucoside and Luteolin-7-Glucoside in Pleurotus porrigens and Schizophyllum commune Mushrooms by Liquid Chromatography–Ion Trap …
  1453. Is Mitochondria Biogenesis and Neuronal Loss Prevention in Rat Hippocampus Promoted by APIGENIN?
  1454. Evaluation of the in vitro and in vivo inhibitory effects of APIGENIN and gallic acid on the growth of Babesia and Theileria parasites
  1455. Validation and Development of HPTLC Method for Simultaneous Estimation of APIGENIN and Luteolin in Selected Marketed Ayurvedic Formulations of ‘ …
  1456. Synthesis of APIGENIN-samarium Complex and Its Anti-hyperuricemia in Mice
  1457. APIGENIN increases cisplatin inhibitory effects on the telomerase activity of triple negative breast cancer cells
  1458. Molecular Docking and Toxicity Test of APIGENIN Derivative Compounds as an Anti-Aging Agent
  1459. APIGENIN-7-O-?-D-Glucuronide Methyl Ester Isolated from Manilkara zapota Leaves
  1460. Optimization of ultrasound-assisted extraction of quercetin, luteolin, APIGENIN, pinocembrin and chrysin from Flos populi by Plackett-Burman design combined …
  1461. Antiangiogenic potential of yogurts added with extracts rich in APIGENIN derivatives
  1462. APIGENIN suppresses inhibitor of apoptosis family protein expression and disrupts Ku70-bax interaction in prostate cancer cells in culture and in vivo
  1463. Evaluation of in-vitro and in-vivo anti-inflammatory activities of APIGENIN and vitexin
  1464. APIGENIN an Naringenin
  1465. Purification of luteolin and APIGENIN from celery leaves using hybrid organic–inorganic monolithic cartridge
  1466. Synthesis and DNA Cleavage Activity of Pyrazinedimethylformamide Bridged APIGENIN Copper (Ⅱ) Complex
  1467. A new strategy for treating Staphylococcus aureus pneumonia: combination therapy of LysGH15 and APIGENIN
  1468. Protective effect of APIGENIN in a rat model of lung ischemia-reperfusion
  1469. Flavonoid APIGENIN Is an Inhibitor of the NAD+ ase CD38: Implications for Cellular NAD+ Metabolism, Protein Acetylation, and Treatment of Metabolic Syndrome …
  1470. Molecular docking studies on APIGENIN as a target with MAPK p38 for cardiovascular diseases
  1471. APIGENIN nanoparticle suppresses sphere formation in CD133+/ALDH1high prostate cancer stem cells through downregulation of stem cell markers
  1472. Nutraceutical APIGENIN: Mechanism of action associated with its anti-inflammatory activity and regulation of dendritic cell metabolism
  1473. The effect of APIGENIN on lipopolysaccharide-induced acute lung injury and its mechanism in mice
  1474. The role of Quercetin and APIGENIN for attenuating hypercholesterolemia
  1475. Anti-cancer Effect of APIGENIN on Human Breast Carcinoma MDA-MB-231 through Cell Cycle Arrest and Apoptosis
  1476. Retracted Article: Identifying the inhibitory mechanism of APIGENIN on the insulin ligand–receptor binding
  1477. Apoptotic mechanism of APIGENIN and rutin in ER+-breast cancer cells, MCF-7
  1478. Nutraceutical APIGENIN regulates DC function in a RelB-dependent manner during neuroinflammation
  1479. Spectroscopic Properties of APIGENIN in Various Bulk Solutions and Aerosol‐OT Reverse Micelles
  1480. Simultaneous Determination of APIGENIN and Quercetin in External Application Liquid of Potentilla kleiniana Wight et Arn by HPLC
  1481. OPTIMIZATION OF APIGENIN LIGAND IN THE 99M TC-APIGENIN COMPOUND SYNTHESIS PROCESS AS A POTENTIAL RADICAL SCAVENGER AGENT
  1482. APIGENIN Attenuates Pulmonary Hypertension by Inducing PASMCs Mitochondria-Dependent Apoptosis Via Inhibiting Hypoxia Inducible Factor 1α-KV1. 5 Channel …
  1483. Development of Drug Delivery System for APIGENIN against Inflammatory Disease-Approach for Clinical Application of Natural Products
  1484. Liquid chromatography-mass spectrometric method for simultaneous estimation of APIGENIN and luteolin from Achillea millefolium Linn.
  1485. Determination of luteolin-7-O-β-D-glucopyranoside, luteolin-7-O-β-D-glucuronopyranoside, and APIGENIN-7-O-β-D-glucuronopyranoside in Ixeris sonchifolia by HPLC …
  1486. APIGENIN inhibits proliferation and migratory properties of Barrett’s esophageal adenocarcinoma cells by targeting PI3K/Akt/mTOR pathway
  1487. Structural basis and energy landscape of APIGENIN-induced cancer cell apoptosis mechanism in PI3K/Akt pathway
  1488. Evaluation of Anti-oxidant and Anti-cancer Properties of Silver Nanoparticles Synthesized by APIGENIN toward Breast Cancer MCF-7 Cell Line
  1489. Research progress on prevention and treatment of T2DM with APIGENIN
  1490. Local orbital locator analysis of isomeric compounds of luteolin and APIGENIN
  1491. Research Progress on Structure Modification and Activity of APIGENIN
  1492. APIGENIN ameliorates ocular surface lesions in a rat model of dry eye disease
  1493. Comparing the Effects of Kaempferol, Galangin and APIGENIN Flavanoids on Basis of its Structural Differences in Increasing of Paraoxonase 1 Activity and Attenuating …
  1494. Neuroprotective effects of APIGENIN in Human Neuroblastoma SH-SY5Y cells Against Rotenone toxicity: a pilot study.
  1495. Potential ABTS Reducing and Anti-collagenase Activity of Scutellarein and APIGENIN
  1496. Co-administrating APIGENIN in a high-cholesterol diet prevents hypercholesterolaemia in golden hamsters
  1497. Role of Bcl-2 signal pathway in APIGENIN preconditioning against cardiomyocytes anoxia/reoxygenation injury
  1498. Simple and sensitive high performance liquid chromatographic (HPLC) method for the determination of the APIGENIN from dried powder of Cosmos bipinnatus, Apium …
  1499. Prediction of potential drug interactions of APIGENIN based on molecular docking and in vitro inhibition experiments
  1500. Anti-adipogenic activity of Carduus crispus and its constituent APIGENIN in 3T3-L1 adipocytes by downregulating PPARγ and C/EBPα
  1501. … and Antioxidant Activity of the Cu (II) Metal Complex with 2-p-Hydroxy Benzoic-4-p-Tolyl Imino-5, 7-two Hydroxy Benzopyran as a Ligand Derived from APIGENIN
  1502. Chemoprevention by APIGENIN
  1503. Red betel APIGENIN compound (Piper crocatum Ruiz & Pav.) as an anti-inflammatory rheumatoid arthritis agent through virtual screening
  1504. Study on kinectics characteristics of the sulfation of APIGENIN by SULTIA3
  1505. A1935 Modulation of TRPV4 by APIGENIN ameliorates renal fibrosis in DOCA salt hypertensive rats
  1506. The role of APIGENIN loaded Nano structured Lipid Carriers in increasing docetaxel efficiency in lung cancer chemotherapy
  1507. Uptake Study on APIGENIN in Caco-2 Cells
  1508. APIGENIN oxidovanadium (IV) cation interactions
  1509. Influence of APIGENIN on the cariogenicity of Streptococcus mutans
  1510. Study on the Electrochemical Behaviour of APIGENIN and its Interaction with DNA
  1511. Evaluation of immunochemotherapy effects of APIGENIN in female balb/c mice with breast cancer
  1512. Efficacy and safety of a new topical hair loss-lotion containing oleanolic acid, APIGENIN, biotinyl tripeptide-1, diaminopyrimidine oxide, adenosine, biotin and …
  1513. APIGENIN and Baicalin, Each Alone or in Low Dose Combination, Attenuated Chloroquine Induced Male Infertility in Adult Rats
  1514. Antioxidant and Inhibition of Elastase Effect of Scutellarein and APIGENIN
  1515. Papatya içeren kozmetiklerde APIGENIN miktar tayini/Determination of APIGENIN in cosmetics formulations containing chamomile
  1516. Analysis of efficacy of L-APIGENIN A in the treatment of Alzheimer’s disease
  1517. Drug delivery approaches for APIGENIN: A review
  1518. Interactions between Dietary Flavonoid APIGENIN and Human Gut Microbiota in vitro
  1519. Effect of APIGENIN on 3T3-L1 Cells
  1520. Effects of APIGENIN on Experimental Ischemia/Reperfusion Injury in the Rat Ovary.
  1521. Toxcity Assessment of the Pesticide, Edifenphos and its Amelioration by APIGENIN.
  1522. Corrigendum to “APIGENIN protects HT22 murine hippocampal neuronal cells against endoplasmic reticulum stress-induced apoptosis”(APIGENIN protects HT22 murine …
  1523. Preparation process of APIGENIN particles by supercritical CO_2 anti-solvent method
  1524. THE EFFECT OF APIGENIN ON THE DEVELOPMENT OF MOUSE EMBRYOS IN VITRO
  1525. CAPILLARY ELECTROPHORESIS OF APIGENIN
  1526. Formulation of APIGENIN containing multiparticular drug delivery systems
  1527. APIGENIN produced by maize flavone synthase I and II protects plants against UV-B-induced damage
  1528. … OF THE OPTIMUM CONCENTRATION OF SNCL2. 2H2O AS A REDUCING AGENT IN THE LABELING OF APIGENIN COMPOUNDS WITH RADIONUCLIDE …
  1529. Antiapoptotic effect of APIGENIN and vitamin E against deltamethrin induced toxicity in rats
  1530. Resveratrol as a bioenhancer to improve anti-inflammatory activities of APIGENIN
  1531. Nuclear overhauser effect in APIGENIN molecule
  1532. APIGENIN Inducing Different Cells Apoptosis through Increasing ROS
  1533. NUCLEAR OVERHAUSER EFFECT IN APIGENIN MOLECULE
  1534. Development and characterization of APIGENIN transfersomal system for skin cancer
  1535. Structure and Biological Activity of the La (Ⅲ) Complex with APIGENIN
  1536. Potential targets prediction of APIGENIN via virtual screening
  1537. APIGENIN relaxes rat intrarenal arteries: involvement of Cl− channels and K+ channels
  1538. Effects of APIGENIN on in vivo pharmacokinetics of doxorubicin in rats
  1539. Potential of the Flavonoid APIGENIN in Regulating Immune Cell Functions During Neuroinflammation in a RelB-dependent Manner
  1540. Effect of APIGENIN on Inhibiting Proliferation and Apoptosis of Human NCI-H1650 Cell Line
  1541. APIGENIN inhibits inflammation and T cell activation from murine lymphocytes
  1542. Study on the stability of scavenging DPPH free radical by Viola philippica APIGENIN.
  1543. The Flavonoid APIGENIN Inhibits Inducible Programmed Death Ligand 1 Expression by Breast Cancer Cells
  1544. Isolation of APIGENIN from Antirrhinum majas
  1545. The Immune-modulatory and Anti-carcinogenic Mechanisms of the Flavonoid APIGENIN
  1546. Analysis of the erythroid differentiation effect of flavonoid APIGENIN
  1547. Study on The PK-PD Model of APIGENIN-7-O-glucronide Based on The Cerebral Ischemia-Reperfusion Injury Model Rats
  1548. Optimization of Extraction Process of APIGENIN in Celery Leaves and Its Antioxidant Activity in Vitro
  1549. In Vivo Evaluation of “Meriva” Curcumin, and APIGENIN as Anti-inflammatory Drugs in a Mouse Model of Chronic Neuroinflammation
  1550. Some of the APIGENIN Derivatives’ Impact on Polyphenol Oxidase Enzyme
  1551. Study on the liver injury induced by APIGENIN in male mice
  1552. APIGENIN and its Nano-Liposomal Formulation for Colorectal Cancer and Bacterial Chemotherapy
  1553. APIGENIN ameliorates streptozotocin induced diabetic nephropathy in rats
  1554. Interaction of APIGENIN and Hesperetin on Xanthine Oxidase Inhibition and Their Inhibitory Mechanism
  1555. APIGENIN extraction from fresh Elsholtzia ciliata herb
  1556. Effect of APIGENIN on the multidrug resistant breast cancer cell line MCF-7/ADR
  1557. … of chronic neuroinflammation on cognition and behaviour in the GFAP-IL6 transgenic mouse and investigation of the flavonoid APIGENIN as a neuroprotective …
  1558. FURTHER EVALUATION OF EUCALIPTOL, CARVACROL, APIGETRIN AND APIGENIN FOR THEIR IN VITRO ANTICANCER POTENTIAL
  1559. The Protective Effects of APIGENIN on LPS-induced Acute Lung Injury in Mice
  1560. Optimal extraction process of APIGENIN in Chromolaena odorata L by orthogonal experiment.
  1561. Effect of APIGENIN on streptozotocin-induced diabetic liver injury in rats
  1562. Pharmacokinetics of APIGENIN-7-O-glucronide in Normal and Middle Cerebral Artery Occlusion Rats
  1563. Themes: Title: APIGENIN protects SK-N-MC cells against human insulin amyloid toxicity
  1564. Effects of APIGENIN and luteolin on p53-dependent apoptosis and autophagy in colon cancer cells
  1565. Synthesis and Recognition of APIGENIN Monodispersed Molecularly Imprinted Polymer
  1566. Effects of APIGENIN on Platelet Derived Growth Factor-induced Migration of Vascular Smooth Muscle Cells
  1567. Effects of APIGENIN on Renal Ischemia/reperfusion Injury Apoptosis in Rats by Fas/FasL
  1568. Antiangiogenic Effects of the APIGENIN and/or Selenium on Ehrlish Bearing Mice
  1569. Synthesis of Schiff Base Metal Derivatives of APIGENIN and Their Antioxidant Activity
  1570. Retraction: Identifying the inhibitory mechanism of APIGENIN on the insulin ligand–receptor binding
  1571. Plant-based product APIGENIN attenuates EAE severity through the modulation of immune cell function (THER7P. 948)
  1572. Pleiotropic Molecular Effects of Dietary Polyphenols Resveratrol and APIGENIN in Leukemia
  1573. Combination Therapy of LysGH15 and APIGENIN as a New Strategy for Treating Pneumonia Caused by Staphylococcus aureus
  1574. APIGENIN (4’5, 7 Trihydroxyflavone) Inhibition of TNF-Alpha-Induced GRO Release in Triple Negative Breast MDA-MB-468 Cells
  1575. Microbial metabolism of prenylated APIGENIN derivatives
  1576. Formulation and Characterization of the Improved Solubility, In Vivo Bioavailability and Antioxidant Activity of APIGENIN-Phospholipid Complex (APLC)
  1577. APIGENIN Inhibits LPS-induced Microglia Activation by Modulating MicroRNA Expression
  1578. APIGENIN induces apoptosis through inhibit of MAPK signaling in A375SM and A375P melanoma cells
  1579. Histopathological study in Lungs of mice implanted with mammary adenocarcinoma (AM3) and treated with flavonoids (APIGENIN)
  1580. Histopathological study in Lungs of mice implanted with mammary adenocarcinoma (AM3) and treated with flavonoids (APIGENIN)
  1581. Inhibitory effect of APIGENIN on proliferation and invasion of human malignant melanoma cells.
  1582. APIGENIN reduces cell viability of Human epidermoid cancer cells (Hep-2)
  1583. Activity of APIGENIN and quercetin on rat hepatic mitochondrial permeability transition pore.
  1584. Effect of APIGENIN-induced autophagy on apoptosis in human gastric cancer cells SGC-7901
  1585. HPLC determination of luteolin and APIGENIN in Herba Scutellariae barbatae
  1586. APIGENIN and Naringenin Increase Apoptosis and Decrease Proliferation via Transcriptional Regulation
  1587. The flavone APIGENIN blocks SREBP-2 activation in hepatic cells
  1588. Spectroscopic Studies on the Interaction of Naringenin, APIGENIN with FTO
  1589. Determination of luteolin and APIGENIN in Apium graveolen L. by HPLC.
  1590. Determination of Naringenin and APIGENIN in Premna fulva Craib. by HPLC
  1591. Determination of quercetin, luteolin and APIGENIN in Matricaria Chamomila L. by PR-HPLC
  1592. Effects of APIGENIN on the Expressions of TGF-β1R II, NF-κB and VEGF Genes in Tumor Tissues of Mice with H29 Colon Cancer
  1593. APIGENIN overcomes drug resistance by blocking signal transducer and activator of transcription 3 (STAT3) signaling in breast cancer
  1594. Anti-cancer effects of APIGENIN by enhancing tumor necrosis factor-related apotosis-inducing ligand-mediated death receptor 5 expression and inhibition of telomerase …
  1595. APIGENIN Modulation of Whole Transcriptome Patterns of TNFα‐Induced Changes in Triple Negative Breast Cancer Cells, MDA‐MB‐231
  1596. Refining the methods of extraction and purification of APIGENIN from Viola yedoensis makino
  1597. Effect of APIGENIN and cisplatin on telomerase activity and expression of its structural proteins in triple negative breast cancer/Noorfaiza A. Aziz
  1598. Total synthesis of APIGENIN glycosides and the effect of these compounds on polyphenol oxidase enzyme activity
  1599. Oral Efficacy of APIGENIN against Cutaneous Leishmaniasis: Involvement of Reactive Oxygen Species and Autophagy as a Mechanism of Action
  1600. Effect of APIGENIN on Leishmania amazonensis Is Associated with Reactive Oxygen Species Production Followed by Mitochondrial Dysfunction
  1601. Simultaneous Determination of Luteolin and APIGENIN in Mongolian Medicine Scabiosa atropurea by RP-HPLC
  1602. Specific role of oxidized species in the bioactivity of two antioxidants: APIGENIN and 20-hydroxyecdysone
  1603. APIGENIN has anti-atrophic gastritis and anti-gastric cancer progression effects in Helicobacter pylori-infected Mongolian gerbils
  1604. Simultaneous Determination of Scutellarin, Protopine, APIGENIN and Tetrahydropalmatine in Dengyan Granules by HPLC
  1605. The flavonoid APIGENIN upregulates CD26/DPPIV on human colorectal carcinoma cells
  1606. Plant Flavone APIGENIN Binds to Nucleic Acid Bases and Reduces Oxidative DNA Damage in Prostate
  1607. Inhibitory Effect of Self-made Jiawei Weijing Decoction and APIGENIN on Proliferation, Cell-cycle and Apoptosis of Lung Adenocarcinoma A549 Cell
  1608. Microencapsulation of plant extracts rich in APIGENIN to be used as chemopreventive agents in functional foods
  1609. APIGENIN inhibit UV-induced melanogenesis through activation of MIF and PAR-2 expression in keratinocytes
  1610. Determination of verbascoside, luteolin and APIGENIN in siphonostegia chinensis by HPLC.
  1611. Synergistic effects of cisplatin and APIGENIN on telomerase expression and telomerase activity in TNBC cells/Associate Professor Dr Gabriele Ruth Anisah Froemming …
  1612. PS 13-22 APIGENIN ATTENUATES ISOPROTERENOL INDUCED MYOCARDIAL INFARCTION IN DIABETIC RATS VIA MODULATION OF PPAR-γ PATHWAY: A PRE …
  1613. Fabrication of Tamarind Gum Based Nanoemulsion Gel of APIGENIN for UV Induced Skin Carcinoma
  1614. Study and ch aracterization of the antioxidant activity of the inclusion complex of APIGENIN with?-cyclodextrin and 2-hydroxylpropyl?-cyclodextrin in solution
  1615. APIGENIN attenuates CCL2 release from TNFα and IL‐1a stimulated MDA‐MB‐231 triple negative breast cancer cells
  1616. Antimicrobial evaluation and quantification of APIGENIN content by HPTLC in methanol stem extract of Cardiospermum halicacabum L
  1617. High-yield production of APIGENIN from celery with ultrasonic-assisted β-glucosidase hydrolysis.
  1618. Determination of scutellarin, baicalein, luteolin and APIGENIN in Herba Scutellariae barbatae by HPLC
  1619. Inhibition of APIGENIN on lipopolysaccharide-induced bone-marrow-derived macrophages inflammation through NF-κB and MAPK.
  1620. Simultaneous Determination of Chlorogenic Acid, Luteolin, APIGENIN and Acacetin in Medicinal Chrysanthemum morifolium by HPLC
  1621. Hypolipidemic Effect of APIGENIN Extracted From Parsley (Petroselinum sativum L.) Leaves In Cadmium Chloride Treated Rats (Part II)
  1622. Effect on oxidative stress, glucose uptake level and lipid droplet content by APIGENIN 7, 4′-dimethyl ether isolated from Piper longum L
  1623. APIGENIN induces apoptosis by suppressing Bcl-xL and Mcl-1 simultaneously through signal transducer and activator of transcription 3 (STAT3) signaling in colon …
  1624. Induction of NRF2-mediated gene expression by dietary phytochemical flavones APIGENIN and luteolin
  1625. Comparison of the molecular interactions of 7′-carboxyalkyl APIGENIN derivatives with S. cerevisiae α-glucosidase
  1626. APIGENIN 7-O-β-D-(6 ″-p-coumaroyl)-glucoside protects against myocardial ischemia/reperfusion injury through inhibition of NF-κB activation
  1627. Haematological and histopathological effects of APIGENIN, phloretin and myricetin based on uterotrophic assay in immature Wistar female albino rats
  1628. … -drying: effect of different encapsulating agents for spray-dried microcapsulesquality and encapsulation efficiency of rosmarinic acid, chlorogenic acid, and APIGENIN
  1629. Simultaneous determination of isoquercetin, morin, quercetin, luteolin and APIGENIN in Limonium sinense (Girard) Kuntze by RP-HPLC
  1630. Inhibiting glucose transporter-1 and the PI3K/Akt pathway with APIGENIN, siRNA, LY294002 or wortmannin affects the radiosensitivity of laryngeal squamous cell …
  1631. 514 Efficacy of APIGENIN on UV-induced melanogenesis through activation of MIF and PAR-2 expression in keratinocytes
  1632. miR-138 overexpression most effectively enhanced efficacy of APIGENIN to impair cell cycle progression and induce apoptosis in human malignant neuroblastoma SK …
  1633. APIGENIN as an anticancer agent
  1634. Rationalizing the therapeutic potential of APIGENIN against cancer
  1635. Antiviral activity of APIGENIN against buffalopox: Novel mechanistic insights and drug-resistance considerations
  1636. Recent insights into the biological functions of APIGENIN
  1637. The anticancer potential of APIGENIN via immunoregulation
  1638. APIGENIN induced autophagy and stimulated autophagic lipid degradation
  1639. Comparative study on the biological effects of sodium citrate-based and APIGENIN-based synthesized silver nanoparticles
  1640. An APIGENIN-based bio-benzoxazine with three polymerizable functionalities: sustainable synthesis, thermal latent polymerization, and excellent thermal properties of …
  1641. APIGENIN-rivastigmine hybrids as multi-target-directed liagnds for the treatment of Alzheimer’s disease
  1642. Multi-spectroscopic, conformational, and computational atomic-level insights into the interaction of β-lactoglobulin with APIGENIN at different pH levels
  1643. APIGENIN as tumor suppressor in cancers: biotherapeutic activity, nanodelivery, and mechanisms with emphasis on pancreatic cancer
  1644. Hepatoprotective Effect of APIGENIN Against Liver Injury via the Non-canonical NF-κB Pathway In Vivo and In Vitro
  1645. Neuroimmunomodulatory and neuroprotective effects of the flavonoid APIGENIN in in vitro models of neuroinflammation associated with Alzheimer’s disease
  1646. The genome sequence of celery (Apium graveolens L.), an important leaf vegetable crop rich in APIGENIN in the Apiaceae family
  1647. APIGENIN inhibits STAT3/CD36 signaling axis and reduces visceral obesity
  1648. APIGENIN role as cell-signaling pathways modulator: implications in cancer prevention and treatment
  1649. Cytotoxicity of APIGENIN toward multiple myeloma cell lines and suppression of iNOS and COX-2 expression in STAT1-transfected HEK293 cells
  1650. Therapeutic potentials of the natural plant flavonoid APIGENIN in polycystic ovary syndrome in rat model: via modulation of pro-inflammatory cytokines and antioxidant …
  1651. APIGENIN suppresses influenza A virus‐induced RIG‐I activation and viral replication
  1652. APIGENIN 7-O-glucoside promotes cell apoptosis through the PTEN/PI3K/AKT pathway and inhibits cell migration in cervical cancer Hela cells
  1653. Investigation of the anti-inflammatory and antioxidant activities of luteolin, kaempferol, APIGENIN and quercetin
  1654. Investigation of possible effects of APIGENIN, sorafenib and combined applications on apoptosis and cell cycle in hepatocellular cancer cells
  1655. Establishment and assessment of cell suspension cultures of Matricaria chamomilla as a possible source of APIGENIN under static magnetic field
  1656. APIGENIN protects human melanocytes against oxidative damage by activation of the Nrf2 pathway
  1657. APIGENIN inhibits histamine-induced cervical cancer tumor growth by regulating estrogen receptor expression
  1658. APIGENIN induces apoptosis by regulating Akt and MAPK pathways in human melanoma cell A375SM
  1659. APIGENIN prevents acetaminophen-induced liver injury by activating the SIRT1 pathway
  1660. APIGENIN, a flavonoid constituent derived from P. villosa, inhibits hepatocellular carcinoma cell growth by CyclinD1/CDK4 regulation via p38 MAPK-p21 signaling
  1661. Enhancing oral bioavailability of APIGENIN using a bioactive self-nanoemulsifying drug delivery system (Bio-SNEDDS): in vitro, in vivo and stability evaluations
  1662. APIGENIN ameliorates doxorubicin-induced renal injury via inhibition of oxidative stress and inflammation
  1663. APIGENIN attenuates the allergic reactions by competitively binding to ER with estradiol
  1664. Effect of luteolin and APIGENIN on the production of IL-31 and IL-33 in lipopolysaccharides-activated microglia cells and their mechanism of action
  1665. Neuroprotective effect of APIGENIN against cerebral ischemia/reperfusion injury
  1666. Epileptic brain fluorescent imaging reveals APIGENIN can relieve the myeloperoxidase-mediated oxidative stress and inhibit ferroptosis
  1667. Prevention by dietary polyphenols (resveratrol, quercetin, APIGENIN) against 7-ketocholesterol-induced oxiapoptophagy in neuronal N2a cells: potential interest for the …
  1668. APIGENIN promotes antibacterial activity via regulation of nitric oxide and superoxide anion production
  1669. A comparison of the effects of APIGENIN and seven of its derivatives on selected biomarkers of oxidative stress and coagulation in vitro
  1670. APIGENIN attenuates pulmonary hypertension by inducing mitochondria-dependent apoptosis of PASMCs via inhibiting the hypoxia inducible factor 1α–KV1. 5 channel …
  1671. Delivery of APIGENIN-loaded magnetic Fe2O3/Fe3O4@ mSiO2 nanocomposites to A549 cells and their antitumor mechanism
  1672. APIGENIN attenuates TGF-β1-stimulated cardiac fibroblast differentiation and extracellular matrix production by targeting miR-155-5p/c-Ski/Smad pathway
  1673. APIGENIN and Abivertinib, a novel BTK inhibitor synergize to inhibit diffuse large B-cell lymphoma in vivo and vitro
  1674. APIGENIN Increases SHIP-1 Expression, Promotes Tumoricidal Macrophages and Anti-Tumor Immune Responses in Murine Pancreatic Cancer
  1675. APIGENIN alleviates renal fibroblast activation through AMPK and ERK signaling pathways in vitro
  1676. APIGENIN-Loaded PLGA-DMSA Nanoparticles: A Novel Strategy to Treat Melanoma Lung Metastasis
  1677. Efficiency comparison of APIGENIN-7-O-glucoside and trolox in antioxidative stress and anti-inflammatory properties
  1678. APIGENIN protects mouse retina against oxidative damage by regulating the Nrf2 pathway and autophagy
  1679. APIGENIN and Structurally Related Flavonoids Allosterically Potentiate the Function of Human α7-Nicotinic Acetylcholine Receptors Expressed in SH-EP1 Cells
  1680. APIGENIN exhibits anti-inflammatory effects in Lps-stimulated Bv2 microglia through activating Gsk3β/Nrf2 signaling pathway
  1681. APIGENIN reverses behavioural impairments and cognitive decline in kindled mice via CREB-BDNF upregulation in the hippocampus
  1682. APIGENIN Modulates Dendritic Cell Activities and Curbs Inflammation Via RelB Inhibition in the Context of Neuroinflammatory Diseases
  1683. Metformin-induced ROS upregulation as amplified by APIGENIN causes profound anticancer activity while sparing normal cells
  1684. Luteolin and APIGENIN attenuate LPS-induced astrocyte activation and cytokine production by targeting MAPK, STAT3, and NF-κB signaling pathways
  1685. A natural flavonoid, APIGENIN isolated from Clerodendrum viscosum leaves, induces G2/M phase cell cycle arrest and apoptosis in MCF-7 cells through the regulation …
  1686. Does Oral APIGENIN Have Real Potential for a Therapeutic Effect in the Context of Human Gastrointestinal and Other Cancers?
  1687. Co-folding of hydrophobic rice proteins and shellac in hydrophilic binary microstructures for cellular uptake of APIGENIN
  1688. APIGENIN alleviated acetaminophen‐induced hepatotoxicity in low protein‐fed rats: Targeting oxidative stress, STAT3, and apoptosis signals
  1689. APIGENIN attenuates Aluminum phosphide-induced cytotoxicity via reducing mitochondrial/Lysosomal damages and oxidative stress in rat Cardiomyocytes
  1690. The natural flavones, acacetin and APIGENIN, induce Cdk-Cyclin mediated G2/M phase arrest and trigger ROS-mediated apoptosis in glioblastoma cells
  1691. APIGENIN upregulation of CD26/DPPIV on colon epithelial cells requires inhibition of casein kinase 2
  1692. Transcriptomics and proteomics analysis of system-level mechanisms in the liver of APIGENIN-treated fibrotic rats
  1693. Effects of APIGENIN on RBL-2H3, RAW264. 7, and HaCaT Cells: Anti-Allergic, Anti-Inflammatory, and Skin-Protective Activities
  1694. Melatonin and calcium modulate the production of rosmarinic acid, luteolin, and APIGENIN in Dracocephalum kotschyi under salinity stress
  1695. The effect of kaempferol and APIGENIN on allogenic synovial membrane-derived stem cells therapy in knee osteoarthritic male rats
  1696. APIGENIN enhanced antitumor effect of cisplatin in lung cancer via inhibition of cancer stem cells
  1697. Protective effects of APIGENIN, APIGENIN-8-sulfonate, and APIGENIN-3′, 8-disulfonate on d-galactosamine-induced acute liver damage in mice
  1698. Protective effect of APIGENIN magnesium complex on H2O2-induced oxidative stress and inflammatory responses in rat hepatic stellate cells
  1699. Novel quercetin and APIGENIN-acetamide derivatives: design, synthesis, characterization, biological evaluation and molecular docking studies
  1700. APIGENIN-loaded solid lipid nanoparticle attenuates diabetic nephropathy induced by streptozotocin nicotinamide through Nrf2/HO-1/NF-kB signalling pathway
  1701. Transcriptome analysis of two structurally related flavonoids; APIGENIN and Chrysin revealed hypocholesterolemic and ketogenic effects in mouse embryonic …
  1702. H19-Wnt/β-catenin regulatory axis mediates the suppressive effects of APIGENIN on tumor growth in hepatocellular carcinoma
  1703. APIGENIN ameliorates oxidative stress and mitochondrial damage induced by multiwall carbon nanotubes in rat kidney mitochondria
  1704. Midkine silencing enhances the anti–prostate cancer stem cell activity of the flavone APIGENIN: cooperation on signaling pathways regulated by ERK, p38, PTEN …
  1705. Investigation of C-glycosylated APIGENIN and luteolin derivatives’ effects on protein tyrosine phosphatase 1B inhibition with molecular and cellular approaches
  1706. Antioxidant APIGENIN relieves age-related muscle atrophy by inhibiting oxidative stress and hyperactive mitophagy and apoptosis in skeletal muscle of mice
  1707. Protective effects of APIGENIN on altered lipid peroxidation, inflammation, and antioxidant factors in methotrexate-induced hepatotoxicity
  1708. APIGENIN promotes osteogenic differentiation of mesenchymal stem cells and accelerates bone fracture healing via activating Wnt/β-catenin signaling
  1709. Bioactive flavonoid APIGENIN and its nanoformulations: a promising hope for diabetes and cancer
  1710. APIGENIN modulates hippocampal CREB-BDNF signaling in high fat, high fructose diet-fed rats
  1711. Comparative study on the extraction of APIGENIN from parsley leaves (Petroselinum crispum L.) by ultrasonic and microwave methods
  1712. CD38 inhibition by APIGENIN ameliorates mitochondrial oxidative stress through restoration of the intracellular NAD+/NADH ratio and Sirt3 activity in renal …
  1713. APIGENIN regulates activation of microglia and counteracts retinal degeneration
  1714. APIGENIN protects mice against 3, 5-diethoxycarbonyl-1, 4-dihydrocollidine-induced cholestasis
  1715. APIGENIN as a candidate prenatal treatment for trisomy 21: effects in human amniocytes and the Ts1Cje mouse model
  1716. APIGENIN and Temozolomide Synergistically Inhibit Glioma Growth Through the PI3K/AKT Pathway
  1717. APIGENIN Prevent Abdominal Aortic Aneurysms Formation by Inhibiting the NF-κB Signaling Pathway
  1718. Impact of coadministration of APIGENIN and bone marrow stromal cells on damaged ovaries due to chemotherapy in rat: An experimental study
  1719. APIGENIN-7-O-β-D-(-6”-p-coumaroyl)-glucopyranoside treatment elicits a neuroprotective effect through GSK-3β phosphorylation-mediated Nrf2 activation
  1720. UHPLC-UV/PDA method validation for simultaneous quantification of luteolin and APIGENIN derivatives from Elaeis guineensis leaf extracts: An application for …
  1721. Overcoming the hypoxia-induced drug resistance in liver tumor by the concurrent use of APIGENIN and paclitaxel
  1722. APIGENIN by targeting hnRNPA2 sensitizes triple-negative breast cancer spheroids to doxorubicin-induced apoptosis and regulates expression of ABCC4 and ABCG2 …
  1723. Salinity stress alters ion homeostasis, antioxidant activities and the production of rosmarinic acid, luteolin and APIGENIN in Dracocephalum kotschyi Boiss
  1724. APIGENIN suppresses TGF-β1-induced cardiac fibroblast differentiation and collagen synthesis through the downregulation of HIF-1α expression by miR-122-5p
  1725. Effects of APIGENIN treatment on random skin flap survival in rats
  1726. APIGENIN, flavonoid component isolated from Gentiana veitchiorum flower suppresses the oxidative stress through LDLR-LCAT signaling pathway
  1727. APIGENIN attenuates allergic responses of ovalbumin-induced allergic rhinitis through modulation of Th1/Th2 responses in experimental mice
  1728. Targeting renal OATs to develop renal protective agent from traditional Chinese medicines: Protective effect of APIGENIN against Imipenem‐induced nephrotoxicity
  1729. Mechanistic insights into the inhibition of pancreatic lipase by APIGENIN: Inhibitory interaction, conformational change and molecular docking studies
  1730. APIGENIN restores endothelial function by ameliorating oxidative stress, reverses aortic stiffening, and mitigates vascular inflammation with aging
  1731. The neuroprotective effect of APIGENIN against OGD/R injury in rat hippocampal neurons.
  1732. Luteolin and its derivative APIGENIN suppress the inducible PD-L1 expression to improve anti-tumor immunity in KRAS-mutant lung cancer
  1733. Development and Characterization of Calcium-Alginate Beads of APIGENIN: In Vitro Antitumor, Antibacterial, and Antioxidant Activities
  1734. The kinetic and thermodynamic studies of solid-liquid extraction of APIGENIN-glycosides from parsley (Petroselinum crispum)
  1735. Effect of APIGENIN on whole transcriptome profile of TNFα‑activated MDA‑MB‑468 triple negative breast cancer cells
  1736. Synergistic Effect of APIGENIN and Curcumin on Apoptosis, Paraptosis and Autophagy-related Cell Death in HeLa Cells
  1737. Kolaviron (Kolaflavanone), APIGENIN, fisetin as potential Coronavirus inhibitors: In silico investigation
  1738. Bioactive APIGENIN loaded oral nano bilosomes: Formulation optimization to preclinical assessment
  1739. Discovery of Novel APIGENIN–Piperazine Hybrids as Potent and Selective Poly (ADP-Ribose) Polymerase-1 (PARP-1) Inhibitors for the Treatment of Cancer
  1740. Production of isoorientin and isovitexin from luteolin and APIGENIN using coupled catalysis of glycosyltransferase and sucrose synthase
  1741. APIGENIN induces apoptosis and counteracts cisplatin‑induced chemoresistance via Mcl‑1 in ovarian cancer cells
  1742. Critical roles of Rad54 in tolerance to APIGENIN‑induced Top1‑mediated DNA damage
  1743. APIGENIN ameliorates D-galactose-induced lifespan shortening effects via antioxidative activity and inhibition of mitochondrial-dependent apoptosis in …
  1744. Inhibitory Effects of APIGENIN on Tumor Carcinogenesis by Altering the Gut Microbiota
  1745. APIGENIN enhances viability of random skin flaps by activating autophagy
  1746. APIGENIN-7-O-β-d-(6″-p-coumaroyl)-glucopyranoside reduces myocardial ischaemia/reperfusion injury in an experimental model via regulating the inflammation …
  1747. Efficient Production of Orientin and Vitexin from Luteolin and APIGENIN Using Coupled Catalysis of Glycosyltransferase and Sucrose Synthase
  1748. Mechanism of Interactions of dsDNA Binding with APIGENIN and Its Sulfamate Derivatives Using Multispectroscopic, Voltammetric, and Molecular Docking Studies
  1749. A novel APIGENIN derivative suppresses renal cell carcinoma via directly inhibiting wild-type and mutant MET
  1750. Modulation of Th17 proliferation and IL-17A gene expression by acetylated form of APIGENIN in patients with multiple sclerosis
  1751. Loading of APIGENIN extracted from parsley leaves on colloidal core-shell nanocomposite for bioavailability enhancement
  1752. Bioengineering of Genetically Encoded Gene Promoter Repressed by the Flavonoid APIGENIN for Constructing Intracellular Sensor for Molecular Events
  1753. APIGENIN Attenuates Acetaminophen-Induced Hepatotoxicity by Activating AMP-Activated Protein Kinase/Carnitine Palmitoyltransferase I Pathway
  1754. APIGENIN and Luteolin Regulate Autophagy by Targeting NRH-Quinone Oxidoreductase 2 in Liver Cells
  1755. Protective effect of APIGENIN on d-galactosamine/LPS-induced hepatocellular injury by increment of Nrf-2 nucleus translocation
  1756. Ethanol-assisted kneading of APIGENIN with arginine for enhanced dissolution rate of APIGENIN: development of rapidly disintegrating tablets
  1757. Improvement of Antioxidative Activity of APIGENIN by B12N12 Nanocluster: Antioxidative Mechanism Analysis
  1758. APIGENIN and Ampicillin as Combined Strategy to Treat Severe Streptococcus suis Infection
  1759. Incorporation of APIGENIN and tt-Farnesol into dental composites to modulate the Streptococcus mutans virulence
  1760. Optimization of Pre-Inoculum, Fermentation Process Parameters and Precursor Supplementation Conditions to Enhance APIGENIN Production by a Recombinant …
  1761. APIGENIN and ethaverine hydrochloride enhance retinal vascular barrier in vitro and in vivo
  1762. Effect of APIGENIN on surface-associated characteristics and adherence of Streptococcus mutans
  1763. APIGENIN and Hesperidin Downregulate DNA Repair Genes in MCF-7 Breast Cancer Cells and Augment Doxorubicin Toxicity
  1764. Data-Independent Acquisition-Based Quantitative Proteomic Analysis Reveals the Protective Effect of APIGENIN on Palmitate-Induced Lipotoxicity in Human Aortic …
  1765. APIGENIN effect against Leishmania tropica amastigotes in vitro
  1766. Protective effect of APIGENIN on ethylene glycol-induced urolithiasis via attenuating oxidative stress and inflammatory parameters in adult male Wistar rats
  1767. APIGENIN attenuated ethylene glycol induced urolithiasis in uninephrectomized hypertensive rats: A possible role of bikunin, BMP-2/4, and osteopontin
  1768. Protective effects of APIGENIN against edifenphos-induced genotoxicity and cytotoxicity in rat hepatocytes
  1769. APIGENIN Ameliorates Scopolamine-Induced Cognitive Dysfunction and Neuronal Damage in Mice
  1770. IV curves of an APIGENIN dye and their analysis by a new parabolic function
  1771. APIGENIN-loaded galactose tailored PLGA nanoparticles: A possible strategy for liver targeting to treat hepatocellular carcinoma
  1772. Comparative biotransformation of luteolin and APIGENIN from the flower extract and the stem‐and‐leaf extract of Dendranthema morifolium Ramat. Tzvel. in rats
  1773. Neuroprotective effect of APIGENIN against hypoxic-ischemic brain injury in neonatal rats via activation of the PI3K/Akt/Nrf2 signaling pathway
  1774. Differential effects of cisplatin combined with the flavonoid APIGENIN on HepG2, Hep3B, and Huh7 liver cancer cell lines
  1775. Luteolin and APIGENIN derived glycosides from Alphonsea elliptica abrogate LPS-induced inflammatory responses in human plasma
  1776. Prophylactic effect of myricetin and APIGENIN against lipopolysaccharide-induced acute liver injury
  1777. APIGENIN inhibits the growth of hepatocellular carcinoma cells by affecting the expression of microRNA transcriptome
  1778. APIGENIN Alleviates Liver Fibrosis by Inhibiting Hepatic Stellate Cell Activation and Autophagy via TGF-β1/Smad3 and p38/PPARα Pathways
  1779. APIGENIN protects against ischemia-/hypoxia-induced myocardial injury by mediating pyroptosis and apoptosis
  1780. Interaction between APIGENIN and sodium deoxycholate with raloxifene: A potential risk for clinical practice
  1781. APIGENIN acts as a partial agonist action at estrogen receptors in vivo
  1782. Chemopreventive Role of APIGENIN against the Synergistic Carcinogenesis of Human Papillomavirus and 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone
  1783. An In Vitro-In Vivo Evaluation of the Antiproliferative and Antiangiogenic Effect of Flavone APIGENIN against SK-MEL-24 Human Melanoma Cell Line
  1784. APIGENIN Improves Hypertension and Cardiac Hypertrophy Through Modulating NADPH Oxidase-Dependent ROS Generation and Cytokines in Hypothalamic …
  1785. APIGENIN, a Partial Antagonist of the Estrogen Receptor (ER), Inhibits ER-Positive Breast Cancer Cell Proliferation through Akt/FOXM1 Signaling
  1786. The effect of luteolin 7-glucoside, APIGENIN 7-glucoside and Succisa pratensis extracts on NF-κB activation and α-amylase activity in HepG2 cells
  1787. APIGENIN Attenuates Mesoporous Silica Nanoparticles-Induced Nephrotoxicity by Activating FOXO3a
  1788. Interaction of APIGENIN-7-O-glucoside with pyrimethamine against Toxoplasma gondii growth
  1789. APIGENIN Reverses Interleukin‐1β‐Induced Suppression of Adipocyte Browning via COX2/PGE2 Signaling Pathway in Human Adipocytes
  1790. Ecophysiological, anatomical, and APIGENIN changes due to uptake and accumulation of cadmium in Matricaria chamomilla L. flowers in hydroponics
  1791. APIGENIN alleviates methotrexate-induced liver and kidney injury in mice
  1792. Effects of APIGENIN and Astragalus Polysaccharide on the Cryopreservation of Bull Semen
  1793. APIGENIN ameliorates hyperuricemic nephropathy by inhibiting URAT1 and GLUT9 and relieving renal fibrosis via the Wnt/β-catenin pathway
  1794. APIGENIN ameliorates hepatic lipid accumulation by activating the autophagy-mitochondria pathway.
  1795. APIGENIN inhibits the growth of colorectal cancer through down-regulation of E2F1/3 by miRNA-215-5p
  1796. The potential protective role of APIGENIN against oxidative damage induced by nickel oxide nanoparticles in liver and kidney of male Wistar rat, Rattus norvegicus
  1797. β-Amyloid Formation, Memory, and Learning Decline Following Long-term Ovariectomy and Its Inhibition by Systemic Administration of APIGENIN and β-Estradiol
  1798. Combined effect of chrysin and APIGENIN on inhibiting the development and progression of colorectal cancer by suppressing the activity of P38‐MAPK/AKT pathway
  1799. Protective mechanism of APIGENIN in diabetic nephropathy is related to its regulation of miR-423-5P-USF2 axis
  1800. miR-34a-5p might have an important role for inducing apoptosis by down-regulation of SNAI1 in APIGENIN-treated lung cancer cells
  1801. Investigation of oxidant/antioxidant and anti‐inflammatory effects of APIGENIN on apoptosis in sepsis‐induced rat lung
  1802. APIGENIN/furfurylamine-based bio-polyamide derivative: Benzoxazine-isocyanide mechanochemistry preparation and application in Pb (II) electrochemical probing
  1803. Effects of APIGENIN on the Expression of LOX‐1, Bcl‐2, and Bax in Hyperlipidemia Rats
  1804. Inhibitory Effect of Acacetin, APIGENIN, Chrysin and Pinocembrin on Human Cytochrome P450 3A4.
  1805. Comparison of diclofenac with APIGENIN-glycosides rich Clinacanthus nutans extract for amending inflammation and catabolic protease regulations in …
  1806. Encapsulation and Characterization of Nanoemulsions Based on an Anti-oxidative Polymeric Amphiphile for Topical APIGENIN Delivery
  1807. APIGENIN Alleviates Oxidative Stress-Induced Cellular Senescence via Modulation of the SIRT1-NAD-CD38 Axis
  1808. APIGENIN attenuates myocardial infarction-induced cardiomyocyte injury by modulating Parkin-mediated mitochondrial autophagy
  1809. … and Antiproliferative Activity of the Ethanolic Extract of Equisetum myriochaetum and Molecular Docking of Its Main Metabolites (APIGENIN, Kaempferol, and Quercetin) …
  1810. Protective effect of myricetin, APIGENIN, and hesperidin pretreatments on cyclophosphamide-induced immunosuppression
  1811. Evaluation of cholinesterase inhibitory and antioxidant activity of Wedelia chinensis and isolation of APIGENIN as an active compound
  1812. Protection of APIGENIN against acrylonitrile-induced sperm and testis injury in rats: involvement of activation of ASK1-JNK/p38 signaling pathway
  1813. Synergistic effect of Betulinic acid, APIGENIN and Skimmianine (BASk) in high cholesterol diet rabbit: Involvement of CD36-TLR2 signaling pathway
  1814. APIGENIN Nanoparticle Attenuates Renal Ischemia/Reperfusion Inflammatory Injury by Regulation of miR-140-5p/CXCL12/NF-κB Signaling Pathway
  1815. APIGENIN exerts chemopreventive effects on lung injury induced by SiO2 nanoparticles through the activation of Nrf2
  1816. Flavones (APIGENIN, Luteolin, Chrysin) and Their Importance for Health
  1817. Experimental Study on the Influence of APIGENIN K and Melatonin in Socket Preservation as Bone Stimulators: An Experimental Study in Beagle Dogs
  1818. A single robust stability-indicating RP-HPLC analytical tool for APIGENIN quantification in bulk powder and in nanoliposomes: a novel approach
  1819. LC-MS/MS Determination of APIGENIN in Rat Plasma and Application to Pharmacokinetic Study
  1820. APIGENIN
  1821. APIGENIN prevents gamma radiation-induced gastrointestinal damages by modulating inflammatory and apoptotic signalling mediators
  1822. Tyrosinase and cholinesterase inhibitory activities and molecular docking studies on APIGENIN and vitexin.
  1823. A comparative study of APIGENIN content and antioxidant potential of Cosmos bipinnatus transgenic root culture
  1824. Investigating the in vitro photothermal effect of green synthesized APIGENIN‐coated gold nanoparticle on colorectal carcinoma
  1825. Development and validation of an LC-MS/MS method for the quantification of flavonoid glucuronides (wogonoside, baicalin, and APIGENIN-glucuronide) in the bile and …
  1826. APIGENIN suppresses proliferation, invasion, and epithelial–mesenchymal transition of cervical carcinoma cells by regulation of miR‐152/BRD4 axis
  1827. An in vitro evaluation of APIGENIN and APIGENIN-7-o-glucoside against hela human cervical cancer cell line
  1828. APIGENIN-7-Glucuronide from Urera aurantiaca Inhibits Tumor Necrosis Factor Alpha and Total Nitrite Release in Lipopolysaccharide-Activated Macrophages
  1829. Sulfation of hesperetin, naringenin and APIGENIN by the human cytosolic sulfotransferases: a comprehensive analysis
  1830. Comparative effects of quercetin, luteolin, APIGENIN and their related polyphenols on uric acid production in cultured hepatocytes and suppression of purine bodies …
  1831. APIGENIN causes necroptosis by inducing ROS accumulation, mitochondrial dysfunction, and ATP depletion in malignant mesothelioma cells
  1832. Co-administration of APIGENIN with doxorubicin enhances anti-migration and antiproliferative effects via PI3K/PTEN/AKT pathway in prostate cancer cells
  1833. Protective effects of APIGENIN against Bisphenol A-induced testis toxicity in Wistar rats through modulating hepatic biochemical biomarkers and histological changes
  1834. Novel Reverse-Phase High-Performance Liquid Chromatography (RPHPLC) Method for the Quantification of APIGENIN in Ocimum Basilicum Linn Seeds (Tukmaria)
  1835. Proteome responses of Rhizobium tropici CIAT 899 upon APIGENIN and salt stress induction
  1836. DEVELOPMENT AND VALIDATION OF HPLC METHOD FOR THE SIMULTANEOUS ESTIMATION OF APIGENIN AND LUTEOLIN IN COMMERCIAL …
  1837. APIGENIN restores endothelial function by ameliorating oxidative stress, prevents foam cell formation, reverses aortic stiffening, and mitigates vascular inflammation …
  1838. … Amyloid Formation, Memory, and Learning Decline Following Long-term Ovariectomy and Its Inhibition by Systemic Administration of APIGENIN and β-Estradiol
  1839. Qualitative and quantitative analyses of labiatenic acid, APIGENIN and buddleoside in Hyssopus officinalis by high-performance thin-layer chromatography
  1840. Evidence for 5‐HT1A receptor‐mediated antiallodynic and antihyperalgesic effects of APIGENIN in mice suffering from mononeuropathy
  1841. APIGENIN Ameliorates Insulin Resistance and Lipid Accumulation by Endoplasmic Reticulum Stress and SREBP-1c/SREBP-2 Pathway in Palmitate-Induced HepG2 …
  1842. H2O2-Scavenging Activity and Hyaluronidase Inhibition Scutellarein and APIGENIN in Ocimum basilicum Extract
  1843. APIGENIN neutralizes the inhibitory effect of inflammation on the osteogenic differentiation of human mesenchymal stem cells
  1844. Effects of APIGENIN, Luteolin, and Quercetin on the Natural Killer (NK-92) Cells Proliferation: A Potential Role as Immunomodulator
  1845. Oleanolic Acid, Ursolic Acid and APIGENIN from Ocimum basilicum as Potential Inhibitors of the SARS-CoV-2 Main Protease: A Molecular Docking Study
  1846. Identification of 3, 3′-O-dimethylellagic acid and APIGENIN as the main antiplasmodial constituents of Endodesmia calophylloides Benth and Hymenostegia …
  1847. Anticalculi activities of APIGENIN hot melt extrusion results with soluplus® and kollidon® va 64 polymers on wistar rats
  1848. Inhibition of CD38 by APIGENIN limits injury-induced osteoarthritis development and associated pain in mice
  1849. Efficacy of Combination Therapy with APIGENIN and Synovial Membrane-Derived Mesenchymal Stem Cells on Knee Joint Osteoarthritis in a Rat Model
  1850. APIGENIN Ameliorates Lead Acetate induced Hyperlipidemia, Hypothyroidism and Hypogonadism in Male Rats
  1851. Hypoglycemic Effects of APIGENIN from Morus Indica in Streptozotocin Induced Diabetic Rats
  1852. The Potential Role of APIGENIN in Diabetes Mellitus
  1853. Development and Validation of UV-Visible Spectrophotometric Method for Estimation of APIGENIN in Parsley Leaves Extract
  1854. Reactivation of maspin by plant flavone APIGENIN through inhibition of class I HDACs and increase in p53 transcriptional activity in prostate cancer cells
  1855. Effect of APIGENIN on H2O2-induced oxidative injury in human hepatocytes L02
  1856. FLAVONOID APIGENIN DARI EKSTRAK DAUN TUMBUHAN RUKAM (Flacourtia rukam) SERTA UJI AKTIVITAS ANTIOKSIDAN DAN ANTIBAKTERI
  1857. A Study on the Interaction Between Kaempferol, APIGENIN and 4-Hydroxybenzoic Acid in Xanthine Oxidase Inhibition
  1858. Study on Tissue Distribution of APIGENIN Nanosuspension in Mice
  1859. Study on RAD51 Gene Regulatory Mechanism of APIGENIN Affecting Cisplatin Sensitivity to NSCLC A 549 Cells
  1860. Effects of APIGENIN on the expression of antioxidant enzymes in Soleus and FDB muscle in animal model
  1861. Synthesis of Silver Nano particles Using Catechin and APIGENIN and Study their Anti-oxidant Effect on the Laboratory Rats
  1862. Corrigendum to” APIGENIN Prevents Deregulation in the Expression Pattern of Cell-Proliferative, Apoptotic, Inflammatory and Angiogenic Markers During 7, 12 …
  1863. Extraction of APIGENIN from Parsley by Combined Treatments of Subcritical Water Extraction (SWE) with Pulsed Electric Fields (PEF) and Intense Pulsed Light (IPL)
  1864. APIGENIN modulates immune checkpoint molecules in pancreatic cancer enhancing anti-tumor immunity
  1865. The protective and Antioxidant Effect of Catechin and APIGENIN on Some Biochemical Parameters in Blood Serum of Rats Exposed to Oxidative Stress Induced by …
  1866. APIGENIN Inhibits the Histamine-Induced Proliferation of Ovarian Cancer Cells by Downregulating ERα/ERβ Expression
  1867. Spatial memory and microglia activation in a mouse model of chronic neuroinflammation and the anti-inflammatory effects of APIGENIN
  1868. Synthesis of 7-O-alkyl or 7-O-acyl Derivatives of Naringenin and APIGENIN
  1869. Preparation of radioiodine-131 labeled APIGENIN anti cancer compound for bioactivity study

 

Share
0
INTERSTELLAR BLEND

Related posts

September 24, 2022

ECKLONIA CAVA


Read more
June 1, 2022

ELLAGIC ACID


Read more
June 1, 2022

CYANIDIN


Read more

Comments are closed.

© 2023 Betheme by Muffin group | All Rights Reserved | Powered by WordPress
    ✕

    Login

    Lost your password?

    Create an account?